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Abstract
In proton therapy, the delivery method named spot scanning, can provide a particu-
larly efficient treatment in terms of tumor coverage and healthy tissues protection. The
dosimetric benefits of proton therapy may be greatly degraded due to intra-fraction mo-
tions. Hence, the study of mitigation or adaptive methods is necessary. For this purpose,
we developed an open-source 4D dose computation and evaluation software, MSPT (Mo-
tion Simulator for Proton Therapy), for the spot-scanning delivery technique. It aims at
highlighting the impact of intra-fraction motions during a treatment delivery by comput-
ing the dose distribution in the moving patient. In addition, the use of MSPT allowed us
to develop and propose a new motion mitigation strategy based on the adjustment of the
beam’s weight when the proton beam is scanning across the tumor.
In photon therapy, a main concern for deliveries using a multileaf collimator (MLC)
relies on finding a series of MLC configurations to deliver properly the treatment. The
efficiency of such series is measured by the total beam-on time and the total setup time.
In our work, we study the minimization of these efficiency criteria from an algorithmic
point of view, for new variants of MLCs: the rotating MLC and the dual-layer MLC. In
addition, we propose an approximation algorithm to find a series of configurations that
minimizes the total beam-on time for the rotating MLC.
Keywords: Proton therapy, photon therapy, simulator, intra-fraction motions, mul-
tileaf collimator decomposition.
Re´sume´
En proton the´rapie, la technique de balayage, permet de traiter efficacement le pa-
tient vis a` vis de l’irradiation de la tumeur et la protection des tissus sains. Ces be´ne´fices
dosime´triques peuvent cependant eˆtre grandement de´grade´s par les mouvements intra-
fraction. Par conse´quent, l’e´tude de me´thodes d’atte´nuation ou d’adaptation est ne´cessaire.
C’est pour cela, que nous avons de´veloppe´ un logiciel ”open-source” de calcul et d’e´valuation
de dose en 4D, MSPT (Motion Simulator for Proton Therapy), pour la technique de ba-
layage. Son but est de mettre en avant l’impact des mouvements intra-fraction en calculant
la re´partition de dose dans le patient. En outre, l’utilisation de MSPT nous a permis de
mettre au point et de proposer une nouvelle me´thode d’atte´nuation du mouvement base´e
sur l’ajustement du poids du faisceau quand celui-ci balaye la tumeur.
En photon the´rapie, un enjeu principal pour les traitements de´livre´s a` l’aide de col-
limateurs multilames (MLC) consiste a` trouver un ensemble de configurations du MLC
permettant d’irradier correctement la tumeur. L’efficacite´ d’un tel ensemble se mesure par
le total beam-on time et le total setup time. Dans notre e´tude, nous nous inte´ressons a`
la minimisation de ces crite`res, d’un point de vue algorithmique, pour de nouvelles tech-
nologies de MLC : le MLC rotatif et le MLC a` double couche. De plus, nous proposons
un algorithme d’approximation pour trouver un ensemble de configurations minimisant
le total beam-on time pour le MLC rotatif.
Mots cle´s : Proton the´rapie, photon the´rapie, simulateur, mouvements intra-fraction,
de´composition de collimateurs multilames.
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La radiation the´rapie est un des traitements contre le cancer le plus utilise´. Ce type de
traitement peut eˆtre de´livre´ de diffe´rentes fac¸ons. Dans cette the`se nous nous inte´ressons a`
une technique couramment utilise´e appele´e la photon the´rapie ainsi qu’a` la proton the´rapie
qui reste peu utilise´e mais qui suscite de plus en plus d’inte´reˆt.
En proton the´rapie nous nous sommes inte´resse´s au proble`me du mouvement des
patients pendant le traitement. Pour cela, nous avons de´veloppe´ un logiciel visant a` re-
produire un traitement de proton the´rapie de´livre´ a` un patient mobile. L’inte´reˆt de ce
simulateur est de rendre compte de l’impact du mouvement sur le traitement. D’autre
part, il peut eˆtre utilise´ pour mettre au point des strate´gies ayant pour but de re´duire
l’impact de mouvement.
En marge de ce travail, nous nous sommes inte´resse´s a` des proble`mes algorithmiques
rencontre´s en photon the´rapie.
Dans une premie`re partie nous introduirons le domaine de la radiation the´rapie et plus
pre´cise´ment : la photon the´rapie et la proton the´rapie. Nous introduirons e´galement des
proble`mes rencontre´s dans ces deux techniques. Dans une seconde partie nous pre´senterons
un logiciel de´veloppe´ pour faciliter l’e´tude du mouvement en proton the´rapie. Enfin nous
exposerons les re´sultats de l’e´tude algorithmique re´alise´e en photon the´rapie.
vi
Chapitre 1
Radiation the´rapie
1.1 Pre´sentation de la radiation the´rapie
La radiation the´rapie est un traitement me´dical visant a` de´truire des cellules cance´reuses
a` l’aide de radiations ionisantes. Ce traitement est apparu en 1896, peu de temps apre`s
la de´couverte des rayons X par le Dr. Roentgen (1895). Au fil du temps, cette technique
a e´volue´ pour donner naissance a` diffe´rents proce´de´s de radiation the´rapie utilise´s de nos
jours : la curiethe´rapie, la photon the´rapie et la proton the´rapie. La curiethe´rapie, ap-
partenant a` la radiation the´rapie interne, consiste a` inse´rer une source radioactive dans
le patient afin de traiter la tumeur en plac¸ant cette source dans la tumeur ou a` proxi-
mite´ de cette dernie`re. La photon the´rapie, appartenant a` la radiation the´rapie externe
(voir Figure 1.1), utilise un rayon a` base de photons, dont l’e´nergie est supe´rieure a` 100
keV, et dont la source, situe´e a` l’exte´rieur du patient, est oriente´e vers la tumeur. La
proton the´rapie, appartenant e´galement a` la radiation the´rapie externe, utilise un rayon
de protons, dont l’e´nergie est situe´e entre 30 et 230 MeV. Son principe est similaire a`
celui de la photon the´rapie pour traiter un patient. Dans le cadre de cette the`se nous nous
inte´resserons a` la photon the´rapie et a` la proton the´rapie.
Figure 1.1 – Illustration de la radiation the´rapie externe : le faisceau de radiations
ionisantes est externe au patient et peut tourner autour de ce dernier.
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1.2 Comparaison entre la photon et la proton the´rapie
De nos jours, la photon the´rapie est un des traitements les plus utilise´s pour traiter
les cancers. La proton the´rapie suscite de plus en plus d’inte´reˆt de par le monde en raison
des be´ne´fices que cette technique apporte aux patients par rapport a` la photon the´rapie.
En effet, la diffe´rence majeure entre ces deux techniques est la quantite´ d’e´nergie de´pose´e
dans le corps du patient, appele´e dose et mesure´e en Gray (Gy), ainsi que sa re´partition.
Il est ne´cessaire de savoir que lors d’un traitement, on cherche a` de´poser une dose tre`s im-
portante au niveau de la tumeur, afin de tuer les cellules cance´reuses, et de limiter autant
que possible la dose rec¸ue par les tissus sains dont les organes particulie`rement sensibles
aux radiations appele´s organes a` risque (OAR). Limiter la dose rec¸ue par les cellules
saines est important afin de ne pas risquer de les tuer ou d’engendrer une de´ge´ne´rescence
de ces cellules qui pourrait conduire a` des tumeurs dites secondaires dont l’apparition
peut se produire a` la suite d’un traitement a` base de radiations. En photon the´rapie le
maximum de dose est de´pose´ rapidement apre`s la pe´ne´tration du rayon dans le patient,
et la dose de´pose´e de´croˆıt progressivement sans devenir nulle en traversant le corps du
patient. En proton the´rapie, le maximum de dose est de´pose´ a` une certaine profondeur,
appele´e profondeur du pic de Bragg (Bragg Peak) de´pendant de l’e´nergie des protons. En
aval de cette profondeur la dose de´pose´e devient nulle. En amont de cette profondeur,
la dose de´pose´e est relativement faible. Si le rayon de protons contient des protons de
diffe´rentes e´nergies (rayon poly-e´nerge´tique), il est possible d’observer plusieurs pics de
Bragg, qui permettent de de´poser une forte dose dans une e´paisseur de tissus de´finie,
appele´e la re´gion cible. La Figure 1.2, pre´sente un sche´ma de la dose de´pose´e par des
photons et des protons en fonction de la profondeur dans un certain milieu. La Figure
1.3, pre´sente la dose rec¸ue par un patient par des rayons de photons et de protons.
Figure 1.2 – Profils de dose pour des photons et des protons.
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Figure 1.3 – Comparaison de la dose de´pose´e dans un patient pour des photons (haut)
et des protons (bas). [Kirsch and Tarbell, 2004]
Comme il est possible de le constater, l’utilisation de protons re´duit conside´rablement
la dose rec¸ue par le patient. Malgre´ cela, la proton the´rapie n’est pas encore tre`s utilise´e
dans le monde. En effet, en Aouˆt 2013, seulement 43 centres de proton the´rapie e´taient
recense´s dans le monde, ce qui correspond a` 122 salles de traitement. Cela repre´sente
0.9% des centres de photon the´rapie [Goethals and Zimmermann, 2013]. Le principal
facteur limitant le de´veloppement de la proton the´rapie est le couˆt : environ 95 millions
d’euros (≈ $130 millions) pour un centre de proton the´rapie et environ 23 millions d’euros
(≈ $30 millions) pour un centre de photon the´rapie. De plus, le traitement d’un patient
ne´cessite plusieurs se´ances d’irradiation, appele´es fractions, dont le couˆt est d’environ 740
euros (≈ $1000) pour la proton the´rapie et d’environ 230 euros (≈ $300) pour la photon
the´rapie [Peeters et al., 2010]. Petit a` petit les entreprises de proton the´rapie ame´liorent
les technologies pour les rendre moins one´reuses. Il est estime´ que d’ici 2030 le nombre de
salles de traitement atteindra 1000 [Goethals and Zimmermann, 2013].
1.3 Des challenges en radiation the´rapie
La photon the´rapie est de´livre´e a` l’aide d’un large faisceau de photons tournant autour
du patient et auquel une forme est donne´e afin de correspondre aux contours de la tumeur,
a` la dose minimale que doit recevoir la tumeur et la dose maximale qui ne doit pas eˆtre
de´passe´e pour les OARs. Cette conformation, en 2 dimensions, est accomplie a` l’aide d’un
collimateur multilames (MLC). Un MLC est compose´ de paires de lames paralle`les pouvant
bloquer ou laisser passer le faisceau (voir Figure 1.4). La planification du traitement
consiste a` de´finir une grille en 2 dimensions de la dose qui doit eˆtre de´livre´e localement au
patient pour chaque angle du faisceau. Cette grille, appele´e plan d’intensite´, est re´alise´e par
une se´quence de configurations du MLC. Bien que la qualite´ d’un plan de traitement soit
juge´e par des parame`tres dosime´triques, deux crite`res permettent d’e´valuer son efficacite´.
Le premier crite`re, appele´ total beam-on time, correspond a` la dure´e totale de l’irradiation
du patient. Il est e´gal a` la somme de la dure´e de chaque configuration du MLC. Le
second crite`re, appele´ total setup time, repre´sente le temps ne´cessaire pour positionner les
lames du MLC pour l’ensemble des configurations. Il est approximativement proportionnel
au nombre de configurations. L’enjeu est de minimiser ces deux crite`res afin d’avoir un
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plan efficace et de s’assurer que le patient ne rec¸oit pas des radiations superflues ou un
traitement prolonge´ inutilement.
(a) Vue d’un Multileaf
Collimator (MLC) dans le
syste`me utilise´ pour de´livrer
le traitement. (b) Une configuration de MLC
Figure 1.4 – Exemples de MLCs
Un traitement de proton the´rapie peut eˆtre de´livre´ principalement de deux fac¸ons :
la technique de diffusion ou la technique de balayage. La technique de diffusion est si-
milaire au proce´de´ utilise´ pour la photon the´rapie, c’est a` dire qu’un large faisceau est
conforme´ pour correspondre a` la forme de la tumeur. Cette technique, tre`s employe´e de
nos jours, commence a` laisser place a` la technique de balayage qui permet une meilleure
pre´cision pour irradier la tumeur et limiter les radiations inutiles rec¸ues par le patient. Ce
proce´de´ emploie un faisceau mono-e´nerge´tique de protons tre`s fin (de l’ordre des quelques
millime`tres) qui est balaye´ sur l’ensemble de la tumeur. Le changement d’e´nergie des pro-
tons, au cours du traitement, permet de modifier la profondeur ou` a lieu le balayage dans
le patient en raison du pic de Bragg (voir Figure 1.5). Cette seconde me´thode, bien que
tre`s pre´cise, est tre`s sensible aux mouvements du patient pendant l’irradiation. Ces mou-
vements, qualifie´s d’intra-fraction, peuvent eˆtre d’origines diffe´rentes comme par exemple :
respiration, battements du cœur, toux, gaz intestinaux, ou le hoquet. Ces mouvements,
peuvent entraˆıner de fortes de´gradations de la dose rec¸ue par le patient. La Figure 1.6
pre´sente un exemple d’irradiation avec et sans mouvement.
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Figure 1.5 – Illustration de la technique de balayage. Pour chaque e´nergie du faisceau de
protons de´finie dans le plan de traitement correspond une position du pic de Bragg (courbe
bleue). Une couche d’e´nergie correspond a` l’ensemble des points situe´s a` la profondeur du
pic de Bragg. La position du faisceau est controˆle´e par un jeu d’aimants. A une e´nergie
et une position de faisceau correspond un poids qui repre´sente la dure´e pendant laquelle
l’irradiation de ce faisceau est maintenue.
Figure 1.6 – Re´sultat de l’irradiation d’une plaque radiographique avec (droite) et sans
(gauche) mouvements. [Paganetti et al., 2012]
Dans le cadre de cette the`se nous aborderons le proble`me de minimisation des crite`res
d’efficacite´ rencontre´s en photon the´rapie et le proble`me de mouvements intra-fraction en
proton the´rapie.
xi
Chapitre 2
MSPT : Un simulateur de
mouvement pour la proton the´rapie
2.1 De´veloppement d’un outil pour l’e´tude des mou-
vements intra-fraction.
Afin d’e´tudier le proble`me de mouvements intra-fraction en proton the´rapie nous avons
de´veloppe´ un logiciel, appele´ MSPT (”Motion Simulator for Proton Therapy”). Ce simu-
lateur est ”open source” et distribue´ sous la licence GNU GPL (v3). Le code source, la
documentation et le manuel utilisateur peuvent eˆtre obtenus a` http://code.google.
com/p/mspt/.
Le but principal de cet outil est de rendre compte de la re´partition de dose dans
le patient lors de mouvements intra-fraction pour un plan de traitement et un certain
mouvement. Le second inte´reˆt de MSPT est de fournir a` l’utilisateur des informations per-
mettant de comparer diffe´rents plans de traitement afin de pouvoir ame´liorer la robustesse
du traitement pour ce patient vis a` vis des mouvements intra-fraction. Une technique de
compensation de mouvement est e´galement mise en œuvre dans MSPT, afin de proposer
une strate´gie visant a` ame´liorer la robustesse des traitements en pre´sence de mouvements
intra-fraction.
Ce simulateur a e´te´ de´veloppe´ en Python 2.7 et utilise des sous-routines en C pour
ame´liorer la vitesse de traitement de certaines ope´rations. Il rec¸oit en entre´e l’image CT
(Computed Tomography) du patient, le plan de traitement (e´nergies des protons, posi-
tions du faisceau pour le balayage et le poids de chaque position qui est e´quivalent a` une
dure´e), le contour des structures du patient (de´limitation du corps du patient, d’organes
et de la tumeur - voir Figure 2.1) et optionnellement la re´partition de dose simule´e dans
un logiciel de planification de traitement. Toutes ces entre´es utilisent le standard DICOM
(Digital Imaging and Communication in Medicine). En outre l’utilisateur fournit un fichier
de parame´trage du simulateur qui de´finit son comportement ainsi que les mouvements du
patient. MSPT fournit a` la fin de la simulation un ensemble de donne´es permettant d’e´valuer
la qualite´ du traitement aussi bien visuellement que quantitativement (voir exemple dans
la Figure 2.2).
xii
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Figure 2.1 – Exemple d’une image CT et de la repre´sentation de diffe´rentes structures du
patient : poumons (orange), re´gion cible comprenant la tumeur (rouge), moelle e´pinie`re
(bleu) et des os de la colonne verte´brale (vert).
Figure 2.2 – Exemple d’une image CT et de la repre´sentation de la re´partition de dose
simule´e dans MSPT.
2.2 Mode´lisation
Le patient est repre´sente´ par des matrices 3D obtenues a` l’aide du CT. Plusieurs
matrices sont utilise´es pour repre´senter la densite´ des tissus, leur pouvoir d’arreˆt, la pro-
fondeur radiologique ainsi que le dose de´pose´e. Pour calculer la dose de´pose´e nous utilisons
le mode`le analytique propose´ par Hong et al. [1996]. Ce mode`le repose sur un calcul dans
l’eau mis a` l’e´chelle pour correspondre a` d’autres milieux. Nous avons duˆ ajouter a` ce
mode`le un facteur de correction de dose de´pendant de l’e´nergie et un facteur de correc-
tion de pouvoir d’arreˆt de´pendant de la densite´ afin de pouvoir faire correspondre la dose
calcule´e dans MSPT a` celle obtenue par un autre logiciel utilise´ comme re´fe´rence dans notre
xiii
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e´tude.
Le traitement est simule´ suivant le plan de traitement fourni par l’utilisateur. Ce plan
de traitement de´finit les angles du faisceau, autour du patient, utilise´s pour l’irradiation.
Pour chaque angle du traitement, MSPT utilise les e´nergies, les positions du faisceau et leur
poids. Afin de correspondre aux informations spatiales du plan nous utilisons les syste`mes
de coordonne´es associe´s a` l’image CT et au plan de traitement (syste`mes de coordonne´es
IEC fixed et IEC gantry). Afin de repre´senter l’e´volution de la re´partition de dose dans
le patient en fonction du temps, chaque poids est divise´ en dure´es unitaires pendant les-
quelles le patient est conside´re´ comme statique. Par exemple, si le poids correspond a` une
dure´e de 10 ms et que la dure´e unitaire est de 1 ms, le poids est divise´ en 10 dure´es uni-
taires. Au de´but de chaque dure´e unitaire la position du patient ainsi que sa mode´lisation
sont mises a` jour afin de calculer la dose rec¸ue pendant la dure´e unitaire.
Les mouvements sont simule´s a` l’aide d’une transformation rigide du corps du patient.
Ils sont de´finis par des fonctions de´pendant du temps. Dans le cadre de notre travail nous
avons utilise´ un mode`le de respiration [Lujan et al., 1999] base´ sur une fonction cosinus.
Nous avons ajoute´ la possibilite´ de faire varier ale´atoirement l’amplitude et la pe´riode de
la respiration en utilisant des variables ale´atoires configurables par l’utilisateur.
2.3 Evaluation du simulateur
Afin d’e´valuer le calcul de dose effectue´ par MSPT, nous avons compare´ la dose simule´e
par notre simulateur, a` celle calcule´e par le mode`le ProtonMachine d’un logiciel commer-
cial de planification de traitement : RayStation (RaySearch Laboratories). Nous avons
tout d’abord effectue´ des simulations de faisceaux mono-e´nerge´tiques dans un volume
d’eau pour diffe´rentes e´nergies entre 30 MeV et 230 MeV. Ces simulations ont montre´ une
tre`s bonne concordance entre MSPT et ProtonMachine (voir Figure 2.3).
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Figure 2.3 – Graphiques repre´sentant la dose en fonction de la profondeur (gauche) et le
profil late´ral (droite) de la re´partition de dose d’un faisceau de protons de 210MeV dans
l’eau avec ProtonMachine (vert) et MSPT (rouge).
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Nous avons ensuite e´value´ le calcul de dose sur des cas de patients. Les re´sultats ont
montre´ une bonne cohe´rence (voir Figure 2.4) malgre´ l’apparition d’artefacts syste´miques
dans les diffe´rents cas utilise´s. Ces artefacts situe´s sur l’extre´mite´ distale de la tumeur
pre´sentent une re´gion de sur-dose (points chauds), le long du contour de la tumeur et
une re´gion sous-dose´e (points froids) apre`s la tumeur (voir Figure 2.5). La cause de cet
artefact n’a pas pu eˆtre mise en e´vidence mais pourrait venir de diffe´rences dans le calcul
de la profondeur radiologique ProtonMachine et MSPT.
(a) (b)
Figure 2.4 – Distribution de dose simule´e pour un patient dans ProtonMachine (2.4a)
et dans MSPT (2.4b).
Points froids
Points chauds
Figure 2.5 – Points chauds et points froids (respectivement situe´s par les rectangles
rouge et bleu).
Nous avons enfin utilise´ le simulateur pour rendre compte de la de´gradation de la dose
rec¸ue par le patient lors de mouvements intra-fraction (voir Figure 2.6). Cette de´gradation
se traduit par une irradiation re´duite de la re´gion de la tumeur, une irradiation accentue´e
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dans les OARs et l’apparition de points chauds et de points froids.
(a) (b)
Figure 2.6 – Distributions de dose calcule´es pour un patient statique (2.6a) et un patient
mobile (2.6b) dans MSPT.
2.4 Compensation du mouvement
Enfin, nous proposons une nouvelle approche de compensation de mouvement base´e
sur l’adaptation du poids de chaque faisceau en fonction du mouvement et sur la posibilite´
de balayer plusieurs fois un meˆme position pour une e´nergie donne´e. Le travail effectue´
correspond a` une e´tude pre´liminaire de cette strate´gie afin de mettre en avant les inte´reˆts
et les limites.
Conside´rons un plan de traitement pour lequel les positions du faisceau de protons
d’e´nergie En sont repre´sente´es par les couples (bi, wi) ordonne´s suivant l’indice i. bi cor-
respond aux coordonne´es de la position du faisceau et wi son poids. Ce plan de traitement
engendre l’irradiation de l’ensemble des (Pi), correspondant aux points cibles des positions
(bi, wi) (la position (bk, wk) irradie le point (Pk) pour un patient statique) du faisceau,
situe´s dans le patient sur la couche d’e´nergie associe´e a` En (ensemble des points situe´s
a` la distance dBP de la source du faisceau, ou` dBP correspond a` la profondeur du pic de
Bragg).On conside`re que (Pi) est irradie´ par le faisceau (t = i, w = wi) ou` t correspond a`
la date d’irradiation de´finie par l’ordre des positions du faisceau et w correspond au poids
du faisceau. La strate´gie de compensation consiste a` changer w de telle sorte qu’a` t = i,
w soit fixe´ a` wk afin d’irradier le point (Pk) le point cible du faisceau a` t = i en raison du
mouvement de´fini par le vecteur v(t) situe´ dans le plan perpendiculaire au faisceau. La
Figure 2.7 illustre ce principe.
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Figure 2.7 – Illustration du traitement, pour un patient mobile, utilisant la technique
de compensation. Les positions du faisceau sont repre´sente´es en vert, le faisceau en rouge,
les points cibles en bleu et le vecteur de de´placement du patient (2D) en orange.
L’e´valuation de cette me´thode nous a permis de montrer qu’elle re´duit fortement l’im-
pact du mouvement sur la re´partition de dose dans le patient. Les erreurs de re´partition
de dose obtenues, par rapport a` la re´partition dans un patient statique, sont tre`s faibles
(infe´rieures a` 5%) et le crite`re indiquant que 95% du volume de la tumeur rec¸oit au moins
95% de la dose prescrite est rempli. Par conse´quent, les erreurs peuvent eˆtre conside´re´es
comme cliniquement acceptables. La Figure 2.8 correspond aux courbes repre´sentant le
volume relatif de la tumeur et d’OARs, recevant au moins une certaine dose, appele´es
DVHs (Dose Volume Histogram). Ces DVHs sont obtenus pour un patient statique et
un patient mobile avec et sans la technique de compensation. Les distributions de dose
correspondantes sont repre´sente´es avec une image CT dans la Figure 2.9. Notre strate´gie
permet pour le moment de compenser seulement des mouvements 2D perpendiculaires
au faisceau. Un de´veloppement en 3D pourrait donc faire partie de futurs travaux de
recherches et d’ame´liorations. De plus, les mouvements simule´s n’e´tant base´s que sur une
transformation rigide du corps du patient, une future e´tude pourrait porter sur la com-
pensation des mouvements pre´sente´e pour des transformations de´formables.
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Figure 2.8 – Comparaison des DVHs pour un traitement de´livre´ a` un patient statique
(Test 1) et a` un patient mobile avec (Test 5) et sans (Test 3) compensation pour un
mouvement de 1.5 cm d’amplitude. Les structures du patient conside´re´es sont la tumeur
(PTV), le poumon droit (Right Lung) et la moelle e´pinie`re (Spinal Cord).
(a)
(b) (c)
Figure 2.9 – Distributions de dose pour un patient statique (2.9a) et un patient mobile
sans (2.9b) et avec (2.9c) compensation.
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Chapitre 3
Quelques re´sultats en photon
the´rapie
3.1 Aspects algorithmiques de la photon the´rapie
Comme mentionne´ pre´ce´demment (Section 1.3), en photon the´rapie la planification
d’un traitement ge´ne`re des plans d’intensite´ correspondant a` des grilles en 2 dimensions.
Par conse´quent, chaque grille peut eˆtre repre´sente´e comme une matrice 2D, appele´e ma-
trice d’intensite´. Le proble`me demandant de trouver pour un plan d’intensite´ l’ensemble
des configurations permettant de re´aliser ce plan peut alors eˆtre conside´re´ comme un
proble`me de de´composition de matrice en matrices binaires. Dans ces matrices binaires,
les 0 correspondent aux re´gions ou` le MLC bloque le faisceau de photons, et les 1 aux
re´gions ou` il irradie le patient. Les proble`mes de minimisation des crite`res total beam-on
time et total setup time peuvent alors correspondre, respectivement, a` des contraintes de
minimisation du nombre de matrices binaires et de minimisation de la somme des coeffi-
cient des matrices binaires. Ces coefficients sont appele´s poids.
3.2 Pre´ce´dents re´sultats algorithmiques
De pre´ce´dents travaux sur le MLC conventionnel ont montre´ que le proble`me de mini-
misation du total beam-on time peut eˆtre re´solu en temps line´aire [Ahuja and Hamacher,
2005].
Burkard [2002] a prouve´ que le proble`me de minimisation du total setup time est NP-
Difficile pour les matrices d’intensite´ ayant au moins 2 lignes. Ce re´sultat a e´te´ renforce´
par Baatar et al. [2005] qui ont montre´ que ce proble`me reste NP-Difficile meˆme pour les
matrices a` 1 ligne.
xix
MSPT: Motion Simulator for Proton Therapy
3.3 Re´sultats algorithmiques pour de nouveaux MLCs
Dans le cadre de ce travail nous nous sommes inte´resse´s a` deux nouvelles technolo-
gies de MLC : le MLC rotatif, dans lequel des rotations de 90◦ sont autorise´es entre 2
configurations et le MLC double couche, correspondant a` deux couches de paires de lames
perpendiculaires entre elles (voir Figure 3.1).
Figure 3.1 – Sche´mas d’un MLC rotatif (gauche) et d’un MLC a` double couche (droite).
Dans une premie`re partie de l’e´tude nous avons de´montre´ que le proble`me de de´composition
dans le cas d’un MLC a` double couche est NP-Difficile lorsque l’on cherche a` minimiser le
crite`re total setup time. Ensuite, nous avons de´montre´ que le proble`me de de´composition
dans le cas d’un MLC rotatif est e´galement NP-Difficile lorsque l’on cherche a` minimiser les
crite`res total setup time et beam on time. De plus, nous proposons un algorithme d’approxi-
mation en temps polynomial permettant de fournir une solution entie`re au proble`me de
de´composition pour un MLC rotatif minimisant le beam on time. Cet algorithme consiste
a` chercher dans un premier temps une solution optimale continue ou` les poids des matrices
sont des valeurs re´elles positives (la contrainte de valeurs entie`res est relaxe´e). Les poids
des configurations horizontales sont ensuite arrondis afin d’avoir une solution entie`re pour
ces configurations. La soustraction de cette solution horizontale a` la matrice d’intensite´
initiale correspond a` la matrice d’intensite´ a` de´composer en utilisant des configurations
verticales du MLC. Cette de´composition utilisant des valeurs entie`res est re´alisable en
temps line´aire ([Ahuja and Hamacher, 2005]). La solution entie`re verticale nous permet
ainsi d’obtenir une solution entie`re, pour le proble`me de de´composition utilisant un MLC
rotatif, garantissant une bonne approximation qui est au plus a` 2m de la solution optimale
continue ou` m correspond au nombre de paires de lames du MLC.
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Chapitre 4
Conclusion
Au cours de cette the`se, nous nous sommes inte´resse´s au domaine de la radiation
the´rapie. Nous avons principalement travaille´ au de´veloppement d’un simulateur de mou-
vement pour la proton the´rapie utilisant la technique de balayage. Le but de ce simu-
lateur est de fournir un outil permettant de rendre compte de l’impact de mouvements
intra-fraction sur le traitement rec¸u par le patient. Un inte´reˆt de ce simulateur est de
pouvoir comparer des plans de traitement afin de trouver celui qui est le plus robuste a`
ces mouvements. De plus, il permet d’e´tudier des me´thodes de re´duction de l’impact du
mouvement comme celle que nous proposons afin d’ame´liorer la qualite´ des traitements
et de les rendre moins sensibles aux mouvements intra-fraction. Enfin, nous nous sommes
inte´resse´s au proble`me de configurations des MLCs pour de nouvelles technologies base´es
sur une double couche de MLCs et un MLC rotatif. Nous avons montre´ que trouver une
se´quence de configurations, pour ces deux types de MLCs, minimisant le total beam on
time et/ou le total setup time est NP-Difficile. Cependant nous proposons un algorithme
d’approximation pour re´soudre le proble`me de minimisation du total beam on time dans
le cas d’un MLC rotatif.
Ces diffe´rents travaux nous ont permis d’une part de rendre accessible un logiciel amene´
a` e´voluer pour permettre d’autres e´tudes visant a` ame´liorer la qualite´ des traitements de
proton the´rapie en cas de mouvements intra-fraction. D’autre part ils ont permis d’e´tudier
une nouvelle approche pour compenser ces mouvements et ainsi rendre les traitements
plus robustes. Enfin, l’e´tude du se´quenc¸age de nouveaux types de MLCs nous a permis de
mettre en avant aussi bien les proble`mes algorithmiques qu’ils soule`vent pour de futures
recherches, que l’inte´reˆt de leur utilisation.
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Glossary
Glossary
CT Number
CT Number is a value assigned to a voxel in a CT image. This value is based on
the Hounsfield Unit. CT numbers for air, water and compact bone are respectively
-1000HU, 0HU, and +1000HU.
Gray
Unit representing the absorbed dose by a medium for ionizing radiation. One gray
is the absorption of one joule of energy, per kilogram of matter:
1Gy = 1 J
kg
.
Hounsfield Unit
Unit to scale the linear attenuation coefficient of a medium compared to the linear
attenuation coefficient of water:
HU = 1000 × µX−µWater
µWater
, where µX is the linear attenuation coefficient (m
−1) of
the medium X, depending on the atomic number, the mass density and the photon
energy.
Mega-electron Volt
1 MeV is equal to 1.60217657 × 10−13 Joules. It corresponds to the energy gained
or lost by the charge of 106 electrons moving across an electric potential difference
of 1 Volt.
Stereotactic Body Radiation Therapy
Stereotactic Body Radiation Therapy is a treatment procedure involving high dose
fractions.
Computed Tomography
Computed tomography is an anatomical imaging technique using X-rays (photons)
that allows the acquisition of a 3D image of a patient. It provides especially a good
rendering of dense tissues such as bones.
Dose-Volume Histogram
A dose-volume histogram is a 2D plot representing the percentage of volume receiv-
ing a certain amount of dose.
Magnetic Resonance Imaging
Magnetic Resonance Imaging is an anatomical imaging technique using variable
magnetic fields that allows the acquisition of a 3D image of a patient. It provides
especially a good rendering of soft tissues such as ligaments.
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Positron Emission Tomography
Positron Emission Tomography is a functional imaging technique using the detec-
tion of pairs of gamma-rays produced indirectly by a positron-emitting radioisotope
injected in the patient bloodstream. This technique allows a 3D acquisition of the
biological activity of a patient.
Single Photon Emission Computed Tomography
Single Photon Emission Computed Tomography is a functional imaging technique
using gamma rays obtained by injecting a radioisotope in the patient bloodstream.
This technique allows a 3D acquisition of the biological activity of a patient.
Treatment Planning System
Software used to plan and optimize a treatment plan.
Radiological Depth
The radiological depth at point P in a medium is the thickness of water having the
same effect on the particle energy as the thickness from the beam’s entrance into
the medium to a given point P .
Let’s consider a beam of energy E1 entering into a patient body. At point P located at
a depth DM , the beam’s energy drops to E0. In water, a beam entering with the energy
E1, will loose some energy and reach E0 at depth DW . Hence, the radiological depth at
P is DW .
Voxel
Volume element representing the resolution of a 3D matrix.
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Acronyms
2D 2-dimensions.
3D 3-dimensions.
4D 4-dimensions.
CFRT Conformal Radiation Therapy.
CT Computed Tomography.
CT# CT Number.
CTV Clinical Target Volume.
DICOM Digital Imaging and Communications in
Medicine.
DVH Dose Volume Histogram.
GTV Gross Tumor Volume.
Gy Gray.
HU Hounsfield Unit.
IEC International Electrotechnical Commission.
IMRT Intensity Modulated Radiation Therapy.
linac Linear Accelerator.
MeV Mega-electron Volt.
MLC Multileaf Collimator.
MRI Magnetic Resonance Imaging.
MU Monitor Units.
OAR Organ At Risk.
PET Positron Emission Tomography.
PRV Planning organ at Risk Volume.
PTV Planning Target Volume.
SBRT Stereotactic Body Radiation Therapy.
SPECT Single Photon Emission Computed Tomogra-
phy.
TPS Treatment Planning System.
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Radiation therapy is one of the most common cancer treatments. It uses ionizing
radiation to kill cells within a tumor. A treatment aims at irradiating with high dose
the tumor and at protecting the so-called organs at risk (OARs), which correspond to
healthy tissues sensitive to radiation. A treatment can be delivered using different types
of radiation: photon-based radiation in the so-called photon therapy, and proton-based
radiation in the so-called proton therapy. Photon therapy is much more used than proton
therapy. Indeed, as of August 2013, the number of proton therapy centers represents
1% of the photon therapy centers [Goethals and Zimmermann, 2013]. The main reason
for this difference is the cost of such medical centers. However, proton therapy arouses
more and more interests due to its advantages in providing an accurate irradiation of
the tumor combined with a good sparing of healthy tissues and organs at risk. It was
shown that protons are preferable to photons, in particular, when it comes to treat tumors
close to dose-sensitive anatomical structures such as in head-and-neck treatments [Chan
and Liebsch, 2008], prostate cancer [Lee et al., 1994] or when it is essential to reduce
toxicity to healthy tissues such as in pediatric patients [Fuss et al., 1999], [Clair et al.,
2004]. Moreover, it was shown that protons allow a greater tumor control probability and
a smaller normal tissue complications probability than photons [Fuss et al., 1999], [Fuss
et al., 2000], [Lin et al., 2000]. This is one of the reasons why more and more studies
focus on this type of radiation therapy both on the clinical and the physical sides.
In proton therapy, mainly two techniques can be used: the scattering and the spot
scanning. However, we focused on the spot scanning delivery strategy. It consists of a
thin proton beam scanned across the tumor volume. It provides a good conformity to
complex tumor shapes, which reduces toxicity to healthy tissues. However, this accuracy
is greatly degraded when the patient moves during the treatment, which is unavoidable
since the patient is alive and the lungs and other organs (e.g., the heart) are constantly
in motion. Such motions are called intra-fraction motions. The problem of intra-fraction
motion has some impact on the overall treatment. The improvement of the treatment’s ro-
bustness to motion requires the capacity of dose computation on dynamic patient dataset
(i.e., a 4-dimensions (4D) treatment planning). Studies are often conducted with the
researcher’s in-house treatment planning system or an expensive clinical treatment plan-
ning system. The limited availability of 4D treatment planning system makes it difficult
to study this subject by a broader category of researchers. This is why we developed
an open-source 4D dose computation and evaluation software, MSPT (Motion Simulator
for Proton Therapy). The main interest of this simulator lies in the ability to render
the impact of a predicted patient motion on a prescribed treatment plan. This capa-
bility makes it an innovative research tool to evaluate and compare different methods
of motion management or mitigation. While the main objective of MSPT is to quantify
the treatment degradation induced by particular motions, it can also be used to elaborate
some compensation methods to improve treatment robustness such as the one we propose.
On the fringe of this work, we tackled algorithmic problems encountered in photon
therapy. We focused on the so-called Intensity Modulated Radiation Therapy (IMRT) de-
livery technique using MLC. A central problem of this technique requires finding a series
of leaves configurations that can be shaped with MLC. From an algorithmic point of view,
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this can be considered as a matrix decomposition problem. We analyzed this problem for
dual-layer MLCs and rotating MLCs. We propose theoretical results for both types of
MLCs and an approximation algorithm for rotating MLCs.
In the first part of this dissertation, we will introduce the field of radiation therapy
and more specifically the proton therapy and photon therapy from an historical and a
physical point of view. We will also introduce the problems addressed in the rest of this
manuscript: intra-fraction motion in proton therapy and MLC decomposition in photon
therapy. In a second part, we will present our simulator MSPT, developped to study the
intra-fraction motion and improve the robustness of treatments as regards to motion.
We will also propose a new approach to reduce the impact of intra-fraction motions.
Finally, we will present algorithmic results and an approximation algorithm for the MLC
decomposition problem.
3
Part I
Radiation Therapy
4
Chapter 1
History of the radiation therapy
The history of radiation therapy begins with the discovery of X-rays (photons with an
energy level approximately between 60 and 100 KeV) in 1895 by Dr. Wilhelm Roentgen
[Ro¨ntgen, 1896] in Germany. This breakthrough changed the medical world by providing
a new non-invasive diagnostic method allowing to see inside a patient in 2-dimensions
(2D), thereby giving birth to a new medical specialty: namely, Radiology. Figure 1.1
shows the first radiography obtained by Dr. Roentgen.
Figure 1.1 – Dr. Roentgen’s first X-ray image. The subject was his wife’s hand. [Baum-
rind, 2011]
Soon after, it was observed that exposure to X-rays could damage body tissues and
in 1896 a first attempt to treat a breast tumor was performed by Dr. Emil H. Grubbe in
Chicago (USA) [Science, 1957; Vujosevic and Bokorov, 2010] using an X-ray machine. It
was followed by other attempts such as in 1896 for a stomach cancer by Victor Despeignes
in Lyon (France). This was the beginning of a new medical field called radiation oncology
[Connell and Hellman, 2009] and more specifically external beam radiation therapy.
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In 1903, Dr. Henri Becquerel, along with Pierre and Marie Curie, won a Nobel Prize in
Physics for the discovery of radioactivity. This team was able to isolate the first known ra-
dioactive elements, named Polonium and Radium, that naturally emit ionizing radiation.
Their research resulted in a new radiation treatment called brachytherapy (also known as
curietherapy or internal radiation therapy). The treatment, which consists in implanting
radioactive seeds within a patient was first used in 1901 by Dr. Henri-Alexandre Danlos
in Paris (France) [Gupta, 1995].
In the 1920’s-30’s the idea of fractionated radiation therapy was introduced. The
treatment was divided over the time, instead of a single large exposure, in order to reduce
toxicity to healthy tissues in the patient. Nowadays, fractionation is still widely used for
all types of radiation therapy techniques [Paganetti et al., 2012].
Early in the development of the radiation therapy, it was recognized that the use of
high energy photon beams (greater than a few hundred keV) would provide better out-
comes. This technique became known as photon therapy. Initially the equipment could
not provide such beams, but in 1924 Gustav Ising invented the particle Linear Accelerator
(linac) concept [Ising, 1924] which was later used by Rolf Widero¨e to build a linac in 1928
[Widero¨e, 1928]. In 1929, Ernest O. Lawrence designed the cyclotron, a ”coiled” linac,
inspired by Ising and Widero¨e research [Bryant, 2010]. As a result of these inventions,
high energy photon beams could be generated, from high energy - for that time - electron
beams, but also high energy protons and ion beams (e.g., 1.25Mega-electron Volt (MeV)
protons by Lawrence’s cyclotron in 1932 [Bryant, 2010]). In 1943, Oliphant proposed the
synchrotron concept [Wilson, 1996] to accelerate charged particles. In 1946, Goward and
Barnes made a first demonstration of an 8MeV synchrotron at Woolwich Arsenal (UK).
Two months later, Elder, Gurewitsch, Langmuir and Pollock, built a 70MeV synchrotron
at the General Electric Laboratory in Schenectady (USA).
In 1946, Robert R. Wilson outlined the importance of protons in radiation therapy
[Wilson, 1946] explaining that protons of 125MeV could penetrate body tissues up to a
range of 12cm and 27cm for protons of 200MeV. In addition, he demonstrated that the bi-
ological damage depends on the density of ionization and that, in the case of protons, this
density of ionization increases considerably near the end of the range. In 1954, Ernest O.
Lawrence used proton beams to treat a first patient at the Lawrence Berkeley Laboratory
in California (USA) [Lawrence, 1957; Paganetti et al., 2012]. This was the beginning of
proton therapy, another external beam radiation therapy method. Figure 1.2 shows this
first patient with Dr. Lawrence.
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Figure 1.2 – 1954: First treated patient at Lawrence Berkeley Laboratory.1
a. c© 2010 The Regents of the University of California, Lawrence Berkeley National Laboratory
In the late 1950’s, a new concept arose in radiation therapy: the Conformal Radiation
Therapy (CFRT), i.e., making a shape of the radiation field conform to the shape of the
target volume in order to minimize the dose received by surrounding healthy tissues while
delivering a high dose to the tumor. Soon after, Dr. Takahashi introduced the Multileaf
Collimator (MLC) device in Nagoya (Japan) [Takahashi et al., 1961; Kobayashi et al.,
1996]. Composed of two sets of facing leaves, it could be moved to conform to the radi-
ation field. It was first used in 1963 by Dr. Wanatabe in [Watanabe, 1963; Kobayashi
et al., 1996] and has been applied both to photon and proton therapy - it is still in use
today.
In 1979, Godfrey N. Hounsfield and Allan M. Cormack where awarded the Nobel Prize
in Physics for the invention of the Computed Tomography (CT), a 3-dimensions (3D) imag-
ing technique using X-rays [Peeters et al., 1979; Raju, 1999]. This breakthrough allowed
radiation oncologists to shift from 2D to 3D treatment planning and therefore consider a
3D radiation delivery.
In 1982, the concept of Intensity Modulated Radiation Therapy (IMRT) was introduced
by Brahme and colleagues [Brahme et al., 1982] in 2D. The IMRT consists in considering
the ”dose distribution” as a ”picture” and using the ”photon beams” as ”pencils” to draw
the ”picture” by changing the ”pencil” thickness, i.e., changing the intensity of photon
beams [Webb, 2003]. This concept was also applied to proton therapy and brachytherapy.
In the late 1970’s and early 1980’s the spot scanning (also called beam-scanning)
technique was introduced for 3D irradiation in proton therapy [Grunder and Leemann,
1977; Goitein and Chen, 1983; Paganetti et al., 2012]. It consists of using magnets to
steer a thin proton (or heavy ion) beam, across the target volume, to control the delivery
in 3D. The goal of this method was to replace the use of broad beams that were shaped
through a collimator.
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In 1991, proton therapy was introduced in France to treat patients at Nice and Orsay.
Nowadays, photon therapy, brachytherapy and proton therapy are still used. While,
photon therapy is one of the most common techniques applied in treating cancer, proton
therapy is becoming more and more popular (see Section 2.3.1 for more details).
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Chapter 2
Principles and physics of radiation
therapy techniques
Principle of Radiation Therapy
Radiation therapy is a cancer treatment, based on ionizing radiation aimed at killing
the cancerous cells of a tumor.
2.1 External beam radiation therapy
2.1.1 Principle
External beam radiation therapy is a technique where the radiation is delivered from
outside the patient. The apparatus delivering the radiation - called the nozzle - can be
attached to a rotating device called the gantry. The gantry rotates around the patient to
aim at the tumor from a given angle. In certain therapy centers, the nozzle can also be
fixed which precludes any rotation. A particle accelerator is located upstream from the
nozzle. Figure 2.1 presents a general example of external beam radiation therapy with a
gantry.
Figure 2.1 – Schematic of an external beam radiation therapy system
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External beam radiation therapy techniques include:
• Photon therapy
• Proton therapy
• Heavy ion therapy
Photon beams are generated by accelerating a beam of electrons, through a linac. This
beam strikes a target made of metal such as tungsten [Khan, 2010]. Protons (hydrogen
ions) and heavy-ions (such as carbon ions) are generated by accelerating these ions in
either a cyclotron or a synchrotron or less commonly a linear accelerator.
2.1.2 Particle accelerators
Particle accelerators do just what their name suggests, they accelerate particles (elec-
trons or ions) to an energy level - corresponding to the particle velocity - so that particles
can penetrate the body as deeply as possible. Although new ways to accelerate particles,
especially for protons and heavy ions, are being investigated (e.g., dielectric wall acceler-
ators or laser driven accelerators [Paganetti et al., 2012]), we will present only the three
primary accelerators currently in use.
Linear accelerator
Linear accelerators (linac) increase the speed of particles along a linear beamline. The
acceleration is produced by oscillating electric potentials, which create electromagnetic
fields, along the beamline. In radiation therapy, linac are generally used to accelerate
electrons over a short distance (order of meter) to produce photons and are small enough
to be located in the gantry. An example of a linear accelerator in a system used for photon
therapy is presented in Figure 2.2.
Figure 2.2 – Example of a linac located in a photon therapy gantry. 1
a. Source: Varian
10
MSPT: Motion Simulator for Proton Therapy
Cyclotron
Cyclotrons accelerate particles along a spiral path from the center to the outer radius,
where the maximum speed is reached, using static magnetic fields perpendicular to a
high frequency alternating electric field. A cyclotron provides a continuous particle beam
with a fixed energy, e.g., around 250MeV for protons used in radiation therapy. In order
to change the beam energy, the extracted particles go through a degrader, which slows
down the particles to the desired energy, and through a range modulator, made of low-Z
materials such as plexiglas, that allow a fine energy tunning before reaching the delivery
nozzle. However, going through degraders reduces the intensity of low energy beams. For
medical facilities, the diameter of a cyclotron can vary between 3.5m (100 tons) and 5m
(200 tons) [Paganetti et al., 2012]. A schematic of a cyclotron and the beamline to the
gantry is presented in Figure 2.3.
Figure 2.3 – Schematic of a cyclotron and the beamline to the gantry. E0: energy of
protons exiting the synchrotron, E1: energy after a first tuning by a degrader, Ed: energy
used for the delivery after a fine tuning. B and u(t) represent respectively the static
magnetic field and the alterning electric field.
Synchrotron
Synchrotons accelerate particles through a circular beamline. The process starts with
the injector, an ion source, that fills the synchrotron with a limited quantity of low en-
ergy particles - in the order of few MeV[Paganetti et al., 2012]. The particles are then
guided through the beamline using time dependent magnetic fields that bend the particle
trajectories, and then are accelerated by kicker magnets placed along the beamline. The
energy of the resulting beam is related to the number of cycles traveled. Once particles
reach the desired energy, a deflector magnet change their trajectory to be extracted and
they are conducted to the gantry by electromagnetic beamline. Therefore, a synchrotron
accelerates particle beams to a desired energy without degraders. As a result, high and
low energy beams have the same intensity (i.e., the same number of protons per time
unit). However, for practical reasons in medical treatments, beams are accelerated to
different energy levels and a fine tuning is performed in the nozzle. Once the synchrotron
spilled all the particles (the spill duration is called the ”spill length”), the injection and
acceleration processes start again. Hence, the particle production is pulsatile. In medical
11
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applications the spill length is around 5s [Kraus et al., 2011] and the time between two
spills is around 2-3s [Smith et al., 2009] for modern synchrotrons.
In medical facilities, synchrotron diameter varies between 6 and 8 meters [Paganetti
et al., 2012]. A schematic of a synchrotron is presented in Figure 2.4.
Figure 2.4 – Schematic of a synchrotron. E0: energy of protons injected in the cyclotron,
Ed: energy used for the delivery.
Cyclotrons and synchrotrons in medical facilities
As mentioned in Section 2.1.2, cyclotrons and synchrotrons require some space and
are located outside the treatment room. This is advantageous in that particle beams can
be provided to several treatment rooms. Illustration of a medical facility and a treatment
room are respectively given in Figures 2.5 and 2.6.
Figure 2.5 – Schematic of a proton therapy center. 2
b. Source: Berkeley Lab - http://newscenter.lbl.gov/2010/10/18/ion-beam-therapy/.
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Figure 2.6 – Gantry in a proton therapy treatment room. The nozzle is able to rotate 360
degrees around the movable patient couch. [Paganetti and Bortfeld, 2005]
Cyclotrons and synchrotrons are both an effective way to accelerate protons. However,
only synchrotons can currently be used to accelerate heavy particles [Paganetti et al.,
2012]. Another difference between these particle accelerators is the time needed to provide
beams of different energies to the gantry as a result of the methods used to change
the energy - around 2-3s for synchrotrons [Smith et al., 2009] and around 50-150ms for
cyclotrons [Pedroni et al., 2004; Schippers et al., 2007].
2.2 Internal beam radiation therapy
The internal beam radiation therapy (also called brachytherapy) consists of inserting
radioactive seeds (such as Caesium-137, Iridium-192) in specific locations in a patient in
order to irradiate the target volume. A schematic of such treatment is presented in Figure
2.7.
Figure 2.7 – Schematic of the brachytherapy principle.
Internal beam radiation therapy, even though mentioned for general knowledge, will
not be studied in the scope of this work.
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2.3 Protons and photons in radiation therapy
The rest of this dissertation will focus on radiation therapies performed by proton and
photon beams.
2.3.1 Establishment and cost comparison
As of August 2013, there were 43 proton therapy centers with a total of 122 treatment
rooms worldwide. This corresponds to 0.9% of conventional photon therapy centers.
However, proton therapy is a growing field and it has been estimated that there will be
1000 treatment rooms by 2030 [Goethals and Zimmermann, 2013]. Cost is the limiting
factor in establishing more proton therapy facilities - e95 millions (≈ $130 millions) for a
proton only facility and e23 millions (≈ $30 millions) for a conventional photon therapy
center. Regarding the cost per fraction, it is estimated respectively to be e740 (≈ $1000)
and e230 (≈ $300) [Peeters et al., 2010].
2.3.2 Radiation comparison
Photon and proton based radiation interact differently with materials. Photon radi-
ation deposits a large amount of energy when entering the material and decreases with
the depth. Proton radiation deposits a relatively small amount of energy when entering
the material and increases to a depth known as the Bragg Peak, at which point no energy
is left and the radiation stops. Figure 2.8 presents the dose profiles, i.e., the energy de-
posited along the depth, for a photon beam, a mono-energetic proton beam, and a beam
composed of protons of different energies (referred to as poly-energetic proton beam). The
target region corresponds to the area that should ideally receive the highest dose. We
can notice that the photons deposit a high amount of energy when entering a medium
and continues to irradiate after the target region, whereas the mono-energetic proton
beam deposits more energy inside the target and nothing after. Figure 2.9 presents the
deposited dose for treatments performed with photons and protons. It clearly shows that
tissues behind the target region can be spared using proton radiation.
Figure 2.8 – Dose profiles for photons and protons.
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Figure 2.9 – Comparison of deposited dose for a treatment: photons (upper panels) versus
protons (lower panels). [Kirsch and Tarbell, 2004]
2.4 Process of a radiation therapy treatment
2.4.1 General treatment planning
Once a tumor has been found and the medical team (e.g., physician, oncologist, physi-
cist, dosimetrist) decides to treat the cancer with radiation, images are taken to locate the
tumor and assess its biological activity. The imaging modalities depend on the decisions
made by the medical team but can include anatomical imaging techniques such as Mag-
netic Resonance Imaging (MRI), CT or ultrasounds and functional imaging techniques
such as Single Photon Emission Computed Tomography (SPECT) or Positron Emission
Tomography (PET).
Using information collected from the images and medical examinations, the clinicians
delineate different volumes that will be used for the planning process [International Com-
mission on Radiation Units and Measurements, 2008]:
• The Gross Tumor Volume (GTV) corresponds to the tumor location visible in the
images.
• The Clinical Target Volume (CTV) corresponds to the GTV and the suspected
microscopic spread of the tumor.
• The Planning Target Volume (PTV) corresponds to a geometrical concept that in-
cludes the CTV and the surroundings of the tumor to take into account geometric
uncertainties such as internal motions of the CTV during the therapy, set-up uncer-
tainties such as positioning and alignment of the beam and the patient, mechanical
uncertainties, and human factors.
• The organs at risk (OARs) correspond to healthy tissues sensitive to radiation that
should receive the smallest possible dose and ideally no dose.
• The Planning organ at Risk Volume (PRV) corresponds to the OARs and the sur-
roundings similarly to the PTV with a goal of ensuring with a high probability that
the OARs are spared.
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Based on the dose prescribed by a physician and the volumes previously defined, a
physicist or a dosimetrist will produce a treatment plan defining the gantry angles and
the control files of the delivery system, such as MLC configurations in photon therapy.
The planning must ensure that the PRV does not receive more than a maximum threshold
and that the PTV receives no less than a minimum threshold. The amount of radiation
is measured in Gray (Gy). A example of minimum dose for a tumor ranges from 60 to
80 Gy and for healthy tissues the maximum dose will vary with the tissue’s sensitivity to
irradiation and are in the order of: 20 Gy for lungs, 50 Gy for bones or 12 Gy for the
eyes. The treatment plan will also define the treatment fractions which correspond to the
administration of portions of the overall treatment. For example, for an adult, one can
plan to deliver 1.8 to 2 Gy per day [Paganetti et al., 2012], five days a week for three to
five weeks. The fractionation of treatment helps protect the patient, since delivering a
high dose to a patient in a single fraction can be lethal. Moreover, healthy cells tend to
recover more easily than cancerous cells from radiation. Therefore, fractionation allows
the former cells to regenerate before being irradiated again. Once the treatment plan has
been approved by the physician, the patient can be treated.
2.4.2 Photon therapy planning and delivery
Several methods exist to deliver a photon therapy treatment. Either the beam can
rotate around the patient and stop at specific angle to deliver the irradiation, such as in
the IMRT technique commonly referred to as the ”step and shoot technique”, or it can
rotate continuously and irradiate continuously such as in the Volumetric Arc Therapy
(VMAT). Another technique, not relying on MLCs but on a thin photon beam (order of
millimeter) to accurately deliver the treatment is called stereotactic radiotherapy (e.g.,
CyberKnifer from Accuray). Among these techniques, we focused on the IMRT, which
offers interesting algorithmic problems.
The IMRT technique uses a nozzle that generates a cone beam that rotates around the
patient and converges on the tumor site. In the planning process, for each of these angles
a 2D dose distribution (also called intensity map or fluence map) across the radiation
beam is computed based on optimization techniques [Hamacher and Ku¨fer, 2002] in order
to plan the desired overall dose. Figure 2.10 presents intensity maps for various gantry
angles. At each gantry angle the beam is shaped using a MLC which consists of a set
of parallel pairs of facing strips referred to as leaves. These strips are composed of high
atomic number material, such as Tungsten, in order to stop radiation. The strips of a
given pair can move toward or away from each other. In the former case, the pair will
form an open gap and in the latter it will block the radiation. A specific positioning of all
the pairs of leaves is called a MLC configuration. Figure 2.11 shows an example of MLC
configuration.
The planning phase consists of finding a fluence map, corresponding to a 2D grid of the
dose that must be delivered locally in the patient for each gantry angle. In order to achieve
these fluence maps, a Treatment Planning System (TPS), using optimization techniques,
computes and finds a set of MLC configurations per gantry angle to be used during the
treatment along with the time each configuration must be maintained. While the quality
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of a plan is judged for dosimetric properties, two criteria are considered to evaluate the
efficiency of the MLC configurations. The first one, the beam on time, corresponds to the
total patient irradiation time and is the sum of the duration of each configuration. The
other criteria is the total setup time, which corresponds to the time needed to shape all
the configurations. This time is approximately proportional to the number of configura-
tions. These two criteria needs to be minimized to have an efficient plan and ensure that
the patient doesn’t receive an unnecessary dose or prolonged treatment.
Figure 2.10 – IMRT grantry angles and intensity maps: IM1, IM2, IM3, IM4.
(a) View of an MLC in a nozzle (b) An MLC configuration
Figure 2.11 – Examples of MLCs
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The MLC described above is the conventional MLC and the most widely used. How-
ever, in the last decade new technologies allowed for the development of new types of
MLCs. Among them the Dual Layer MLC and the Rotating MLC will be presented in
Part III Section 2.2. In the scope of this thesis, we studied, in Part III, the minimization
of the beam on time and the total setup time for these new types of MLCs.
2.4.3 Proton therapy planning and delivery
In proton therapy, protons are accelerated in a particle accelerator and conducted to
the nozzle through an electro-magnetic beamline. The gantry allows the nozzle to ro-
tate around the patient. In the planning phase, one defines the angles where the gantry
stops. Based on these angles, the prescribed dose and the fractions of a treatment plan
are computed and optimized in a TPS. The treatment plan provides energies to be used
to irradiate the 3D volume of the tumor.
There is a Bragg Peak associated with each proton energy (see Section 2.3.2) as well
as a so-called energy layer which corresponds to the set of positions in the patient’s
body where the Bragg Peak will occur. Note that, due to the heterogeneity of tissue
mass densities, an energy layer may not correspond to a plane layer. In order to cover a
wider region than the width of the Bragg Peak, one can combine proton beams of several
energies which will generate a so-called Spread-Out Bragg Peak (SOBP) (see Figure 2.8).
This SOBP is used to cover the entire depth of the tumor. On the way to the tumor,
the amount of dose deposited by the beams will accumulate while staying in a moderate
scale compared to the dose applied to the tumor. This technique leads to better coverage
of the tumor and minimizes the impact to healthy tissues, especially behind the tumor.
These energy layers are defined during the planning to control the depth of the tumor (see
Figure 2.12). The irradiation of an energy layer is controlled by the delivery technique
used. There exists two main methods described below.
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Figure 2.12 – Principle of energy layers
The first method (see Figure 2.13), called scattering, uses a beam that is broaden
through two scatterers in order to cover the entire tumor or a large portion of it. This
broaden beam width can be in the order of several centimeters. The beam is then shaped
laterally and vertically by the use of a collimator (also called aperture). A range compen-
sator adjoining the aperture allows for fine and local tuning of the Bragg Peak positions
over the beam’s surface (see Figure 2.14), especially for the distal energy layer. The aper-
ture and range compensator are machined specifically for each patient.
Figure 2.13 – Scheme of beam scattering delivery
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Figure 2.14 – Example of brass aperture and range compensator.3
c. Picture from http://www.massgeneral.org/radiationoncology/AboutProtonTherapy.aspx
The second method, called spot scanning, uses a narrow pencil beam to deliver dose
to the target in a spot by spot fashion. The principle of this technique is to laterally and
vertically deviate a thin proton beam (a so called “beamlet” in the order of millimeters)
using a set of steering magnets and to sequentially change the energy of the beam in order
to create a SOBP (see Figure 2.8). By controlling the beam deviation one can scan an
entire energy layer using a mono-energetic beam. The beam stays at a given position
for a certain amount of time, called weight, to deliver a certain amount of protons. This
weight is measured in Monitor Units (MU). In the case of discrete spot scanning delivery,
the beam can be turned off between two spots. It can also be kept on in the so-called
raster scanning. As mentioned earlier, the principle of multiple energy layers is used to
allow a 3D scanning of the tumor site (see Figure 2.15).
Figure 2.15 – Scheme of the spot scanning technique.
One difference between the scattering and the spot scanning techniques is the sensi-
tivity to motion. Scattering is less sensitive to motions and range uncertainties since the
beam covers a wide area. However, spot scanning allows a better conformity to complex
shapes especially if there are concavities in the tumor. Moreover, it provides a better con-
formity to the proximal part of the target and does not require patient specific aperture
and compensator.
The planning phase, performed through a TPS, consists of determining the set of en-
ergies to use in order to form a SOBP. Moreover, for the scattering method, the aperture
and the range compensator must be machined. In the scanning technique, a set of beam
positions associated with a weight is defined and optimized for each energy layer. The
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result is a treatment plan consisting of a set of beam parameters (E,X, Y,W ) where E is
the beam energy (also defining the target energy layer), X and Y control the deviation of
the beam in the energy layer and W is the duration of the irradiation of this given spot.
Finally, the TPS can also synthesize the treatment plan as an expected dose distribution
in the patient volume.
2.5 Radiation therapy challenges
2.5.1 Uncertainties in radiation therapy
The quality of radiation therapy treatments is influenced by random and systemic
uncertainties due to the equipment as well as patient motions.
Uncertainties are mainly composed of setup uncertainties and range uncertainties.
Setup uncertainties refer to the patient-device positioning. This type of uncertainty is in
the order of ±1.5mm [Paganetti et al., 2012]. Range uncertainties are due, among other
things, to uncertainties in the CT Number (±3.5% of range), in the Bragg Peak position
(±1.3mm), in the SOBP position (±0.6− 1.0mm) and the range computation in tissues
with complex heterogeneities (±1mm).
Motions can be either inter-fraction or intra-fraction. Inter-fraction motions consist in
all the varying shapes in the patient body between one fraction to another. For instance,
weight variations, tumor swelling or shrinkage, full or empty bladder or intestinal gas can
generate motions of the tumor or of the OARs which can result in their underdosage or
overdosage, respectively. Intra-fraction motions are all the motion occurring during the
delivery: e.g., breathing, heart beats, hiccup, cough. The spot scanning in proton ther-
apy is particularly sensitive to intra-fraction motions since it relies on a thin proton beam.
2.5.2 Mitigation techniques in radiation therapy
Different techniques are used to cope with the uncertainties and the motions during
a treatment. In general, in facilities, periodical commissioning of the treatment devices,
the TPS, or the imaging machines helps reduce uncertainties. During the planning phase,
designing margins around the tumor and the OARs, as described in Section 2.4.1, al-
lows one to take into account uncertainties and encompass different tumor positions that
could occur during the treatment. Moreover, the choice of the number of beams or the
beam angles has an impact on the effect of uncertainties and motions during treatments.
For example, if the amplitude of a motion along a given direction is smaller than in the
other directions, one could place the beam along this direction. Moreover, increasing the
number of beam angles allows one to lower the error between the planned dose and the
actual delivered dose for each beam angle, thereby increasing the likelihood of properly
irradiating the tumor.
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To deal with inter-fraction motion, some strategies of re-planning between fractions
have been shown to be effective [Hansen et al., 2006].
During the delivery, internal or external markers can be used to properly align the
patient and the treatment device. They can also be used to infer the tumor position such
as in fluoroscopy using radioactive internal markers, the Calypsor system (Varian) us-
ing electro-magnetic internal markers, or simply by using external visual markers. With
these inferences, the delivery machine can be adapted in real time such as in the beam
tracking method [Bert et al., 2010] based on the adaptation of the beam position and
energy, or in the dynamic MLC technique [Sawant et al., 2009] based on the adaptation
of the MLC configuration. These markers can also be used to deliver the treatment using
the beam-gating [Keall et al., 2006], which consists of irradiating the patient only when
the markers reach a specific position. Another strategy used during the treatment to
reduce the impact of motion is to control the patient breathing cycle either by asking
the patient to hold his/her breath while being irradiated, coaching the patient to breathe
with audio and/or visual cues, or by administering anesthesia [Bert and Durante, 2011].
Other strategies, such as abdominal compression [Keall et al., 2006], tend to limit the
motion amplitude.
2.5.3 Intra-fraction motion in proton therapy
The effect of motion on radiation dose delivery is especially large in proton therapy,
particularly when spot scanning is used as the delivery technique. Since spot scanning
uses a narrow pencil beam to deliver dose to the target in a spot by spot fashion, any
motion during the delivery can result in undesirable hot spots in healthy tissue or cold
spots in target. The resulting dose distribution in the patient may substantially differ
from the expected one. Figure 2.16 shows the difference between the irradiation received
by a static and a moving radiographic film.
Figure 2.16 – Results of irradiation without (left) and with (right) motion on a radio-
graphic film. [Paganetti et al., 2012]
The problem of intra-fraction motion in spot scanning proton therapy has been widely
studied with a number of promising solutions [Zenklusen et al., 2010; Bert et al., 2012;
Eley et al., 2014]. These solutions require the capacity of dose computation on a dynamic
patient dataset, i.e., 4-dimensional treatment planning, and are often conducted with
the researcher’s in-house treatment planning system or an expensive clinical treatment
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planning system. The limited availability of such 4D treatment planning systems makes
it difficult to study this subject by a broader category of researchers. Based on these
assumptions, in the scope of this thesis, we decided to make a contribution by developing
a tool, named MSPT (Motion Simulator for Proton Therapy), aiming at computing and
rendering the evolution of the dose distribution during the treatment delivery. In addi-
tion, we developed a motion compensation technique in MSPT to provide a new approach
for a motion mitigation method based on the adaptation of the beam’s weight. These
developments will be addressed in Part II.
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Chapter 1
MSPT a new tool to study
intra-fraction motions
1.1 Development of a proton therapy motion simu-
lator
As introduced in Part I Section 2.5, intra-fraction motions, especially breathing mo-
tions, can substantially degrade the quality of a proton therapy treatment using the spot
scanning technique. In order to highlight the impact of these motions on the resulting
dose distribution and provide a research tool to evaluate and compare different methods
of motion management or mitigation, we decided to develop MSPT. It is a 4D dose com-
putation and evaluation software.
Before developing MSPT, different strategies were considered to perform simulations.
Using a commercial treatment planning system (TPS), such as RayStation (RaySearch
Laboratories) or Eclipse (Varian), appeared to be not flexible enough regarding the con-
trol of motion and often not available to researchers outside a proton therapy center.
Such software are especially expensive: around e500 000 (≈ $650 000) for a license and
the proton therapy treatment planning functionalities outside a proton therapy facility.
Moreover, since these software are dedicated to medical use they can be viewed as black
boxes and modifying them or adding third-party plugins is not possible. This limits
greatly their use as part of our research. We also considered using a Monte-Carlo engine
such as the well-known Geant4 [Agostinelli et al., 2003; Allison et al., 2006; Archambault
and Beaulieu, 2003], and TOPAS [Perl et al., 2012](a simulation toolkit built on top of
Geant4), which are both freely available and provide accurate dose calculation. However,
despite of the dosimetric accuracy, it requires a significant amount of computer time to
perform dose computation (e.g., in the order of a couple of hours for a single pencil beam
using Geant4, and less than a minute in MSPT on a laptop). Moreover, Geant4 or TOPAS
require a deep expertise in Monte-Carlo dose calculations and some experience to setup
properly proton-therapy simulations. To keep our work with the focus of applied research,
we wanted to be able to compute dose distribution in a relatively short time frame and
obtain a result close to the dose distribution provided by a commercial TPS. We also
wanted this software easily adaptable and accessible such that any user could match it
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to their TPS. To our knowledge, no openly distributed dose computation software has
become available to meet these requirements. That is why we created the proton therapy
simulator, MSPT, based on an analytical dose calculation model specific for spot scanning
deliveries.
MSPT source code, user guide and documentation are available at:
http://code.google.com/p/mspt/. It is distributed under the GNU GPL (v3) license.
1.2 MSPT objectives
While MSPT has been developed with the will of providing an open-source and flexible
software to make it broadly applicable, two main objectives were important: render the
impact of intra-fraction motion and provide a tool to compare treatment plan or mitigation
techniques to improve the treatment robustness to motion.
1.2.1 Render the impact on the dose distribution
The first ability of MSPT is to render the final dose distribution resulting from the
delivery of a treatment plan to a dynamic patient. This is made possible by the imple-
mentation of physical models used to reproduce the interaction between proton beams
and matter and described in Section 3.3. However, to be able to render the evolution and
the final dose distribution, in the entire patient volume, for a treatment delivered to a
moving patient, we also had to introduce motion models and allow these motions during
the delivery of a single pencil beam. The patient and motions representations will be
addressed in Section 3.2.
1.2.2 Improve the treatment robustness
The second interest of MSPT is to provide information to the user to be able to com-
pare dose distributions such as dose-volume histograms, hot and cold spots and statistical
comparisons of the dose distributions. It also provides the 3D resulting dose distributions
to let the user perform more specific comparisons outside MSPT. The outputs are described
in Section 2.4. Based on these information, the user could compare different treatment
strategies for a same patient and could decide which one is more robust to motion.
In addition, a motion compensation technique has been developed in MSPT, which
adapts the weight of each beam position without changing the treatment plan. This
results in a treatment equivalent to the initial one but with a different scanning path
more adapted to the motion simulated. This scanning path is provided to the user as
another output to offer help in the improvement of the initial plan, with the objective of
making the plan more robust to motion.
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Simulator implementation
2.1 Simulator implementation
MSPT was developed in Python 2.7, for the flexibility of this programming language
and using subroutines encoded in C to improve the execution speed of critical parts. Dig-
ital Imaging and Communications in Medicine (DICOM) files are read using the library
PyDICOM [Mason, 2012]. Matrices manipulations rely on SciPy [Jones et al., 2001] and
Numpy [Van Der Walt et al., 2011] packages. 2D graphics are rendered using Matplotlib
package [Hunter, 2007].
MSTP has the ability to model scanning pencil beam based on measured data or an
existing beam model from other treatment planning systems. Currently, a beam was
modeled after an existing beam model called ”ProtonMachine” in RayStation (RaySearch
Laboratories), a commercial TPS. This model is later referred to as ProtonMachine.
2.2 About MSTP’s development
The development of MSTP has been a major part of this thesis. It represents almost 3
years of development. During these 3 years we had to become familiar with the proton
therapy and have a good understanding of the spot scanning delivery technique (e.g.,
mechanical and physical aspects of the delivery systems) and the underlying physics. In
addition, it was necessary to become familiar with clinical knowledge, such as the data
used by TPS or the data used by clinicians to evaluate the quality of a treatment plan.
This has been made possible thanks to the collaboration with physicists from the depart-
ment of radiation oncology at the University of Iowa. They followed the development
since the beginning and shared their expertise. Moreover, they helped us by planning and
simulating static proton therapy treatments in RayStation. These plans and simulations
were used to evaluate MSTP (see Chapter 4) and were also used as a basis for our motion
and compensation simulations.
In order to develop a tool that could be of interest for future research in the field of
proton therapy we wanted to ensure that the dose calculations performed by MSTP were
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coherent with the dose calculations obtained from ProtonMachine. Obtaining close results
required a lot of effort and ingenuity as RayStation can be viewed as a tool whose inter-
nal details are hidden to the user. For example, data such as the number of protons per
monitor units (MU), or the dose profiles (i.e., curves representing the dose as a function
of depth) for all the energies used by ProtonMachine were not accessible and necessitated
reverse engineering or auxiliary studies. The dose and stopping power correction factor
functions (see Section 3.3) illustrate some of these auxiliary studies.
To facilitate the use of MSTP, we designed it such that it could handle DICOM files
dedicated to radiation therapy and DICOM image files (see Section 2.3), which is the
typical data used by clinical TPS. More generally, DICOM is a standard used in medical
facilities for communication and storage of medical information. Handling these files re-
quired a good knowledge of the DICOM standards in order to extract all the data needed
to simulate the delivery (e.g., number of fractions, number of beams, beam angles, body
structures, pencil beam position relative to the patient). This resulted in the development
of the dicomReader package (see Section 2.5) that could be used as a standalone package.
Based on the various competencies and data acquired we designed, implemented and
evaluated MSTP. The documentation has been generated with Sphinx1 and is available on
MSTP’s website. The implementation can be described in a few figures: 24 classes, around
400 functions and more than 12500 lines of code.
2.3 The DICOM standard
In this section, we will present briefly the DICOM standard in order to provide suf-
ficient background information to the reader for a better understanding of the following
sections.
The DICOM standard is defined by the American College of Radiology (ACR) and
the National Electrical Manufacturer’s Association (NEMA). It describes transmission
and storage protocols for clinical data and images. This standard is used in any medical
facility. Its design is object-oriented. The description of the DICOM standard is complex
and goes beyond the scope of this thesis. Therefore, we will provide a brief and simplified
presentation2. The DICOM objects used in MSTP contain a set of Attributes (associated to
a Tag corresponding to a unique identification number) corresponding to data elements
stored in the object. The data stored can be for example a string, a number, an array or
another object. A first object used in MSTP is the CT Image object storing the patient
images. The patient image being a 3D volume, each slice (or frame) of the volume is
stored in a CT Image object. Hence, a CT Image object stores a 2D image. The patient
3D image corresponds to a series of CT Image objects. The extension of the DICOM
standard for radiation therapy is the DICOM RT standard and is composed of different
objects. Those used in MSTP are: RT Dose, RT Structure Set and RT Plan. The RT
1. http://sphinx-doc.org/
2. More details about the DICOM standard can be obtained at http://medical.nema.org/
standard.html.
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Dose object stores the dose distribution planned in a TPS as a result of the treatment
plan defined by the RT Plan. The RT Structure Set object stores the volumes of interest
defined in the patient, such as, tumor, heart or lung.
Table 2.1 provides an example of data stored in the slice of a CT Image (i.e., a CT
Image object). Some attributes relate to the patient information or the image acquisi-
tion. The main attributes used in MSTP are Slice Thickness, Image Position (Patient),
Image Orientation (Patient), Rows, Columns, Pixel Spacing, Pixel Data, Rescale Slope
and Intercept.
Tag Attribute Value Description
(0008, 0016) SOP Class UID CT Image Storage
This attribute describes the
type of data stored in the object
(0008, 0018) SOP Instance UID 1.3.12.2.1107.5.99.2.20599.30000011122902110259300016743
Identification number of the instance
of the object
(0008, 0022) Acquisition Date ’20120515’ Date of the image acquisition
(0010, 0010) Patient’s Name ’Anonymous’ Name of the patient
(0018, 0015) Body Part Examined ’CHEST’ Body part of the patient being examined
(0018, 0050) Slice Thickness ’3.0’ Thickness of the image slices in mm
(0020, 0032) Image Position (Patient) [’-249.51171875’, ’-411.51171875’, ’197.000000’]
Coordinates [x,y,z] of the top left pixel
of the current slice in mm
(i.e., pixel [0,0] in the slice).
(0020, 0037) Image Orientation (Patient) [’1’, ’0’, ’0’, ’0’, ’1’, ’0’]
Coordinates of the orientation vectors of
the first row and the first column with
respect to the patient.
(0028, 0010) Rows 167 Number of rows
(0028, 0011) Columns 167 Number of columns
(0028, 0030) Pixel Spacing [’3.0’, ’3.0’]
Spacing between rows and
columns in mm
(7fe0, 0010) Pixel Data Array of 55778 bytes Array storing the pixel values
(0028, 1053) Rescale Slope ’1’ The slope and intercept are the parameters
of the affine transformation to obtain the
true pixel intensity (in HU) from Pixel Data.
(0028, 1052) Rescale Intercept ’-1024’
... ... ...
Table 2.1 – Portion of a CT Image object representing a 2D slice of the patient CT image.
Table 2.2 provides an example of data stored in a RT Structure Set object. An instance
of this object stores all the contours defined on all the slices of the CT Image for each
region of interest (ROI) in the patient (i.e., each body structure delineated). Each ROI
named by ROI Name, is stored as a sequence of contours and each contour is defined by
a set of points defined by the attribute Contour Data. Each Contour Data is related to a
specific slice of the CT image. Contour Data corresponds to the delineation of the ROI
in this CT slice.
Tag Attribute Value Description
(0008, 0016) SOP Class UID RT Structure Set Storage
This attribute describes the
type of data stored in the object
(0008, 0018) SOP Instance UID 1.2.826.0.1.3680043.8.176.201264162510337.48.4226207444
Identification number of the instance
of the object
(3006, 0026) ROI Name ’Tumor’ Name of the selected ROI
(3006, 0042) Contour Geometric Type ’CLOSED PLANAR’
Type of contour (’CLOSED PLANAR’
or ’POINT’)
(3006, 0046) Number of Contour Points ’30’ Number of points in the current contour
(3006, 0050) Contour Data
[’6.4141769237’, ’-115.4705176’, ’102’,
’5.2292955389’, ’-115.0995526’, ’102’,
...
’6.4141769237’, ’-115.4705176’, ’102’]
Coordinates of the points defining
the contour in a slice of the CT Image.
... ... ... ...
Table 2.2 – Portion of a RT Structure Set object storing the contours of the regions of
interest in the patient.
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Table 2.3 provides an example of data stored in a RT Plan object. An instance of
this object stores all the beam directions (i.e., gantry angles). For each beam direction, a
sequence of energies is defined. For each energy, a list of positions associated to weights is
saved. The number of attributes used in MSTP is substantial. However, some of the main
attributes used are Number of Fractions Planned, Nominal Beam Energy, Gantry Angle,
Isocenter Position, Scan Spot Position Map, Scan Spot Meterset Weights, and Scanning
Spot Size.
Tag Attribute Value Description
(0008, 0016) SOP Class UID RT Ion Plan Storage
This attribute describes the
type of data stored in the object
(300a, 0003) RT Plan Name ’Test Plan’ Name of the treatment plan
(300a, 0009) Treatment Protocols ’PencilBeamScanning’ Type of treatment used.
(300a, 0078) Number of Fractions Planned ’3’ Number of fractions.
(300a, 0086) Beam Meterset ’484.53744762’ Total number of MU delivered.
(300a, 0015) Nominal Beam Energy Unit ’MEV’ Energy units used in the plan.
(300a, 0114) Nominal Beam Energy ’118.56781803’ Energy used.
(300a, 011e) Gantry Angle ’180’
Angle of the gantry rotation
in degrees.
(300a, 012c) Isocenter Position [’-46.75731948’, ’-117.8241278’, ’69.994276167’]
Coordinates (related to the CT Image)
of the origin of the coordinate system
used to define the pencil beam position
in the treatment plan (IEC fixed coordinate
system - see Section 3.1).
(300a, 0394) Scan Spot Position Map
[-13.5, -11.5,
-26.0, -16.5]
(x,y) positions of the pencil beams defined
in the IEC gantry coordinate system (see
Section 3.1). Two positions are defined
in this example.
(300a, 0396) Scan Spot Meterset Weights
[0.024522660300135612,
0.005508291535079479]
Weight of each pencil beam position in MU.
(300a, 0390) Scan Spot Tune ID ’5 0 mm’ Information about the pencil beam’s width.
(300a, 0398) Scanning Spot Size [11.774100303649902, 11.774100303649902]
These values are the horizontal and vertical
Full Width Half Maximum (FWHM) in mm
and allow the calculation of the pencil beam’s
widths corresponding to the standard deviation
of a Gaussian distribution. In this example, the
FWHM of 11.77 results in a sigma value of 5 mm,
as expected from Scan Spot Tune ID.
... ... ... ...
Table 2.3 – Portion of a RT Plan object storing the entire treatment plan.
Table 2.4 provides an example of data stored in a RT Dose object. An instance of
this object stores a 3D dose distribution. The main attributes used in MSTP are Slice
Thickness, Image Position (Patient), Image Orientation (Patient), Number of Frames,
Rows, Columns, Pixel Spacing, Grid Frame Offset Vector, Dose Grid Scaling, and Pixel
Data.
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Tag Attribute Value Description
(0008, 0016) SOP Class UID RT Dose Storage
This attribute describes the
type of data stored in the object
(0018, 0050) Slice Thickness ’3’
Thickness of the slices of the 3D
dose distribution matrix stored
in Pixel Data.
(0020, 0032) Image Position (Patient) [’-196.3120157’, ’-299.5664854’, ’-309’]
Coordinates in mm of the voxel [0,0,0]
(in the 3D dose distribution matrix)
defined in the coordinate system
used for the CT image.
(0020, 0037) Image Orientation (Patient) [’1’, ’0’, ’0’, ’0’, ’1’, ’0’]
Coordinates of the orientation vectors of
the first row and the first column with
respect to the patient.
(0028, 0008) Number of Frames ’183’
Number of frames (slices) in the 3D
dose distribution matrix.
(0028, 0010) Rows 81 Number of rows.
(0028, 0011) Columns 136 Number of columns.
(0028, 0030) Pixel Spacing [’3’, ’3’] Spacing between rows and columns in mm.
(3004, 0002) Dose Units ’GY’ Dose units.
(3004, 000c) Grid Frame Offset Vector [’0’, ’3’, ... , ’540’, ’543’, ’546’]
This vector contains the offset from the first
frame depth in mm. For example, the second frame
has an offset of 3 mm. The first frame depth is -309 mm
(Image Position (Patient)), so the depth of the second
frame is -306 mm.
(3004, 000e) Dose Grid Scaling ’0.00078957540579’
Scaling factor for the dose data stored in Pixel Data in
order to obtain a 3D matrix in units of Dose Units
(7fe0, 0010) Pixel Data Array of 4031856 bytes Array storing the 3D dose distribution.
... ... ... ...
Table 2.4 – Portion of a RT Dose object storing the 3D dose distribution.
2.4 Simulator inputs and outputs
The simulator receives as inputs the treatment plan (energies, beam positions, weights),
the patient CT image, the contour of the structures (e.g., entire patient body, organs, tu-
mor), and optionally, the dose calculated by another TPS. These four inputs are all in
the DICOM standard.
In addition to the DICOM files, MSPT receives optionally a configuration file which
set global variables in MSPT controlling the delivery parameters, the a priori motion in-
formation which can be either from a 4D CT analysis or any function describing motion
trajectories, the compensation strategy and the outputs. The details of the configuration
parameters can be found in the following sections and in the user manual on MSPT website.
MSPT provides different outputs to be able to assess the quality of the delivery both
visually and quantitatively. For instance, the 3D matrices representing the patient, in-
cluding defined structures, can be saved as stacks of 2D images or as 3D matrices. Dose
distribution matrices, expected and computed, are stored in DICOM files and as stack
of 2D images. Dose Volume Histograms (DVHs) are stored as 2D images and as lists of
dose-volume data points. Hot and cold spots are stored as 2D images along with statistics
in a text files summarizing the quantity of hot and cold spots per structure.
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Figure 2.1 – Example of visual outputs: a CT slice with several binary masks of different
body structures (left) and the dose distribution of a single proton pencil beam (right).
2.5 Simulator architecture
In this section, we will present an overview of the main python packages we developed
to build MSPT and the principal relationships between them as well as between them and
the main python extensions in C. Figure 2.2 presents the overall organization of MSPT: it
shows the 23 classes used for the simulations. Another utility class called Email has not
been represented in the figure since this class is not mandatory for simulations. However,
if the user decides to use this functionality, it is instantiated along with SimulatorMSPT
in the main function.
Figure 2.2 – Class diagram of MSPT.
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Package simulator
The package simulator, controls at a high level the overall process of the simulation.
The two main classes are GlobalVariables and SimulatorMSPT. The former is derived from
a dictionary and used to manage MSPT settings defined by the user. The later, instantiated
by the main function, receives the inputs from the user, instantiates the main objects
(patient, motion, motion monitor, depth-dose curves of reference and scanning path)
and uses them to instantiate the object of the class SimulatorDelivery responsible for the
simulation of the delivery. Moreover, at the end of the simulation, SimulatorMSPT stores
the overall simulation outputs such as the entire final dose distribution or the comparison
between the expected dose distribution and the computed one.
Package dicomReader
The package dicomReader has been developped on top of PyDICOM to be able to
load DICOM data and more specifically CT (series of CT Image objects), treatment plan
(RT Plan object), body structures (RT Structure Set object) and expected dose distri-
bution (RT Dose object) through the class DicomManager. We implemented different
types of readers: dicomCTReader in charge of the CT image files, dicomRPReader in
charge of the treatment plan, dicomRSeader in charge of the patient body structures, and
dicomRDReader in charge of the expected dose distribution. The DICOM data is loaded
through these readers, which are initialized from the SimulatorMSPT object. In addition,
we implemented the classes ScanningPathMultipleBeams and ScanningPath, which aims
at storing the treatment plan (gantry angles in ScanningPathMultipleBeams and ener-
gies, beam positions and beam weights in ScanningPath) along with the scanning path
parameters (e.g., number of repaintings, type of volumetric repainting) provided in MSPT
configuration file. These classes are also instantiated from the SimulatorMSPT object.
Finally, a module ctToDensityConv has been created to load and provide a function to
obtain the conversion data from CT Number (CT#) to mass density.
Package patient
The package patient contains the class Patient storing all the data of the patient
model: 3D arrays of CT#, density, relative stopping power, radiological depth, expected
dose distribution and the binary masks of the body structures. The patient is initialized
in the SimulatorMSPT object.
Package physics
The package physics manage the depth-dose curves, through the class DDCurves, and
the stopping-power reference data with the StoppingPower class. The depth dose curves
and stopping power data of reference are initialized in SimulatorMSPT object.
Package motion
The package motion contains the different types of motions that can be used along with
the model of the motion monitoring system. Classes implemented for motions are Motion-
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Cos (i.e, motion simulated as a cosine function), MotionNoisyCos (i.e, motion based on a
cosine function with random amplitude and period variations), MotionBreathCough (i.e.,
motion derived from MotionNoisyCos simulating a patient coughing), MotionBreathHic-
cup (i.e., motion derived from MotionNoisyCos simulating a patient with a hiccup) and
MotionRecorded (i.e., a list of motion observations). The class MotionMonitor models a
motion monitoring system.
Package scanning
The package scanning contains the class SimulatorDelivery that simulates the delivery
process for a Patient static or moving according to a certain motion and irradiated by
given ScanningPathMultipleBeams and ScanningPath.
Package extensionC
The package extensionC contains all the python extensions implemented in C: calcu-
lation of the dose distribution of a single pencil beam (beamletSimulation()), calculation
of the radiological depth (calcRadiolDepth()) and functions used to build the patient
data: CT (fillCTArray()), density (fillDensityArray()), expected dose (fillDoseArray())
and stopping power (fillStopPwrArray()) arrays. These extensions are standalone func-
tions called through interface python functions.
Main organization
In this section, we present how are used and organized the different classes, modules
and functions previously mentioned. We will present the main tasks of a simulation in
MSPT (i.e., build the patient model and perform the simulation of the delivery) from a
programming point of view. The physics related details of the simulation are presented
in the next chapter.
The dependencies and principal functions called from a Patient object are summarized
in figures 2.3 and 2.4. The initialization of a Patient object relies on the information pro-
vided by the input DICOM files. It starts with the modeling of the patient body tissues
(physics details in Section 3.2.1). It consists of representing the patient as a 3D array
where each voxel corresponds to a physical entity (e.g., mass density, stopping power). In
a first step, the CT# are obtained from DicomCTReader with the function dataForAt-
tribute(). In the Patient object the 3D array is filled by the function fillCTArray(). Then,
the conversion from CT# to density is performed with a conversion table accessed by the
function getConversionTableCTToMassDens() from the module ctToDensityConv. The
3D density array is initialized by the function fillDensityArray(). The third step generates
3D binary masks of the body structures. The function getMasksForAssociatedDicomIm-
age() of the DicomRSReader returns them to the Patient object. If the user provides the
expected dose distribution, the function dataForAttribute() of the dicomRDReader and
the function fillDoseArray() initialize the 3D array representing this expected dose dis-
tribution. This step finishes the initialization. During the simulation of the delivery the
3D stopping power array is filled based on the 3D density array and the conversion data
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obtained from getConversionTableStpPwrForEnergy() and filled by the function fillStop-
PwrArray(). Finally, the computation of the dose distribution requires the calculation of
the radiological depth in the patient. This is performed by the function calcRadiolDepth().
Figure 2.3 – Diagram representing the dependencies used to build a Patient.
Figure 2.4 – Diagram representing the main function calls from the Patient object to
initialize and update the patient model.
The dependencies and principal functions called from a SimulatorDelivery object are
summarized in figures 2.5 and 2.6. During the simulation of the delivery gantry angles are
provided through an iterator of ScanningPathMultipleBeams and the positions, weights
and energies of the pencil beam are provided through an iterator of ScanningPath. At ev-
ery proton energy transition, during the delivery, the corresponding depth dose curve data
is obtained through the function dataForEnergy(). Before every computation of the dose
distribution induced by a pencil beam the true displacement vector of the patient body
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is obtained through the function getDisplacementVectorAtTime(). In addition, based on
this displacement vector, the radiological depth in the patient body re-computed and
accessed by getPatientDataForDisplVector(). Finally the dose distribution is calculated
with the function beamletSimulation().
In the implementation of the mitigation strategy we rely on the model of a motion mon-
itoring system (i.e., Monitor). Since its accuracy can vary, depending on MSPT settings,
we refer to the motion information provided as a measurement (i.e., true displacement
vector plus or minus some measurement error). To obtain this measurement the delivery
simulator invokes the function getMotionMeasurement(). This measurement is accessed
only when the pencil beam position changes.
Figure 2.5 – Diagram representing the relationships between the classes used to simulate
the delivery of a treatment in SimulatorDelivery).
Figure 2.6 – Diagram representing the main function calls from the SimulatorDelivery
object during the simulation of a delivery.
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Physics models
3.1 Coordinate systems
MSPT relies on three main coordinate systems to represent the patient being treated
and to simulate the delivery of a treatment. The first is the DICOM patient coordinate
system (see Section 3.1), which corresponds to the coordinate system defined in the pa-
tient CT images. The second coordinate system, called the International Electrotechnical
Commission (IEC) fixed coordinate system (see Section 3.1), is used to define specific
positions to relate position defined for the delivery and the DICOM patient coordinate
system. In addition, in MSPT, it is also used to define patient motion parameters. The
third coordinate system, namely the IEC gantry coordinate system (see Section 3.1), is
used to define the positions for the delivery at a specific gantry angle. We will present
these three coordinate systems in details in the next sections.
DICOM patient coordinate system
The patient is represented as volume by a 3D matrix from the CT image. Indices
of the volume elements (voxel) start at the top left corner of the first image slice (also
referred to as frame). The CT DICOM file specifies the location, in the DICOM patient
coordinate system, of this first voxel.
The DICOM patient coordinate system is defined by the Xdicom, Ydicom and Zdicom
axis. It is defined in the DICOM images by the abscissa (Xdicom) and ordinate (Ydicom)
orientation vectors are stored in the attribute Image Orientation Patient, expressing the
direction cosine of the first row of voxels and the first column with respect to the pa-
tient. Zdicom corresponds to the cross product of Xdicom and Ydicom. For example, if
Image Orientation Patient = [0, 0, 1, 0, 1, 0], the Xdicom axis is along the first row of vox-
els, Ydicom axis is along the first column of voxels and Zdicom is along the image frames’
direction.
Figure 3.1 shows the coordinate system and the voxel indexing system.
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Figure 3.1 – DICOM patient coordinate system and voxel indexing system.
The transformation matrix from voxel indices to the coordinate system is defined as
follows [Medical Imaging and Technology Alliance, 2011] :
Px
Py
Pz
1
 =

Xx∆i Yx∆j Zx∆k Sx
Xy∆i Yy∆j Zy∆k Sy
Xz∆i Yz∆j Zz∆k Sz
0 0 0 1


i
j
k
1
 (3.1)
Where:
• Px, Py, Pz are respectively the x, y, z coordinates of the voxel (k, j, i) in the volume
in units of mm.
• Sx, Sy, Sz are the coordinates of the Image Position Patient attribute in the CT
DICOM file. It corresponds to the coordinates, in mm, of the voxel (0, 0, 0).
• Xx, Xy, Xz are the components of direction cosine of the first row of voxels (from
the Image Orientation Patient attribute in the CT DICOM file).
• Yx, Yy, Yz are the components of direction cosine of the first column of voxels (from
the Image Orientation Patient attribute in the CT DICOM file).
• Zx, Zy, Zz are the components of direction cosine of the frames’ direction with
respect to the cross product between Xdicom and Ydicom.
• k, j, i are respectively the frame, row and column indices. They start at 0.
• ∆k, ∆j, ∆i are respectively the frame, row and column spacings of the voxels in
units of mm.
IEC coordinate systems
The IEC [International Electrotechnical Commission, 2011] defines standard coordi-
nate systems for equipment and data related to the process of radiation therapy. In our
38
MSPT: Motion Simulator for Proton Therapy
simulator, we used the IEC Fixed and Gantry coordinate system. These coordinate sys-
tems are Cartesian right-handed and are represented in Figure 3.2.
The IEC fixed (with respect to the patient/table) coordinated system has its origin at
the isocenter defined in the treatment plan. Its ZIEC Fixed axis points upward (i.e, toward
the nozzle when the gantry angle is 0◦ and the YIEC Fixed axis points along the gantry
rotation axis.
The IEC gantry coordinate system is the IEC fixed coordinate system rotated clock-
wise around the YIEC Fixed axis (i.e., the YIEC Gantry axis). Its ZIEC Gantry axis points toward
the nozzle.
Figure 3.2 – IEC Coordinate systems
For a clock-wise gantry rotation θ, a rotation matrix calculates the mapping of points
defined in the IEC fixed to the IEC gantry coordinate system:
XIEC Gantry
YIEC Gantry
ZIEC Gantry
1
 =

cos(θ) 0 sin(θ) 0
0 1 0 0
− sin(θ) 0 cos(θ) 0
0 0 0 1


XIEC Fixed
YIEC Fixed
ZIEC Fixed
1
 (3.2)
The transformation matrix to convert the coordinates of the DICOM coordinate sys-
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tem to the IEC fixed coordinate system:
xIECfixed
yIECfixed
zIECfixed
1
 =

1 0 0 −Ix
0 0 1 −Iy
0 −1 0 Iz
0 0 0 1


xdicom
ydicom
zdicom
1
 (3.3)
where I : (Ix, Iy, Iz) is the position of the treatment plan isocenter in the DICOM
coordinate system.
3.2 Patient and motion models
3.2.1 Patient representation
To model the patient, we first convert the CT# of each voxel into mass densities using
a default or user-defined conversion table and, then, into relative proton stopping powers,
which quantifies the proton energy loss induced by each voxel. Figure 3.3, represents the
default conversion table from CT# to mass density. It was obtained from RayStation
data.
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Figure 3.3 – Conversion from CT# to mass density
The conversion from mass densities into relative proton stopping power (i.e., rela-
tive to water proton stopping power) is based on a linear interpolation of mass stopping
power values. This interpolation uses tables storing the mass stopping power for proton
energies ranging from 30 MeV to 230MeV with a step of 5 MeV, later referred to as
”energies of reference”, for each of the following media: air (1.205 × 10−3 g.cm−3), adi-
pose (0.920 g.cm−3), water (1.0 g.cm−3), skeletal muscle (1.04 g.cm−3) and cortical bone
(1.85 g.cm−3). Hence, for a given proton energy and density one can easily compute the
mass stopping power using a linear interpolation between the energies and between the
densities. The mass stopping power table were obtained from the database PSTAR (Phys-
ical Measurement Laboratory) [Berger et al., 2005]. These tables provide for the mass
stopping power values, which are multiplied by the density to obtain the stopping power
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and divided by the stopping power of water in order to obtain the relative stopping power.
3.2.2 Motion management
The motion information, provided as an input, controls the motion simulation. The
motion consists of a function f : (x, y, z, t) 7→ (x′, y′, z′), time dependent providing the
new position of each voxel or intended delivery spot in the patient.
For the purpose of testing MSPT, the motion is currently simulated using a rigid body
transformation based on a breathing model, later referred to as ”ideal breathing model”,
defined by Lujan et al. [1999] and slightly modified by George et al. [2005] and Seco et al.
[2009], relying on a cosine function as follows:
x(t)
y(t)
z(t)
 =

x0
y0
z0
+

bx cos(
2pit
τx
+ φx)
by cos(
2pit
τy
+ φy)
bz cos(
2pit
τz
+ φz)

(3.4)
where (x0, y0, z0) is the initial position in the IEC fixed coordinate system, bx, by, bz are
respectively the motion amplitudes along the XIEC Fixed, YIEC Fixed and ZIEC Fixed axis, τx,
τy, τz the respective motion periods and φx, φy, φz the respective starting phase. Figure
3.4 shows an illustration of the breathing model along one axis.
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Figure 3.4 – Illustration of x(t) for the ideal breathing motion model: bx = 1.5 cm,
τx = 4.0 s, φx = 0 rad.
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In order to simulate more realistic breathing motions we developed other models to
allow variability in motion amplitude and period and to allow unexpected events such as
hiccup and cough.
To introduce variability in motion amplitude and period in the breathing model, we
included random variables in the ideal breathing motion model:
x(t)
y(t)
z(t)
 =

x0
y0
z0
+

brand x cos(
2pit
τrand x
+ φx)
brand y cos(
2pit
τrand y
+ φy)
brand z cos(
2pit
τrand z
+ φz)

(3.5)
where brand x, brand y and brand z are the random variables, calculated for each new
breathing cycle, representing the motion amplitude along the three coordinate system axis.
τrand x, τrand y, τrand z are the random variables, also calculated for each new breathing cycle,
representing the motion period for each coordinate. The breathing cycles for each axis
are calculated respectively by: b t
τx
c, b t
τy
c, b t
τz
c. All the random variables are associated
to a normal distribution. brand x is associated to the probability density function:
gx(u) =
1
σbx
√
2pi
e
−0.5×
u− bx
σbx
2
where σbx is the standard deviation of the distribution set by the user. brand y and
brand z are similarly defined . τrand x is associated to the probability density function:
hx(u) =
1
στx
√
2pi
e
−0.5×
(u− τx
στx
)2
where στx is the standard deviation of the distribution set by the user. τrand y and
τrand z are similarly defined. We will later refer to this model as ”irregular breathing
model”. Figure 3.5 shows an illustration of the breathing model along one axis.
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Figure 3.5 – Illustration of x(t) for the irregular breathing model: bx = 1.5 cm, σbx = 0.15
cm, τx = 4.0 s, στx = 0.4 s, φx = 0 rad. Note: the peaks present at 4 s and 8 s are due to
the random variations of brand x and τrand x occurring every new cycle. The ideal breathing
model is represented in dotted line.
To model unexpected events, we added variations to the motion amplitude at random
dates during the delivery. These variations were applied to the irregular breathing model.
The first event modeled, namely the hiccup, is considered as a periodical event starting
at a random date thic, and occurring every τhic seconds during Nhic cycles, where thic, τhic
and Nhic are random variables set at the motion initialization. Currently for testing, these
random variables are respectively associated to a uniform distribution over [0, 10[ (i.e, the
hiccup starts between 0 and 10 seconds after the beginning of the delivery), a uniform
distribution over [0, 3[ (i.e, the hiccup period is between 0 and 3 seconds) and a discrete
uniform distribution over [0, 10[ (i.e, the hiccup can occur between 1 and 10 times). The
motion amplitude is the sum of the amplitude from the irregular breathing model and a
random variable associated to a normal distribution of average
bx
2
(respectively
by
2
and
bz
2
) and standard deviation
σbx
2
(respectively
σby
2
and
σbz
2
). Figure 3.6 presents an illus-
tration of hiccups. The second event modeled, namely the cough, is considered as a single
event occurring at a random date obtained with a uniform distribution. For testing, this
random date is currently comprised between 0 and 30 seconds. Figure 3.7 presents an
illustration of a cough.
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Figure 3.6 – Illustration of x(t) with the hiccup model: bx = 1.5 cm, σbx = 0.15 cm,
τx = 4.0 s, στx = 0.4 s, φx = 0 rad. Hiccups dates of hiccup are indicated by the red
dotted lines. The motion without the hiccups is represented by the black dashed curve.
The ideal breathing model is represented in dotted line.
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Figure 3.7 – Illustration of x(t) with the cough model: bx = 1.5 cm, σbx = 0.15 cm,
τx = 4.0 s, στx = 0.4 s, φx = 0 rad. Cough date of hiccup is indicated by the red dotted
line. The motion without the cough is represented by the black dashed curve. The ideal
breathing model is represented in dotted line.
Presently, the user can also import motion information as a list of dates and displace-
ments from the initial position for each coordinate component. New motion functions
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could be implemented by the user or be part of future developments of MSPT.
In order to simulate a motion monitoring system, we add to the displacement vec-
tor a ”measurement noise” vector modeled by a random variable, for each coordinate
component. Hence, the motion measured by the monitoring system is:
xmeasure(t)
ymeasure(t)
zmeasure(t)
 =

x(t)
y(t)
z(t)
+

δrand x
δrand y
δrand z
 (3.6)
where δrand x is associated to the normal distribution of standard deviation σδx and a
mean value of 0. δrand y and δrand z are similarly defined. A new measurement noise vector
is generated for each motion measurement. The parameters σδx, σδy, and σδz, which can
be set in MSPT configuration file, model the monitoring system accuracy.
3.3 Dose calculation
We simulate the proton beams with the analytical beam model introduced by Hong
et al. [1996]. As often in medical physics, the model is based on computations in water,
a well-known uniform medium, and relies on a scaling procedure to another medium.
The model can be presented as follows. Let us consider the Cartesian coordinate system
whose origin is at the beam source and whose Z axis is along the beam. The beam source,
O(0, 0, 0) is defined by the virtual source-axis distance defined, for each beam rotation
angle, in the treatment plan. This corresponds to the distance between the virtual beam
source and the plan isocenter. Let P (x, y, z) be a point in the patient in this coordinate
system. Let Q(0, 0, z) be the orthogonal projection of P on the Z axis. Then, the dose d
received at P (x, y, z) is defined as:
d(x, y, z) = DDw(rpl(z), E0)×
(
ssd+ rplQ
z
)2
× 1
2pi(σtotQ)
2
× exp
(
− x
2 + y2
2(σtotQ)
2
) (3.7)
where:
• rpl(z) corresponds to the radiological depth, at Q, defined as the thickness of water
needed to obtain the same stopping power as the set of media encountered on the
beam’s trajectory in the patient, from the entrance point to Q. It is computed as
the cumulative stopping power relative to water of each medium encountered along
the beam [Szymanowski and Oelfke, 2002] using the ray-tracing algorithm presented
in [Siddon, 1985]. It quantifies the energy lost by protons to reach point Q and the
corresponding thickness of water needed to obtain the same energy loss.
• DDw(rpl(z), E0) corresponds to the dose deposited in Q considering a water envi-
ronment for a beam of protons of initial energy E0.
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• ssd is the distance from the source to the surface of the patient. It is computed using
the ray-tracing algorithm previously mentioned. The distance is measured from the
source to the first intersection between the ray and the patient’s body surface.
• The beam’s width is modeled by a two dimensional Gaussian which standard devi-
ation is the radial emittance term σtotQ . It corresponds to the sum of the beam’s
width at the patient entrance and the beam spreading function defined analytically
in [Hong et al., 1996]. The beam’s width at the patient entrance corresponds to the
scanning spot size provided in the treatment plan, σsize. The spreading function
defined in [Hong et al., 1996] is:
σQ(rpl(z)) = (0.0275×R + 0.12085× 10−4 ×R2)
×(0.33×
(
rpl(z)
R
)
+ 0.69×
(
rpl(z)
R
)2
)
(3.8)
where R is the depth of the Bragg Peak for a proton beam of energy E0. Hence,
σtotQ is computed as:
σtotQ =
√
σ2size + σ
2
Q (3.9)
As previously mentioned, MSTP has the ability to model scanning pencil beam based
on measured data or an existing beam model from other treatment planning systems.
Currently, the beam was modeled after the model ”ProtonMachine” from RayStation.
In order to match the absolute dose of ProtonMachine’s dose distributions in water, we
added a dose correction factor λ(E0) depending on the energy E0, represented in Figure
3.8. Hence, Equation 3.7 becomes:
dc(x, y, z) = λ(E0)× d(x, y, z) (3.10)
where, dc(x, y, z) is the dose calculated by MSPT at P. Physically, the correction factor
λ(E0) accounts of the change of Monitor Unit (MU) response at different proton energies,
as the plan imported and computed in MSPT aims at performing absolute dose compu-
tation with input MU for each beam. Users can easily define the λ correction factor to
match their proton machine.
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Figure 3.8 – Dose correction factor λ as a function of energy.
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The dose correction factors are obtained through simulations of 1 MU pencil beams
in a volume of water for different energy levels. A first simulation, for a given energy
E0, in ProtonMachine provides a dose distribution with an average dose of d1. The same
simulation in MSPT, with a dose correction factor of 1.0, provides an average dose of d2.
The dose correction factor for E0 is calculated as: λ(E0) =
d1
d2
.
In order to match the stopping power values used in ProtonMachine for various densi-
ties, we apply a multiplying factor to the stopping power obtained from PSTAR database.
The multiplying factor depends on the density and is represented in Figure 3.9. It mainly
has an impact on low densities up to 0.8 g.cm3, after what it stays close to 1. Physically,
this factor aims at correcting the approximation made when calculating the stopping
power for tissues whose densities are comprised between the ones of air (1.2×10−3 g.cm3)
and adipose (0.9 g.cm3), which were the only body media available in PSTAR for density
lower than 0.9 g.cm3. This correction factor can also be user-defined.
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Figure 3.9 – Stopping power correction factor (SPCF) as a function of mass density.
The correction factor was obtained through simulations of a single proton pencil beam,
of fixed energy, in an homogeneous medium, of a given density, using ProtonMachine and
MSPT where the correction factor was set to 1.0. In both dose distribution computed, we
measured the distance between the beginning of the ray in the medium and the Bragg
Peak. Then, we calculated the ratio of these distances, which correspond to the scaling
factor γ of the given density: γ =
d1
d2
, where d1 and d2 are respectively the distances
measured in the dose grid obtained respectively from ProtonMachine and MSPT. γ corre-
sponds also to the ratio of the radiological depth, which will be introduced in the next
section. γ calculation relies on the assumption that the Bragg Peak occurs, for a given
medium, at the same depth in ProtonMachine and in MSPT. We repeated this process
for a set of densities in the range 1.205 × 10−3 g.cm−3 to 1.85 g.cm−3. In media of low
density the Bragg Peak can occur outside the volume considered for the simulation if the
medium m represented is not thick enough. Therefore, when the Bragg Peak is outside
this volume a slab of water can be added such that the Bragg Peak occurs in water. Then,
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γ = 1 +
dw2 − dw1
dm1 × Smw , where dw1 and dw2 are the depths in water where the Bragg Peak
occurs respectively in the dose distribution of the ProtonMachine and MSPT. dm1 is the
thickness of m penetrated by the beam which is the same in both dose distributions. Note
that dm1 should be greater than the thickness of the slab of water for a better accuracy.
Finally, Smw is the relative proton stopping power of m.
The depth-dose curves of the energies of reference have been generated from simula-
tions of mono-energetic proton beams in water using ProtonMachine. This dose compu-
tation was later also used to benchmark the accuracy of MSPT. To generate these integral
depth dose curves, we integrated the 3D dose distribution obtained along the X and Y
axis to obtain the dose along the depth, i.e., Z axis. To obtain the integral depth-dose
curves for other energies, later referred to as ”interpolated energies”, we interpolate be-
tween those already generated. The interpolation for a desired energy E1, starts with
finding the two consecutive energies E0 and E2 in the list of ”energies of reference” such
that E0 < E1 < E2. Using a linear interpolation between the Bragg Peak positions BP0
and BP2, respectively for E0 and E2, we obtain the Bragg Peak location BP1 for E1.
Then, we shift the depth-dose curve of E2, along Z, by the difference between BP2 and
BP1 and keep the portion of the curve where the depth is positive. Finally, we scale the
curve by a factor α to ensure that the number of protons used in a 1MU beam of energy
E2 is preserved, as performed in ProtonMachine. To do so, we compute the number of
protons (NE2) used to reach 1MU at E2 as:
NE2 =
AE2 × ρwater
E2
(3.11)
where AE2 is the area under the depth-dose curve in [Gy.cm
3], ρwater the water density in
[Kg.cm−3] and E2 the energy expressed in Joules. Then, we calculate the area under the
current depth-dose curve for E1 (i.e, AE1curr). Finally, we calculate the scaling factor α
between the expected area under the curve for E1 (i.e, AE1) and AE1curr, in order to have
the same number of protons equals to NE2 . Hence, we obtain:
α =
AE1
AE1curr
=
NE2 × E1
ρwater × AE1curr
(3.12)
where E1 is expressed in Joules. Depth-dose curves used by MSPT can also be user-defined.
3.4 Delivery process
To simulate the delivery, MSPT follows the order of beam angles, energy layers (deliv-
ered from the highest energy to the lowest), spot positions and delivery duration (i.e.,
spot weights) provided by the plan. In order to be able to compute the dose distribution
in 4D and to render its evolution in the entire volume at a low time scale, we divide the
time spent by the beam at a position, e.g., 10 ms, into units of time of, for example, 1
ms, between which we consider the patient as non-static. Therefore, every unit of time
the patient position and the radiological depth are updated using the motion information.
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The dose distribution corresponding to the new position is then computed.
In order to take the time into account during the delivery, we created a timer, rep-
resenting the time during the delivery. This timer is updated based on events occurring
during the delivery. Table 3.1 summarizes events having a fixed duration during the
delivery. Through MSPT configuration file, the user can easily set new values for these
events.
Action Duration Condition Source
Gantry rotation 1 rpm None [Ding et al., 2007]
Energy transition 50 ms Cyclotron [Schippers et al., 2007]
Energy transition 2.1 s Synchrotron [Smith et al., 2009]
Spill duration 5s Synchrotron [Kraus et al., 2011]
Lateral scanning speed 10 m.s−1 None
[Kraus et al., 2011],
[Kang et al., 2007]
Vertical scanning speed 10 m.s−1 None
[Kraus et al., 2011],
[Kang et al., 2007]
Table 3.1 – Temporal values of some delivery’s events.
Two other events, whose duration depends partly on the treatment plan, were also
considered: the time needed to move the beam from one position to another and the time
spent at a spot position. The former event’s duration is calculated as follows:
tmove = max
( | pi+1x − pix |
vlateral
,
| pi+1y − piy |
vvertical
)
(3.13)
where pi =
( pix
piy
)
is the current beam position, pi+1 =
( pi+1x
pi+1y
)
is the next position,
vlateral is the lateral scanning speed, and vvertical is the vertical scanning speed. The time
the beam needs to remain at a position is fixed, in the treatment plan, by the weight in
MU:
tspot =
weight [MU ] × number of protons per MU [protons.MU−1]
extraction rate [protons.s−1]
(3.14)
The number of protons per MU used in ProtonMachine is 1 × 109. According to
Gro¨zinger et al. [2008] the typical time per beam position is around 5 to 10 ms. Hence
we considered it to be 10 ms and using the average beam’s weight of 0.073 MU obtained
in a real treatment plan computed with ProtonMachine, we fixed the extraction rate
to 7.3 × 1010 protons.s−1. The number of protons per MU and the extraction rate are
parameters that can be modified by the user in MSPT configuration file.
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Simulator evaluation
In order to assess the consistency of the dose calculations in MSPT we performed a
series of evaluations using ProtonMachine as a benchmark.
A first part of the evaluation consists of simulations of single mono-energetic proton
beams in a volume of water. Water, being a well-known medium, is often used as a
reference for calculations or experiments in radiation therapy physics. For example, depth-
dose curves of reference used for dose calculation in commercial TPS are obtained from
analysis of beams in water. In calculations, the data in water is scaled or transformed
to be used for other media. A second part of the evaluation consists of simulations for
patient cases in order to assess the coherency of the dose calculation in environments more
complex than water. The last part of the evaluation consists of a comparison between a
static delivery and a dynamic delivery in MSPT to show the impact of motion.
4.1 Simulations in water
First we compared the dose distributions obtained in water for many energies using
ProtonMachine and MSPT. We simulated in MSPT mono-energetic proton beams of 1 MU
in a volume of water for the ”energies of reference” (i.e., energies ranging from 30 MeV
to 230 MeV, with a 5 MeV step) and 19 ”interpolated energies” in the range 39 MeV -
119 MeV, corresponding to the set of energies used in a patient treatment plan. Then, we
computed the same beams in ProtonMachine. Finally, we compared the dose distributions
considering, for each energy, the depth-dose curve, the location of the Bragg Peak and
the lateral dose profiles at the Bragg Peak using the standard deviation σ of the Gaussian
curves obtained.
Figure 4.1 shows examples of dose profiles obtained at 55, 130 and 210 MeV. The av-
erage (± standard deviation) and the median of the dose errors observed for the energies
of reference were 0.2% (± 2.5%) and 0%. These statistics were 2.4% (± 11.9%) and 0%
for interpolated energies. In the former case, 99% of the sample points of the depth-dose
profiles had a dose error smaller than 5% and 93% in the latter case.
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Figure 4.1 – Plot representing the depth dose curve for the beamlet dose distributions
obtained at 55 MeV, 130 MeV and 210 MeV (respectively top left, top right and bottom)
with ProtonMachine and MSPT in water, for the same monitor units.
We compared the Bragg Peak location for each energy level in the sets of energies of
reference and interpolated energies (see Figure 4.2). One can notice that MSPT matches
closely the depths of Bragg Peaks obtained with ProtonMachine. For the energies of refer-
ence, no difference was found in the Bragg Peak location. Regarding interpolated energies
(39 - 119 MeV), an average error of 1.1 mm (± 1.5 mm) was found. This is acceptable
considering the dose grid size of 3 mm.
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Figure 4.2 – Absolute difference of Bragg Peak depth for beamlets simulated with Pro-
tonMachine and MSPT for energies ranging from 30 MeV to 230 MeV in water.
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We further analyzed the lateral dose profiles at the Bragg Peak from ProtonMachine
and MSPT. As illustrated in Figure 4.3 for given energies (55, 130 and 210 MeV), they are
in agreement. In Figure 4.4, we plot the differences between the standard deviation, σ,
computed from the lateral profiles being considered as Gaussian curves for each energy.
The average difference of σ, for the energies of reference, is 0.17 mm (± 0.16 mm).
Regarding interpolated energies, the average difference found was 0.06 mm (± 0.03 mm).
In both sets, the error is smaller than the dose grid-resolution. The average difference
is smaller for interpolated energies since these energies are only in the low and medium
energy range (< 119 MeV).
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Figure 4.3 – Plot representing the lateral profiles at the Bragg Peak for the beamlet
dose distributions obtained at 55, 130 and 210 MeV (respectively top left, top right and
bottom) with ProtonMachine and MSPT in water.
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Figure 4.4 – Plot representing sigma for the dose distributions computed in ProtonMachine
and MSPT for energies ranging from 30 MeV to 230 MeV in water.
In this verification process we observed that the dose distributions obtained for the
energies of reference were matching closely the dose distribution obtained with Proton-
Machine. For the interpolated energies, larger errors were observed at the Bragg Peak
depth or the fall-off after the Bragg Peak. The evaluation of the Bragg Peak positions
for this set of energies showed that the average error was 1 mm: 7 energies had an er-
ror of 3 mm, corresponding to the dose grid resolution, and 12 of them were correctly
located. Moreover, the Bragg Peak location easily induces large dose errors especially
when a slight shift of the depth of the Bragg Peak has occurred. This explains why the
standard deviation of the dose error for interpolated energies is large while only 7% of
the sample points used in the depth-dose profiles had an error larger than 5%. For both
sets of energies, the error of σ stayed smaller than the grid resolution. The difference
observed at high energies can be explained by the consideration of nuclear interactions
in ProtonMachine beam’s spreading model unlike MSPT. Overall, we can observe similar
trends for both σ curves. Therefore, the MSPT model of the beam’s spread is consistent
with ProtonMachine’s. As MSPT aims at evaluating and comparing the effect of motion on
different plans or different motion management/mitigation strategies, the absolute dose
accuracy is not of highest concern; we consider the dosimetric accuracy achieved in MSPT
as acceptable for its purpose.
4.2 Simulations on patient datasets
A second part of MSPT evaluation focused on the dose distributions simulated for 8
patient cases with different treatments summarized in Table 4.1.
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Tumor
Location
Patient
Index
Tumor size
(cm3)
Beam angle(s)
(degrees)
Prescription per
fraction (Gy)
Head and neck HN1 89 180 1.8
Lung Lung1 143 220 / 320 1.8
Lung Lung2 21 270 2
Lung Lung3 89 180 1.8
Lung Lung4 28 200 6
Lung Lung5 21 15 10
Lung Lung6 207 180 15
Pelvis Pelvis1 1447 90 / 270 2.16
Table 4.1 – Patient cases summary
First, we will present the most representative cases: one case (Lung1) that shows an
excellent match with ProtonMachine, and one case (Lung6) that highlights an artifact
observed when comparing MSPT to ProtonMachine. Then we will present the overall
comparisons.
4.2.1 Example of patient case simulation
The first example of a patient case simulation is for a lung tumor treatment (Lung1
in Table 4.1). We compare the dose distributions planned and calculated with Proton-
Machine and re-computed in MSPT. We analyze, for both distributions, the dose-volume
histogram, which is the principal tool used by clinicians to evaluate the quality of a treat-
ment plan. The size of the lung tumor is 143cm3(GTV). It relies on 2 beams with gantry
angles of 220◦ and 320◦. The dose prescription is 180cGy per fraction. To compare the
DVHs quantitatively, we consider dosimetric parameters, which are often used to assess
the quality of a treatment plan: the dose delivered to 95% (D95%) and 5% (D5%) of the
tumor volume and the normalized volume of different body tissues receiving a given per-
centage of the prescribed dose: 10% (V10), 33%(V33), 50%(V50), 66%(V66) and 90%(V90).
We also compare the mean dose received by these tissues (Dmean). In addition, we perform
a 3D gamma test [Low et al., 1998] to analyze the differences between the distributions.
Figure 4.5 shows the resulting DVHs for ProtonMachine and MSPT. We can observe
that they are similar. Tables 4.2 and 4.3, summarize the dosimetric parameters measured
in dose distributions obtained in ProtonMachine and MSPT, respectively for the tumor and
other body tissues.
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Figure 4.5 – DVH comparison between ProtonMachine and MSPT for the lung tumor case.
Tissue D95% (cGy) D5% (cGy)
ProtonMachine MSPT ProtonMachine MSPT
GTV 178.5 174.5 193.5 203.5
Table 4.2 – Dose received by 95% and 5% of the tumor volume for simulations in Proton-
Machine and in MSPT.
Tissue Software V10(%) V33(%) V50(%) V66(%) V90(%) Dmean(cGy)
Bone
ProtonMachine 16 8 4 2 0 11.87
MSPT 14 8 4 2 1 10.85
Right Lung
ProtonMachine 60 44 19 11 5 53.63
MSPT 58 42 16 10 5 51.68
Esophagus
ProtonMachine 40 34 31 28 21 56.65
MSPT 40 35 33 30 24 61.18
Table 4.3 – Volume receiving 10, 33, 50, 66 and 90 % of the prescribed dose and the
average dose received by the OARs in ProtonMachine and in MSPT.
The tumor coverage between ProtonMachine and MSPT was comparable. The error was
2.24% for D95% and 5.16% for D5%. Moreover, considering the other tissues, the average
differences of relative volume were small: 1.3%, 1.0%, 1.7%, 1.0% and 1.3% respectively for
V10, V33, V50, V66 and V90. The average difference of the mean dose received by the OARs
(Dmean) was 6.7%. In addition, the 3D gamma analysis comparing the dose distributions
from ProtonMachine and MSPT yielded a passing rate of 96% using a standard threshold
of 3 mm / 3%; showing an excellent match between the computed data and the data used
as a benchmark. The good agreement between them was also confirmed visually (see in
Figure 4.6) when overlaying the dose distributions and the patient CT image.
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(a) (b)
Figure 4.6 – Dose distributions computed in ProtonMachine (4.6a) and in MSPT (4.6b)
overlaying the patient CT image (transverse plane located near the middle of the tumor).
The comparisons of the dose distributions in patient data sets showed that those com-
puted in MSPT were in agreement with those from ProtonMachine. The differences are
clinically acceptable based on the DVH distribution and a 3D Gamma passing rate of
96% using 3 mm / 3% criteria.
4.2.2 Artifact observed in the dose distribution
An artifact was observed when comparing the dose distributions obtained from the
ProtonMachine and simulated in MSPT. We will present this artifact on the following
Stereotactic Body Radiation Therapy (SBRT) lung tumor case (Lung6 in Table 4.1): the
size of the tumor is 208 cm3(PTV). It relies on a single beam with a gantry angle of 180◦.
The dose prescription is 1.5 Gy per fraction.
Figure 4.7 presents images of the resulting dose distributions. Figure 4.8 shows the
DVHs obtained from ProtonMachine and MSPT. One can note that a part of the PTV
received a higher dose in MSPT than in ProtonMachine, which corresponds to hot spots,
and that a part of the right lung received a lower dose, which correspond to cold spots.
These hot and cold spots can be located more clearly in Figure 4.9. This artifact was
observable in the different data sets but was not always as clear as in this example.
Since this problem occurred in the different data sets, we can consider that this artifact
is a systemic error. We investigated the source of this problem without finding a clear
origin. However, the main assumption is that differences appear in the radiological depth
between ProtonMachine and MSPT, which could result in a non exact matching of the
stopping power values assigned to the density values in both software. If one, wanted to
match exactly MSPT to ProtonMachine, a deeper study should be performed to assert or
refute our assumption and obtain a more accurate stopping power correction factor (see
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Section 3.3). In the context of our work, the goal being to compare static and dynamic
situation, to render the impact of motion, this study was not decisive and therefore, we
did not led further the investigation.
(a) (b)
Figure 4.7 – Dose distributions computed in ProtonMachine (4.12e) and in MSPT (4.12f)
overlaying the patient CT image (transverse plane located near the middle of the tumor).
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Figure 4.8 – DVH comparison between ProtonMachine and MSPT: observation of hot spots
in the PTV and cold spots after the tumor (right lung) in MSPT dose distribution.
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Cold spots
Hot spots
Figure 4.9 – Hot and cold spots (respectively located by the red and blue rectangles)
present in the comparison of the dose distributions (Figure 4.7). They are overlaying
the patient CT image. The rectangles correspond to the hot and cold spots indicated in
Figure 4.8.
4.2.3 Overall comparison
To compare the dose distributions of all the patient cases we consider the following
DVH dosimetric parameters: the dose delivered to 95% (D95%) and 5% (D5%) of the
tumor volume and the normalized volume of different body tissues receiving a given per-
centage of the prescribed dose: 10% (V10), 33%(V33), 50%(V50), 66%(V66) and 90%(V90).
We also compare the mean dose received by these tissues (Dmean). The gamma analysis,
requiring a lot of time and being carried out by our collaborators, is not performed on
all the patient cases. Therefore, we don’t use this criterion in our comparison. Figures
4.11 and 4.12 show the resulting dose distributions obtained for the different patients in
ProtonMachine and in MSPT. Figure 4.10 presents the resulting DVHs. Tables 4.4 and 4.5
provide the dosimetric measures respectively for the tumor and the OARs.
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(c) Lung2
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Figure 4.10 – DVHs of the 8 patient cases for ProtonMachine and MSPT
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(a) HN1 in ProtonMachine (b) HN1 in MSPT
(c) Lung1 in ProtonMachine (d) Lung1 in MSPT
(e) Lung2 in ProtonMachine (f) Lung2 in MSPT
(g) Lung3 in ProtonMachine (h) Lung3 in MSPT
Figure 4.11 – Images of the dose distributions of patient cases HN1, Lung1, Lung2 and
Lung3 for ProtonMachine (left column) and MSPT (right column).
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(a) Lung4 in ProtonMachine (b) Lung4 in MSPT
(c) Lung5 in ProtonMachine (d) Lung5 in MSPT
(e) Lung6 in ProtonMachine (f) Lung6 in MSPT
(g) Pelvis1 in ProtonMachine (h) Pelvis1 in MSPT
Figure 4.12 – Images of the dose distributions of patient cases Lung4, Lung5, Lung6 and
Pelvis1 for ProtonMachine (left column) and MSPT (right column).
Patient HN1 Lung1 Lung2 Lung3 Lung4 Lung5 Lung6 Pelvis1
D95% error (%) 1.91 2.84 2.60 7.77 1.48 3.86 3.03 0.01
D5% error (%) 0.51 3.86 9.68 15.96 8.38 42.23 9.77 0.16
Table 4.4 – Average error of the dosimetric parameters in the tumor volumes of the
different patient cases. The error is relative to the maximum dose of the tumor volume.
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Patient V10 error (%) V33 error (%) V50 error (%) V66 error (%) V90 error (%) Dmean error (%)
HN1 2.50 0.99 1.00 1.00 0.00 0.69
Lung1 1.33 1.00 1.67 0.99 1.33 6.74
Lung2 3.50 2.00 0.50 0.00 0.00 41.62
Lung3 1.33 0.67 0.67 0.67 0.00 30.38
Lung4 2.00 0.00 0.00 0.00 0.00 6.44
Lung5 2.50 0.50 0.00 0.00 0.00 8.09
Lung6 4.50 1.00 0.00 1.00 1.50 12.76
Pelvis1 2.25 2.25 1.25 1.00 0.50 2.90
Table 4.5 – Average error of the dosimetric parameters in the OARs of the different patient
cases.
Visually, from Figures 4.11 and 4.12, we can say that dose distribution appear similar
except at the border of the tumors where overdosed regions are visible (in red). The visual
comparison of the DVHs (see Figure 4.10) indicates that in both software the dose-volume
curves follow the same trend and the same order of magnitude. In addition, the error for
the D95% and D5% values (see Table 4.4) are respectively 2.35% and 9.55%. The compar-
ison of the dose distributions in the OARs (see Table 4.5) indicates that the average dose
received differs by 13%. The large dose differences in the OARs, more specifically for cases
Lung2 and Lung3, are located in organs filled with air: carina and esophagus. However,
in Table 4.5 we can note that the differences of volume receiving a certain percentage of
the prescribed dose are smaller than 5% and that the largest differences represent less
than 10% of the dose prescription.
Based on the average error for the D95% value, we can say that the dose coverage,
which is the principal goal of the treatment, obtained in MSPT is comparable to the cov-
erage in ProtonMachine. The main difference observed is at the border of the tumor, as
described in Section 4.2.2. The D5% error and the overdosed regions in the dose distri-
bution images indicate this difference. In addition we can observe that the error is larger
in lung cases. That is why we think that the presence of lungs on the beam’s trajectory
impacts the dose calculation. Lungs density lies in the range between air (1.2 × 10−3
g.cm−3) and adipose (0.9 g.cm−3), where the stopping power correction factor (see Sec-
tion 3.3) is important. This factor improved significantly this problem but did not remove
it entirely. That is why we think that the mass stopping power factor function could be
refined to improve its accuracy. In addition, the stopping power being the key element
of the radiological depth, this strengthens our assumption that the artifact is due to the
radiological depth. The mean dose difference for the OARs represent is around 13%,
which is higher than the 5% acceptability threshold. However this difference at the scale
of the treatment represents less than 10% of the dose prescription. Than is why we can
observe that the DVH curves of MSPT and ProtonMachine are close. Therefore, we can
consider that the dose distributions of MSPT, while not being comparable, are coherent
with the dose calculation in ProtonMachine. The source of the dose differences for the
OARs has not been found, but might be the result of the overdose occurring in the tumor.
To conclude we can say that MSPT reproduces the expected dose coverage, but overdoses
the border of the tumor especially in lung cases. This might impact the dose distribution
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in the OAR and explain the dose differences but this has not yet been proven. However,
DVHs present the same overall trend and the same order of magnitude as ProtonMachine.
So we can we can consider that the dose distributions of MSPT, while not being comparable
for all cases, are coherent with the dose calculation in ProtonMachine. Finally, as men-
tioned previously, in the context of our work the primary goal was to be able to compute
as dose distribution coherent with the dose calculation performed by ProtonMachine in
order to compare static and dynamic dose distributions in MSPT. Therefore, we consider
the results as acceptable for our study.
4.3 Impact of motion
As previously mentioned, with MSPT, one can evaluate the robustness in regards to
motion of a treatment plan by performing a first simulation for a static patient and a sec-
ond simulation with a moving patient. To simulate the motion, we use the ideal breathing
model described in Section 3.2.2. The motion amplitudes are 0.5, 1 and 1.5 cm for re-
spectively, X, Y and Z axis. The respective motion periods are 5, 4 and 3 seconds. These
values correspond to realistic amplitudes and periods of breathing motions Seco et al.
[2009]. To show the impact of motion on the dose distribution we compare the dose dis-
tributions using the dosimetric parameters D95% and D50%. We perform the experiment
on the lung tumor case presented previously.
To present a concrete delivery example, we chose to model a synchrotron due a longer
time delay for the energy transitions, even though the user could use a cyclotron model.
We set different time and distance parameters based on data provided in the literature
and in the treatment plan. The rotational speed of the gantry is set to 1 rotation per
minute [Ding et al., 2007], the time to change the beam’s energy is set to 2.1 s [Smith
et al., 2009], the spill duration is set to 5 s [Kraus et al., 2011] and the lateral and vertical
scanning speed are both set to 10 m.s−1 [Kraus et al., 2011]. The number of protons per
MU used in ProtonMachine is 1 × 109 protons per MU. The extraction rate was set to
7.3×1010 protons.s−1. The time to move from one beam position to another is estimated
as the maximum between the time for the lateral shift and for the vertical shift. The beam
size used is read from the treatment plan and is equal to 5 mm. The distance between
energy layers is approximately 3 mm at low energies and 7 mm at high energies.
To show the impact of the motion simulated in MSPT, we compared the resulting dose
distributions of a treatment plan of a patient in a static and a moving situation. First,
comparing the DVHs (see Figure 4.13), one can easily observe that the tumor coverage has
been highly degraded due to the motion. This is validated by the dosimetric parameters
(see Table 4.6) D95% and D50%. Indeed, in the static patient, 95% of the tumor volume
received 97% of the dose prescription (i.e., 174.5 cGy) and 50% of the tumor volume
received 102% of the prescription (i.e., 184 cGy); whereas, in the moving patient 65% of
the prescription (i.e., 118.5 cGy) was delivered to 95% of the tumor and 89% (i.e., 160.5
cGy) to 50% of the tumor.
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Figure 4.13 – Comparison of DVHs for a delivery on a static and dynamic patient.
D95%(cGy) D50%(cGy)
Static patient 174.5 184
Dynamic patient 118.5 160.5
Table 4.6 – Dose received by 95% and 50% of the tumor volume for the delivery of a
treatment plan simulated, for a patient static and the same patient moving, in MSPT.
We visually compared dose distributions (see Figure 4.14), for transverse planes located
near the middle and in the vicinity of a border of the tumor. First, we noted some dose
heterogeneities in the target region (Figures 4.14a and 4.14b), which was validated by
the cold spots present in Figure 4.15a corresponding to underdosed areas. Moreover, the
comparison of Figures 4.14c and 4.14d exhibits a great difference in the delivery of the
two target spots. As illustrated in Figure 4.15b the targets are missed (presence of cold
spots) while other regions have been wrongly irradiated (hot and cold spots).
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(a) (b)
(c) (d)
Figure 4.14 – Dose distributions computed overlaying a patient CT image (transverse
planes), for a static (4.14a, 4.14c) and a moving patient (4.14b,4.14d). Slices 4.14a and
4.14b are located near the middle of the tumor and slices 4.14c and 4.14d are located near
a border of the tumor.
(a) (b)
Figure 4.15 – Hot and cold spots present in the dose distribution of the moving patient
overlaying the patient CT image (transverse planes). They correspond to the dose distri-
butions in Figure 4.14. Slice 4.15a is located near the middle of the tumor and slice 4.15b
is located at a border of the tumor.
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The presence of cold spots in the tumor, the presence of hot spots in regions that were
not supposed to be irradiated and the differences of 32% for the D95% parameter and 13%
for D50% in the tumor indicate that the tumor is not properly targeted and healthy tissues
are wrongly irradiated. Therefore, this treatment plan delivered to this dynamic patient
did not achieve its goal: the tumor did not received enough dose and healthy tissues were
not properly protected. These conclusions indicate that the plan used is not robust to
the patient intra-fraction motions. One would have to consider another treatment plan
or implement mitigation methods.
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Chapter 5
Compensation technique
In order to improve the robustness to motion of the spot scanning technique we pro-
pose a new approach based on a beam weight compensation technique. This work on this
mitigation strategy is preliminary study to show some interests and limitations of this
approach.
Other mitigation strategies already exist. One of the most common techniques is the
beam gating [Keall et al., 2006; Minohara et al., 2000], which consists of irradiating the
patient only when the patient reaches a certain phase of the breathing motion (see Figure
5.2). Patient motions, such as breathing, can also be controlled through coaching [Hughes
et al., 2008] by audio or visual feedback in order to limit the cycles variability. Motion
can also be dealt with through breath-hold technique [Wong et al., 1999] or apnea and
anesthesia [Eckermann et al., 2011]. These techniques are promising solutions but tend
to be constraining for the patient since.
Figure 5.1 – Illustration of the beam gating delivery. Patient motions are represented in
blue and threshold level for gating in green. The patient is being irradiated when the
beam is ”on” and the beam is ”off” otherwise.
Other promising strategies more specific to the spot scanning techniques have been
investigated: the repainting (also called re-scanning) [Zenklusen et al., 2010] and the
beam tracking [Bert et al., 2012; Saito and Bert, 2012]. The repainting technique consists
of delivering the planned dose into several cycles instead of a single pass. The goal is
to obtain a high scanning speed by reducing the time spent at each spot position and
reduce the risk of large localized dose discrepancies. While this technique is encouraging
it does not take into account the patient motions during the delivery. The beam tracking
method (see Figure 5.2) calculates the target displacement and uses this information
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to adapt the beam position (lateral compensation: scanning magnets adapt the beam
position) and beam energy (longitudinal compensation: adaptation of the thickness of
material encountered by the beam to move the Bragg peak position) to aim the planned
target point in the patient. This method is particularly promising, however, it requires
the compensation both for the position and the energy. That is why we wanted to develop
and study a technique that only adapts the beam’s weights, that take into account the
patient intra-fraction motion and that can be delivered without constraining the patient.
Figure 5.2 – Illustration of the beam tracking system. [Saito and Bert, 2012]. The motion
monitoring system measures the patient displacement, the 4D treatment planning (4D
TP) calculates the target displacement and the therapy control system (TCS) controls
the compensation (i.e., beam position and energy).
5.1 Principle of the compensation technique
The overall principle of our compensation strategy is to adapt the pencil beam’s weight
to the point in the patient targeted by the beam. The weight to be used is obtained from
the patient displacement vector and the weight of the beam position that was originally
planned for the irradiation of this target point.
More formally, let us consider an treatment plan, for which the beam positions for
the beam energy En are represented by the points (bi, wi), where i indicates the beam
index, bi the beam position and wi the corresponding planned weight. This plan in-
duces the irradiation of respective (Pi), the target points of the energy layer associated
to En in a static patient (see Figure 5.3) located at the depth of the Bragg peak. (Pi)
is irradiated by the beam (t = i, w = wi) where t is the date and w the weight of the beam.
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Figure 5.3 – Illustration of the delivery for a static patient. Beam positions are represented
in green. Beams are represented in red. Target points in the patient are represented in
blue.
One can now consider the same treatment plan delivered to a moving patient. The
motion is considered in 2D, in the plan orthogonal to the beam direction, as a displacement
vector v(t). As an example, at date t = 2, the beam will be at position b2 and will deliver
a weight w2. However, because of v(t) at t = 2, another target point than P2 can be
irradiated, e.g., P5, which would receive an irradiation corresponding to w2 instead of w5
(see Figure 5.4).
Figure 5.4 – Illustration of the delivery for a moving patient without the compensation
technique. Beam positions are represented in green. Beams are represented in red. Target
points in the patient are represented in blue. The 2D displacement vector is represented
in orange.
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Let us consider v(t) being expressed as v(t) =
( vH(t)
vV (t)
)
, where vH(t) and vV (t) are
respectively the horizontal and vertical components of v(t). As previously explained in
the example, at date t = 2, the beam is positioned at b2 and targets P5. The compensation
technique relies on the adaptation of the beam weight w, which is set to w5 instead of w2
(see Figure 5.5).
Figure 5.5 – Illustration of the delivery for a moving patient with the compensation
technique. Beam positions are represented in green. Beams are represented in red. Target
points in the patient are represented in blue. The 2D displacement vector is represented
in orange.
For a given beam energy, En, we say that the beam position bi =
( biH
biV
)
, where biH and
biV are respectively the horizontal and vertical components of the beam position, can be
compensated at the date t, if for a given displacement v(t) =
( vH(t)
vV (t)
)
of the patient body,
there exists bk =
( bkH
bkV
)
, with wk > 0, in the neighborhood of the positions
( biH−vH(t)
biV −vV (t)
)
belonging to the beam positions planned for En. Hence, if bi can be compensated at t,
the beam’s weight is set to wk. The neighborhood, is defined by the rectangle centered at( biH−vH(t)
biV −vV (t)
)
of length ∆H and width ∆V , where ∆H and ∆V are respectively the minimum
horizontal and vertical distances (> 0) between two consecutive beam positions.
5.2 Strategy of the compensation technique
5.2.1 Strategy presentation
The strategy used for the compensation of 2D motions orthogonal to the beam’s
directions relies on the non-volumetric re-scanning principle. For each energy level, the
pencil beam moves at the positions in order. Once the beam is set at a position bi, if it can
be compensated (see previous section) the weight is adapted and the entire planned weight
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wk is delivered (i.e., wk is not divided as in the conventional re-scanning technique), and
wk will not be used for another future position. If the position cannot be compensated,
the beam moves to the next position. When all the positions have been scanned once, the
beam re-scans all the positions to deliver the weights that have not been used to irradiate
the targets. The number of re-scans is not limited. However, if one needs to prevent from
a high number of re-scans, it is possible to add a margin around the planned positions
(see Figure 5.6).
Figure 5.6 – Illustration of the delivery for a moving patient with the compensation
technique where a margin is added around the planned positions. Beam positions are
represented in green. Beams are represented in red. Target points in the patient are
represented in blue. The 2D displacement vector is represented in orange.
To generate the margin we represent the initial spot positions of an energy layer in
a 2D array as a binary image: 1 at the spot positions and 0 otherwise. We apply the
dilation, a morphological operator, to this binary image to extend the region covered by
the initial positions. The structuring element used for the dilation is a single pixel of
the considered image. The dilation is repeated a number of times corresponding to the
number of iterations needed to achieve the margin thickness parameter provided in the
configuration file. To each pixel of the 2D representation, in the margin area, is associated
a beam position, of weight w = 0, defined based on ∆H and ∆V previously introduced,
which corresponds to the dimensions of a pixel. Figure 5.7 presents an example of the 2D
representation of the initial beam positions and the margin.
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Figure 5.7 – Example of a 2D representation of the beam positions (in green), the margin
region (in red) and the region where no beam position is defined (in blue) for a single
energy layer.
The spot positions are updated at the end of each scan in order to keep only the initial
beam positions whose weight has not been used for the irradiation. The margin is then
recomputed.
The user can control the margin in the MSPT configuration file.
5.2.2 Compensation algorithm
In this section we will present the compensation algorithm. We will keep the notations
introduced in Section 5.1. Variables used in Algorithm 2 correspond to variables defined
in Algorithm 1. Algorithm 1 represents the overall process of the compensated delivery.
The process of the function used to determine whether the compensation can be applied
for a beam position is presented in Algorithm 2.
Algorithm 1: Algorithm of the compensated delivery. TP is the treatment plan
provided by the user.
1 begin
2 foreach Gantry angle in TP do
3 foreach Energy level in TP do
4 Build lpos the list of all the beam positions;
// Note: if margin is used, include in lpos the margin beam positions
with weight = 0 if margin is used.
5 Build lplan the list of all the beam positions (weights > 0);
6 while lplan is not empty do
7 foreach Beam position bi in lpos do
8 Set the beam position to bi;
9 Get the patient displacement vector v(t);
// Obtained from the motion monitoring system.
10 if Compensation is possible then
// Compensation is possible: See Algorithm 2.
11 Get the beam’s weight wk;
12 Irradiate the target (bi, wk);
13 Update lplan: remove wk from bk;
// wk being the weight associated to bk in TP
14 else
15 do nothing;
16 return;
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Algorithm 2: Algorithm to test whether the compensation is possible.
1 begin
2 foreach Beam position bj in lplan do
3 (distH ,distV ) ← Euclidean distance (bj , bi − v(t));
// Calculate independently horizontal and vertical distances: resp.
distH and distV .
4 if distH < ∆H and distV < ∆V then
// i.e., bj is in the rectangle centered on bi − v(t) of length ∆H and
width ∆V
5 bk ← bj;
6 wk ← wj;
7 return True;
8 else
9 do nothing;
10 return False;
5.3 Evaluation of the compensation
To evaluate the compensation method we perform simulations on the SBRT lung tu-
mor case presented in Section 4.2.2 and using the MSPT settings presented in Section 4.3.
The simulations settings are summarized in Table 5.1. Dose distributions comparisons is
based on the DVHs and the dosimetric parameters, which are often used to assess the
quality of a treatment plan: the dose delivered to 95% (D95%) and 5% (D5%) of the tumor
volume and the normalized volume of different body tissues receiving a given percentage
of the prescribed dose: 10% (V10), 33%(V33), 50%(V50), 66%(V66) and 90%(V90). We also
compare the mean dose received by these tissues (Dmean). The body tissues considered
are the OARs: right lung and spinal cord. Figure 5.8 locates the different volumes. Fi-
nally, to evaluate the quality of the compensation in Sections 5.3.1 and 5.3.1 we also refer
to the clinical criterion used to ensure that a treatment plan achieves the desired tumor
coverage: 95% of the tumor volume received 95% of the prescribed dose Rx (D95% ≥ 95%
Rx). For this treatment Rx = 1.5 cGy. In our situation the dose distribution used as a
reference is the static delivery simulated in MSPT. Therefore,in order to consider that this
dose distribution meets the plan requirement, D95% ≥ 95% Rx, we will assume that the
dose prescription is the D95% value of this static dose distribution.
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(a) (b)
Figure 5.8 – Delineation of the tumor and the OARs overlaying a patient CT image (left:
transverse plane, right: coronal plane): in green the tumor, in red the spinal cord and in
blue the right lung.
The motions are simulated with the irregular motion model with φx, φy, φz set to zero.
Other motion parameters are presented in Table 5.1. We consider motions of moderate
amplitude (i.e., 0.5 cm) and of large amplitude (i.e., 1.5 cm). The standard deviation of
the Gaussian distribution applied to the variability of amplitude and the period is set to
20% of the amplitude or the period [Heath et al., 2009].
To highlight interests and limitations of the compensation strategy we study different
motion amplitudes, we consider the use of a margin and finally we show the impact of
the motion monitoring system accuracy.
Test index
Intra-
fraction
motion
Motion Compen-
sation
Motion
monitoring
[σδx, σδy, σδz]
in cm
Hiccup
or CoughAmplitude
[bx, by, bz]
in cm
Amplitude
[σbx, σby, σbz]
in cm
Period
[τx, τy, τz]
in s
Period
[στx, στy, στy]
in s
1 No - - - - - - -
2 Yes [0.5, 0.5, 0] [0.1, 0.1, 0] [4, 4, 0] [0.8, 0.8, 0] No - No
3 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] No - No
4 Yes [0.5, 0.5, 0] [0.1, 0.1, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0, 0, 0] No
5 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0, 0, 0] No
6 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0.3, 0.3, 0] No
7 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [0.75, 0.75, 0] No
8 Yes [1.5, 1.5, 0] [0.3, 0.3, 0] [4, 4, 0] [0.8, 0.8, 0] Yes [1.5, 1.5, 0] No
Table 5.1 – Table summarizing the tests performed to evaluate the compensation method.
Note : ’-’ means that it doesn’t apply to the corresponding test.
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5.3.1 Evaluation of the compensation for moderate amplitude
motions
In this section we evaluate the compensation strategy for a moderate motion amplitude
(i.e., 1.5 cm) using Tests 1, 2 and 4 (see Table 5.1). Figures 5.9 and 5.10 show the resulting
dose distributions of the three experiments in transverse (parallel to the beam) and coronal
planes (parallel to the motion plane and orthogonal to the beam) obtained near the center
of the tumor. Figure 5.11 presents the resulting DVHs of the dose distributions for the
three experiments. Tables 5.2 and 5.3 summarize the dosimetric parameters considered
for the comparison.
(a)
(b) (c)
Figure 5.9 – Dose distributions computed overlaying a patient CT image (transverse
planes), for a static (5.9a) and a moving patient without (5.9b) and with (5.9c) compen-
sation.
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(a)
(b) (c)
Figure 5.10 – Dose distributions computed overlaying a patient CT image (coronal planes),
for a static (5.10a) and a moving patient without (5.10b) and with (5.10c) compensation.
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Figure 5.11 – Comparison of DVHs for a delivery on a static (Test 1) and dynamic patient
with (Test 4) and without (Test 2) compensation for a 0.5 cm motion amplitude.
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Test index D95% (cGy) D5% (cGy)
1 1399.5 1816
2 1141 2009.5
4 1367.5 1824.5
Table 5.2 – Dose received by 95% and 5% of the PTV on a static (Test 1) and dynamic
patient with (Test 4) and without (Test 2) compensation for a 0.5 cm motion amplitude.
Tissue Test index V10(%) V33(%) V50(%) V66(%) V90(%) Dmean%(cGy)
Right Lung
1 17 11 8 6 4 158.33
2 20 12 9 6 3 172.15
4 17 11 8 6 3 159.31
Spinal Cord
1 1 0 0 0 0 9.28
2 2 0 0 0 0 12.24
4 1 0 0 0 0 9.81
Table 5.3 – Volume receiving 10, 33, 50, 66 and 90 % of the prescribed dose and the
average dose received by the OARs in MSPT on a static (Test 1) and dynamic patient with
(Test 4) and without (Test 2) compensation for a 0.5 cm motion amplitude.
Visually, from Figures 5.9 and 5.10, we can observe that the dose distributions of
the static and the compensated delivery are close, whereas heterogeneities are visible in
the tumor in the case of the non-compensated delivery. The observation of the DVHs
and the dosimetric parameters show the similar results. Indeed, based on the DVHs,
the tumor coverage is degraded without the compensation, whereas it stays close to the
expected one with the compensation. The difference of D95% and D5% measurements are
respectively 2.3% and 0.5% for the compensated delivery, and 18.5% and 10.7% without
the strategy. Moreover, considering other body tissues, the average differences of relative
volume between the static and compensated delivery were: 0%, 0%, 0%, 0% and 0.5%,
respectively for V10(%), V33(%), V50(%), V66(%), V90(%). The average difference of dose
received by 50% of these tissues (D50%) is 0%. The differences between the static and
non-compensated deliveries were: 2%, 0.5%, 0.5%, 0%, 0.5%, and 4.2% respectively for
V10(%), V33(%), V50(%), V66(%), V90(%) and D50%. The differences between the static
and the compensated deliveries can be explained by the parameters ∆H and ∆V , de-
fined in the compensation strategy. Indeed, these parameters allow small shifts from the
planned beam position and can induce dosimetric errors similar to errors introduced by
motions. Keeping ∆H and ∆V small enough (in the order of the distance between two
consecutive spots) reduces greatly the errors. As explained in the introduction of Sec-
tion 5.3, we consider prescribed dose being the D95% value of the static dose distribution.
Therefore, Rx = 1399.5. In order to be acceptable a dose distribution should achieve the
criterion:D95% ≥ 95% Rx. From Table 5.2, we can claim that the compensated delivery,
unlike the non compensated delivery, achieved this criterion.
Overall, the compensation improved significantly the dose distribution since the error
to the static delivery for the D95% parameter dropped from 18.5% to 2.3% of the dose
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distribution. Moreover, the average difference of dose received by the OARs decreased
from 4.2% to 0%. Therefore, this mitigation technique allows a better coverage of the
tumor and a better sparing of OARs. Finally, the compensated delivery met the D95% ≥
95% Rx requirement to be clinically acceptable.
5.3.2 Evaluation of the compensation for large amplitude mo-
tions
In this section we evaluate the compensation strategy for a large motion amplitude
(i.e., 1.5 cm) using Tests 1, 3 and 5 (see Table 5.1). Figures 5.12 and 5.13 show the
resulting dose distributions of the three experiments respectively in a transverse plane
and in a coronal plane obtained near the center of the tumor. Figure 5.20 presents the
resulting DVHs of the dose distributions for the three experiments. Tables 5.4 and 5.5
summarize the dosimetric parameters considered for the comparison.
(a)
(b) (c)
Figure 5.12 – Dose distributions computed overlaying a patient CT image (transverse
planes), for a static (5.12a) and a moving patient without (5.12b) and with (5.12c) com-
pensation.
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(a)
(b) (c)
Figure 5.13 – Dose distributions computed overlaying a patient CT image (coronal planes),
for a static (5.13a) and a moving patient without (5.13b) and with (5.13c) compensation.
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Figure 5.14 – Comparison of DVHs for a delivery on a static (Test 1) and dynamic patient
with (Test 5) and without (Test 3) compensation for a 1.5cm motion amplitude.
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Test index D95% (cGy) D5% (cGy)
1 1399.5 1816
3 600 1849.5
5 1367.5 1823.5
Table 5.4 – Dose received by 95% and 5% of the PTV on a static (Test 1) and dynamic
patient with (Test 5) and without (Test 3) compensation for a 1.5 cm motion amplitude.
Tissue Test index V10(%) V33(%) V50(%) V66(%) V90(%) Dmean%(cGy)
Right Lung
1 17 11 8 6 4 158.33
2 29 16 9 3 0 193.87
5 18 11 9 6 3 161.43
Spinal Cord
1 1 0 0 0 0 9.28
3 11 1 0 0 0 44.49
5 1 0 0 0 0 9.69
Table 5.5 – Volume receiving 10, 33, 50, 66 and 90 % of the prescribed dose and the
average dose received by the OARs in MSPT on a static (Test 1) and dynamic patient with
(Test 5) and without (Test 3) compensation for a 1.5 cm motion amplitude.
Visually, from Figures 5.12 and 5.13, we can observe important heterogeneities in the
dose distribution without the compensation strategy and notice that the tumor is not
properly covered. On the contrary, the dose distribution using the mitigation technique
provides a better tumor coverage and appears to be closer to the expected dose distri-
bution of the static case. The DVHs and the dosimetric parameters confirm this visual
observation. Indeed, based on the DVHs, the tumor coverage is highly degraded without
the compensation, whereas it is close to the expected coverage with the compensation: the
use of the compensation decreases D95% error from 57% to 2.29% and the D5% error from
1.8% to 0.41%, which indicates an significant improvement of the tumor coverage, espe-
cially when considering the D95% parameter. Moreover, considering other body tissues,
the average differences of relative volume between the static and compensated delivery
were: 0.5%, 0%, 0.5%, 0% and 0.5%, respectively for V10(%), V33(%), V50(%), V66(%)
and V90(%). The average difference of dose received by 50% of these tissues (D50%) is
2.42%. The differences between the static and non-compensated deliveries were: 11%,
3%, 0.5%, 1.5%, 2%, and 30.40% respectively for V10(%), V33(%), V50(%), V66(%), V90(%)
and D50%. This shows that the compensation strategy helps preserve the OARs since the
average error of the dose received decreases from 30.40% to 2.42%. As explained in the
previous section, the differences between the static and the compensated deliveries can
be explained by the parameters ∆H and ∆V . In addition, these parameters constrain-
ing the distance between the beam position (bi in Algorithm 1) and the position being
compensated (bk in Algorithm 1) limit the dosimetric errors, which can explain why the
doses received by 95% of the tumor in the compensated delivery for the moderate (Test
4) and the large (Test 5) motion are the same. From Table 5.4, we can claim that the
compensated delivery, unlike the non compensated delivery, achieved the criterion D95%
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≥ 95% Rx.
The delivery without the compensation strategy presents important differences in the
dose distribution. As for the delivery applying the strategy, the errors are smaller than
5%. In addition, it achieved the tumor coverage criterion. Therefore, the compensated
dose distribution can be considered as clinically acceptable. We can say that based on
the results the compensation strategy mitigate greatly the impact of motion and improves
the robustness of the treatment plan.
5.3.3 Compensation with and without margin
In this section, we study the use of margins for the beam positions in the compensation
strategy by repeating Test 5 (see Table 5.1) with and without margin. The margin
thickness was set to one half of the motion amplitude.
(a) (b)
Figure 5.15 – Dose distributions computed overlaying a patient CT image (transverse
planes), for a moving patient using the compensation strategy with (5.16a) and without
(5.16b) margin.
(a) (b)
Figure 5.16 – Dose distributions computed overlaying a patient CT image (coronal planes),
for a moving patient using the compensation strategy with (5.16a) and without (5.16b)
margin.
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Figure 5.17 – Comparison of DVHs for a compensated delivery on a dynamic patient for
a 1.5 cm motion amplitude with and without margin.
Test D95% (cGy) D5% (cGy)
Margin 1359.5 1849.5
No Margin 1367.5 1823.5
Table 5.6 – Dose received by 95% and 5% of the PTV on a dynamic patient for a delivery
using the compensation strategy with and without margin for a 1.5 cm motion amplitude.
Tissue Test V10(%) V33(%) V50(%) V66(%) V90(%) Dmean(cGy)
Right Lung
Margin 17 11 8 6 3 157.00
No Margin 18 11 9 6 3 161.43
Spinal Cord
Margin 1 0 0 0 0 9.65
No Margin 1 0 0 0 0 9.69
Table 5.7 – Volume receiving 10, 33, 50, 66 and 90 % of the prescribed dose and the
average dose received by the OARs in MSPT on a dynamic patient for a delivery using the
compensation strategy with and without margin for a 1.5 cm motion amplitude.
Visually, from Figures 5.15 and 5.16, the dose distributions appear to be similar even
though we can observe small heterogeneity differences. Based on the DVHs both dose
distribution are in agreement. The comparison of the dosimetric parameters shows that
the tumor coverage is equivalent: the differences are 0.6% and 1.4% for the D95% and the
D5% parameters (see Table 5.6). In other tissues (see Table 5.7), the average absolute
differences for the dosimetric parameters V10, V33, V50, V66, V90 are respectively 0.5%, 0%,
0.5%, 0% and 0%. The difference of mean dose received by these tissues is 2.3%. These
low differences show that both deliveries provide an equivalent dose distribution.
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Mean Stdev Min Max Median
Margin 7.4 2.9 2 13 7
No Margin 202 905 33 3299 565
Table 5.8 – Re-scanning statistics for a delivery using compensation with and without
margin.
Even though, the dose distributions are equivalent, we also compared the delivery
process in both cases (see Table 5.8). The treatment plan delivered 19 energy layers,
comprised between 39 and 118 MeV, representing 3839 beam positions. The minimum,
maximum, median and average number of beam position for this entire treatment plan
were respectively 2, 373, 221 and 202 over all the energy layers. Considering the results
in Table 5.8, the use of margins reduced significantly the number of re-scanning: from
202 to 7.4 in average. In addition, the number of re-scanning varies less than without
the margin: the standard deviation decreases from 905 to 2.9. However, the improvement
in the number of re-scanning induces a higher number of beam position changes: 89771
with a margin instead of 85618. Therefore, this strategy, if applied, would be more
interesting if the cost of energy transition is high and must be avoided such as in the
case of volumetric repainting using a synchrotron. In addition, parameters ∆H and ∆V
have also an impact on both the number of re-scannings and the number of beam position
changes. Reducing the value of ∆H and ∆V (respectively increasing their value) would
reduce (respectively increase) the likelihood of possible compensations (i.e., If statement
being True in Algorithm 1), which would induce more (respectively less) re-scannings and
beam position changes in order to deliver the planned dose.
5.3.4 Evaluate the impact of the monitoring system accuracy
In this section we compare Tests 5 (σδ = 0 cm), 6 (σδ = 0.3 cm), 7 (σδ = 0.75 cm)
and 8 (σδ = 1.5 cm) - see Table 5.1 - to show the impact of the modeled accuracy of the
motion monitoring system.
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(a) (b)
(c) (d)
Figure 5.18 – Dose distributions computed overlaying a patient CT image (transverse
planes), for a moving patient with compensation for different monitoring accuracy: σδ =
0 cm (5.18a), 0.3 cm (5.18b), 0.75 cm (5.18c), 1.5 cm (5.18d).
(a) (b)
(c) (d)
Figure 5.19 – Dose distributions computed overlaying a patient CT image (coronal planes),
for a moving patient with compensation for different monitoring accuracy: σδ = 0 cm
(5.19a), 0.3 cm (5.19b), 0.75 cm (5.19c), 1.5 cm (5.19d).
84
MSPT: Motion Simulator for Proton Therapy
0 500 1,000 1,500 2,000 2,500
0
20
40
60
80
100
Dose (cGy)
R
el
at
iv
e
V
ol
u
m
e
(%
)
σδ = 0
σδ = 0.3
σδ = 0.75
σδ = 1.5
Spinal Cord
Right Lung
PTV
Figure 5.20 – Comparison of DVHs for a delivery on a dynamic patient with compensation
for a 1.5 cm motion amplitude to evaluate the impact of the motion monitoring system
accuracy.
σδ cm D95% (cGy) D5% (cGy)
0 1367.5 1823.5
0.3 1277 1852.5
0.75 1022.5 1966
1.5 779.5 2235.5
Table 5.9 – Dose received by 95% and 5% of the PTV on a dynamic patient for a delivery
using the compensation strategy for different accuracy of the motion monitoring system.
Tissue σδ cm V10(%) V33(%) V50(%) V66(%) V90(%) Dmean(cGy)
Right Lung
0 18 11 9 6 3 161.43
0.3 20 11 8 5 2 157.62
0.75 23 12 7 4 1 161.78
1.5 25 12 6 2 0 157.51
Spinal Cord
0 1 0 0 0 0 9.69
0.3 1 0 0 0 0 11.21
0.75 1 0 0 0 0 12.96
1.5 10 0 0 0 0 37.58
Table 5.10 – Volume receiving 10, 33, 50, 66 and 90 % of the prescribed dose and the
average dose received by the OARs in MSPT on a dynamic patient with compensation for
different accuracy of the motion monitoring system.
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σδ cm
Difference
D95%(%)
Difference
D5%(%)
0.3 6.6 1.6
0.75 25.2 7.8
1.5 43.0 22.6
Table 5.11 – Table summarizing the average dosimetric differences, for the tumor, for dif-
ferent values of σδ, and where the delivery with σδ = 0 cm is considered as the benchmark.
σδ cm
Difference
V10(%)
Difference
V33(%)
Difference
V50(%)
Difference
V66(%)
Difference
V90(%)
Difference
D50%(%)
0.3 1.0 0 0.5 0.5 0.5 3.2
0.75 2.5 0.5 1.0 1.0 1.0 12.0
1.5 8.0 0.5 1.5 2 1.5 19.2
Table 5.12 – Table summarizing the average dosimetric differences, for the OARs, for
different values of σδ, and where the delivery with σδ = 0 mm is considered as the bench-
mark.
Visually, from Figures 5.18 and 5.19, we can see that the accuracy of the monitoring
system has an impact of the quality of the final dose distribution. If we consider the
dose distribution obtained at σδ = 0 cm as a reference, we can observe that the dose
distribution obtained with σδ = 0.3 cm is in agreement with the reference. However, for
other values of σδ = the dose distribution becomes highly heterogeneous in the tumor.
The analysis of the DVHs and the dosimetric parameters confirms the visual observation.
As summarized in Table 5.11, the error of the D95% parameter increases with σδ from
6.6% to 43.0%, which indicates that the tumor coverage is greatly degraded. The sparing
of OARs is also impacted by the change of σδ. The error of the average dose received by
the OARs increases rapidly from 3.2%. These results show the impact of the σδ used to
model the accuracy of the motion monitoring system. Moreover, it shows, as one could
expect, that the quality of the dose distribution obtained with the compensation depends
greatly on the accuracy of the monitoring system. Finally, the errors of the D95% and
D50% parameters for σδ = 0.3 cm being slightly greater than 5%, indicates that such
compensation strategy would require that the system measuring the motion should have
an accuracy smaller than 3 mm.
5.4 Discussion on the compensation
In this chapter we introduced a compensation strategy, which aims at mitigating the
impact of motion on the dose distribution. We evaluated it based on a moderate and large
motion. Moreover, we studied the use of the margins described in our strategy. Finally,
we highlighted the impact of the accuracy modeled for the motion monitoring system
used to provide the motion information for the compensation strategy.
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The results obtained from the evaluation of the compensation technique for moderate
and large motions, showed that it is able to reduce significantly the impact of the motion
and provides a dose distribution close to the one obtained for a static delivery. From a
clinical point of view, the difference between the compensated and the static dose distri-
butions is clinically acceptable. Based on the study related to the use of margins for the
strategy, applying margins provides an equivalent dose distribution and reduces greatly
the number of re-scanning which would be interesting for applications where the number
of re-scanning must be controlled or minimized. However, it requires more displacements
of the beam, which has an impact on the overall treatment time. Finally, the consid-
eration of the accuracy of the monitoring system showed, as one could expect, that the
improvements brought by our mitigation strategy decrease with the accuracy.
As previously explained, the compensation strategy has been developed for 2D mo-
tions. However, it could be improved and more interesting clinically if extended to 3D
motions by considering the radiological depth changes due to the motion. This could
make it an interesting feature to consider in the treatment planning process to improve
the robustness of treatment plans to motion. In addition, only rigid body transformation
is considered in our implementation. The implementation of deformable body transfor-
mation could be part of future improvements.
Finally, our compensation strategy provides a new approach where the beam weights
are adapted to the motion. It improves significantly the dose distribution in the patient.
However, it would require further research to improve the compensation strategy and
show if it could be clinically relevant.
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Closing remarks on MSPT
MSPT’s advantages
MSPT offers a new tool to study intra-fraction motions in proton-therapy treatments
using the spot scanning technique. The first interest of MSPT is to render the impact
of intra-fraction motions on the dose distribution for a given treatment plan. This is
achieved by simulating the delivery with a low time scale (e.g., 1 ms by default), which
can be set by the user. Moreover, it can be used to compare different treatment plans or
mitigation strategies, designed to treat a patient, and to observe what are the resulting
dose distributions if the patient moves during the treatment in order to find the plan that
would be best suited for the motions and the patient. This comparison can also consider
different types of motions to improve the robustness of the plan. MSPT has also been
developed in such a way that it imports directly the treatment plan and the patient data
from DICOM files, which is the standard of the TPS’s output data. In addition, MSPT
has been designed such that the users could match it to their own proton machine, which
make it an adaptable software. Finally, MSPT is an open-source software which make it a
research tool that can evolve, be re-usable and be widely available.
MSPT’s limitations
MSPT present some limitations. Indeed, the use of an analytical pencil beam model to
compute the dose distribution provides a calculation less accurate than with Monte-Carlo
simulations. However, this allows a faster calculation of a single pencil beam. The use of a
low time scale for the motion simulation reduces the speed of the overall dose distribution
calculation. The speed depends also linearly on the number of beam positions in the
treatment plan and the size of the CT image being used to model the patient, which
can lead to long simulation time and important memory space used if the plan contains
a high number of spots or if the size of matrices modeling the patient is high. Finally,
the systemic artifact highlighted in Section 4.2.2 can also be a limitation if one wants
to compare dose distributions obtained in a patient from a TPS and from MSPT. Such
situation would require a further study.
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Part III
Some Results in Photon Therapy
89
Chapter 1
Algorithmic aspects of photon
therapy
As mentioned in Part I Section 2.4.2, in photon therapy, a treatment plan provides
a set of intensity maps representing a 2D grid for each beam angle of the local levels of
intensities that must be achieved by a treatment. The radiation generated by the linac
is uniform. Therefore, in order to achieve the varying intensities, this radiation needs
to be modulated. For this purpose, each intensity matrix is delivered through an MLC.
Radiation can either be blocked by the MLC leaves or pass through the gap between the
endpoint of the leaves. Therefore, each intensity map is realized by a sequence of MLC
configurations, each of which is maintained for a certain amount of time, corresponding
to the intensity and measured in MU.
From an algorithmic point of view, 2D matrices can represent intensity maps where
each intensity is given as a positive integer. Therefore, these matrices have to be decom-
posed into a weighted sum of binary matrices. Parts of the photon beam that are not
blocked by the MLC are represented by ’1’ in the binary matrix and by ’0’ otherwise.
Each binary matrix denotes an MLC configuration and the weight corresponds to the
associated intensity. These binary matrices respect the consecutive 1 property (C1P -
i.e., the 1s occur consecutively as a single block in each row) to represent a gap between
the endpoint of the leaves.
Of course, there are many ways of decomposing a given intensity matrix. So, the
challenge is to select the decomposition that can be delivered the most efficiently. While
the quality of the decomposition is evaluated based on dosimetric properties, two main
criteria assess its efficiency:
• The total beam-on time: the total amount of time the patient is being irradiated.
This metric is proportional to the sum of intensities used in the decomposition. It
needs to be minimized to lower the excess of dose received.
• The total setup time: the total amount of time spent shaping the apertures. This
metric is approximately proportional to the number of matrices used in the decom-
position. It needs to be minimized to reduce the duration of a fraction.
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Although closely related, these two efficiency criteria are not equivalent. From an al-
gorithmic point of view, these efficiency criteria correspond to minimization problems
later referred to as the beam-on time minimization problem and the total setup time
minimization problem.
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Chapter 2
Algorithmic results in photon
therapy
In this chapter, we will present algorithmic results obtained for the minimization prob-
lems, introduced in the previous chapter. First, we will provide existing results for these
problems obtained for the conventional MLC results that will be used in the following
sections. Then, we will introduce new types of MLCs in order to present, in a third part,
the results obtained for the minimization problems applied to these MLCs.
Before presenting existing results, let us define more formally the minimization prob-
lems as matrix decomposition problems:
• The total beam on time minimization problem:
Let M be an integer matrix. Let us find a set S = {M1,M2, . . .Mn} of binary C1P
matrices and a set α = {α1, α2, . . . αn} of integer values, such that M =
∑n
i=1 αiMi,
and that minimizes ton =
∑n
i=1 αi.
• The total setup time minimization problem:
Let M be an integer matrix. Let us find a set S = {M1,M2, . . .Mn} of binary C1P
matrices and a set α = {α1, α2, . . . αn} of integer values, such that M =
∑n
i=1 αiMi,
and that minimizes tsetup = card(S).
2.1 Previous algorithmic results
In this section, we will present existing algorithmic results that will be used in the
next sections.
The total beam-on time minimization problem was proven to be solvable in linear time
[Ahuja and Hamacher, 2005] for conventional MLCs (introduced in Part I Section 2.4.2).
To illustrate this result we can look for an optimal decomposition minimizing the total
beam-on time on the following example:
Let M be an integer matrix defined by:
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2 4 3 7 1 4 33 4 5 2 1 6 7
5 1 6 7 3 3 4

We consider that there are no interactions between the rows, since one row of the intensity
map is achieved by one pair of MLC leaves and that the pairs are considered independent.
Therefore, each row can be decomposed independently. Let us start for example with the
first row R1: [
2 4 3 7 1 4 3
]
We start the algorithm by searching for the minimum value of this vector. In R1, the
minimum value is 1. This value will be the weight of the first configuration of the first pair
of leaves. Taking the minimum value ensures that a maximum number of positions in the
row can be irradiated simultaneously. The binary vector (binary vectors and associated
weights will be displayed in green to differentiate easily binary vectors and intensity
vectors) corresponding to the configuration is:[
1 1 1 1 1 1 1
]
After applying the configuration with weight 1, the remaining intensities are:[
1 3 2 6 0 3 2
]
The value 0 appears in the intensity vector at the 5th position. In order to respect the con-
secutive 1 property, we must consider independently the left segment (
[
1 3 2 6
]
), later
referred to as l, and the right segment (
[
3 2
]
), later referred to as r. This corresponds
to using the left or right MLC leave to block the beam at the 5th position. This divides
the initial problem into two sub-problems where the same algorithm will be applied. If
we start with l, the intensity vector is:[
1 3 2 6 X X X
]
whereX, corresponds to positions that must be blocked by the MLC leaves. The minimum
value is 1. The binary vectors corresponding to the leaves configuration is:[
1 1 1 1 0 0 0
]
Once this configuration is applied with the weight 1 the value 0 appears at the first po-
sition. Therefore it must be blocked in the future configuration. The remaining intensity
vector is: [
X 2 1 5 X X X
]
The minimum value is 1 and the associated binary vector is:[
0 1 1 1 0 0 0
]
This results in the following intensity vector:[
X 2 X 5 X X X
]
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Again, the problem to decompose l is divided into two sub-problems: l1 to irradiate the
2nd position and l2 to irradiate the 4
th one. The first intensity vector considered is:[
X 2 X X X X X
]
The minimum weight is 2 and the associated binary vector is:[
0 1 0 0 0 0 0
]
Similarly, the weight used for l2 is 5, and the associated binary vector is:[
0 0 0 1 0 0 0
]
Then, we repeat the algorithm for r. The intensity vector is:[
X X X X X 3 2
]
The minimum value is 2. The binary vector associated to this weight 2 is:[
0 0 0 0 0 1 1
]
The final intensity vector is: [
X X X X X 1 X
]
The final weight is 1 and is associated to the binary vector:[
0 0 0 0 0 1 0
]
Hence, R1 results from the weighted sum of these configurations:
1× [1 1 1 1 1 1 1]
+1× [1 1 1 1 0 0 0]
+1× [0 1 1 1 0 0 0]
+2× [0 1 0 0 0 0 0]
+5× [0 0 0 1 0 0 0]
+2× [0 0 0 0 0 1 1]
+1× [0 0 0 0 0 1 0]
The resulting beam-on time for R1 is: 1 + 1 + 1 + 2 + 5 + 2 + 1 = 13.
Similarly we obtain the following decomposition for the second row R2:
1× [1 1 1 1 1 1 1]
+1× [1 1 1 1 0 0 0]
+1× [1 1 1 0 0 0 0]
+1× [0 1 1 0 0 0 0]
+1× [0 0 1 0 0 0 0]
+5× [0 0 0 0 0 1 1]
+1× [0 0 0 0 0 0 1]
The resulting beam-on time for R2 is: 1 + 1 + 1 + 1 + 1 + 5 + 1 = 11.
The weighted sum of the configuration vectors for the third row R3 is:
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2× [1 1 1 1 1 1 1]
+3× [1 0 0 0 0 0 0]
+1× [0 0 1 1 1 1 1]
+1× [0 0 0 0 0 0 1]
+3× [0 0 1 1 0 0 0]
+1× [0 0 0 1 0 0 0]
The resulting beam-on time for R3 is: 2 + 3 + 1 + 1 + 3 + 1 = 11.
According to Ahuja and Hamacher [2005], the optimal beam-on time is the maximum
of the rows beam on time. Therefore, in our example the optimal beam-on time topt =
max{13, 11, 11} = 13. The construction of the optimal matrix decomposition follows the
process: for each row in {R1, R2, R3}, select a configuration vector: {R11 , R21 , R31} with
respective beam-on time {w11 , w21 , w31}. Then, construct the matrix:
S1 =
R11R21
R31

and set the beam-on time of S1 to wmin1 = min{w11 , w21 , w31}. Then reduce the beam-on
time of R11 , R21 , R31 by wmin1 . If the beam-on time of one of these configuration vectors
becomes zero, remove it from the configuration vectors of the corresponding row. For
example, if the beam-on time of R21 becomes zero, remove R21 from the configuration
vectors of R2. Then repeat the process until no configuration vector remains to obtain
the matrices of an optimal decomposition.
Let us apply this iterative process to the rows of M . For example:
S1 =
R11R21
R31
 =
1 1 1 1 1 1 11 1 1 1 1 1 1
1 1 1 1 1 1 1

where w11 = 1, w21 = 1, w31 = 2. The beam-on time for S1 is wmin1 = 1. After reducing
the beam-on time of R11 , R21 and R31 by wmin1 , the beam-on times associated to R11
and R21 become null. Hence, R11 and R21 are removed from the possible configuration
vectors, but R31 can still be used with a beam-on time of 1. If we repeat this process until
all the configuration vectors have been removed, a possible optimal solution to minimize
the beam-on time is:
M = 1× S1 + 1× S2 + 1× S3 + 1× S4 + 1× S5 + 3× S6 + 2× S7 + 1× S8 + 2× S9
where:
S2 =
1 1 1 1 0 0 01 1 1 1 0 0 0
1 1 1 1 1 1 1
 ; S3 =
0 1 1 1 0 0 01 1 1 0 0 0 0
0 0 1 1 1 1 1
 ;
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S4 =
0 1 0 0 0 0 00 1 1 0 0 0 0
0 0 0 0 0 0 1
 ; S5 =
0 1 0 0 0 0 00 0 1 0 0 0 0
0 0 0 1 0 0 0
 ;
S6 =
0 0 0 1 0 0 00 0 0 0 0 1 1
1 0 0 0 0 0 0
 ; S7 =
0 0 0 1 0 0 00 0 0 0 0 1 1
0 0 1 1 0 0 0
 ;
S8 =
0 0 0 0 0 1 00 0 0 0 0 0 1
0 0 1 1 0 0 0
 ; S9 =
0 0 0 0 0 1 10 0 0 0 0 0 0
0 0 0 0 0 0 0

Finally, the beam-on time of this optimal solution is: topt = 1+1+1+1+1+3+2+1+2 = 13
as expected.
The second minimization problem, namely the total setup time minimization prob-
lem, was proven NP-hard for matrices with at least two rows [Burkard, 2002]. This
NP-hardness result was strengthened by Baatar et al. [2005] who proved that even for
matrices with a single row the problem is strongly NP-hard.
2.2 Technological variants of MLCs
The conventional MLC, introduced in Part I Section 2.4.2, consists of a set of parallel
pairs of leaves that can move towards or apart from each other. However, different MLC
settings have been introduced during the last decade: the rotating MLC and the multi-
layer MLC.
2.2.1 Rotating MLC
Some recent contributions tackle the use of collimator rotation in the decomposition
of a given intensity matrix (i.e., for a given fixed linac angle) [Broderick et al., 2009; Dou
et al., 2006; Milette, 2008; Milette et al., 2006; Otto, 2005; Otto et al., 2005; Schmuland,
2006; Wang et al., 2006] (see schematic in Figure 2.1). This technology has been built on
delivery machines and the practical efficiency of this technique was stated in [Webb, 2010].
From a Consecutive 1 Property (C1P) point of view, a rotating collimator allows each
intensity matrix to be decomposed in both row C1P or column C1P configurations. For
example, decomposing the following intensity matrix with only row C1P configurations
requires at least 7 of them whereas only 6 configurations are needed if rotation is allowed
(the last two configurations are column C1P).
1 4 2 5
1 3 3 2
1 3 5 5
6 4 6 0
 =

0 0 0 1
0 0 1 1
0 0 1 1
1 1 1 0
 +

0 0 0 1
0 1 1 1
0 0 1 1
1 1 1 0
 +

0 1 1 1
1 1 1 0
0 1 1 1
1 1 1 0
 +

1 1 1 1
0 0 0 0
1 1 1 1
1 1 1 0

+ 	
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+

0 1 0 1
0 0 0 0
0 0 0 0
1 0 1 0
 +

0 1 0 0
0 1 0 0
0 1 1 1
1 0 1 0

Figure 2.1 – Schematic of a rotating MLC.
2.2.2 Multi-Layer MLC
A Multi-Layer MLC is composed of multiple layers of leaves. It was originally patented
by Yao [1997] in 1997 and has been intensively studied since 2003. Most studies consider
two orthogonal layers, referred to in the literature as the dual-MLC [Hughes, 2003; Jarray
and Picouleau, 2012; Liu et al., 2009, 2008; Oh et al., 2007] (see schematic in Figure 2.2),
which has already been tested in some delivery machines [Liu et al., 2009]. Topolnjak et
al. investigated the use of three layers placed every 60 degrees [Topolnjak et al., 2005,
2004]. The state-of-the-art is presented in Webb [2012] which claims the efficiency of the
gear. For example, decomposing the following intensity matrix with only C1P matrices
(even allowing MLC rotations) requires a linear number of configurations whereas only 2
are needed when using a dual-MLC (↑ and → represent respectively vertical and horizontal
blocking leaves).
1 0 1 0 1 . . . 0
0 1 0 1 0 . . . 1
1 0 1 0 1 . . . 0
0 1 0 1 0 . . . 1
1 0 1 0 1 . . . 0
...
...
...
...
...
. . .
...
0 1 0 1 0 . . . 1

=

1 ↑ 1 ↑ 1 . . . ↑
← + ← + ← . . . +
1 ↑ 1 ↑ 1 . . . ↑
← + ← + ← . . . +
1 ↑ 1 ↑ 1 . . . ↑
...
...
...
...
...
. . .
...
← + ← + ← . . . +

+

+ → + → + . . . →
↑ 1 ↑ 1 ↑ . . . 1
+ → + → + . . . →
↑ 1 ↑ 1 ↑ . . . 1
+ → + → + . . . →
...
...
...
...
...
. . .
...
↑ 1 ↑ 1 ↑ . . . 1

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Figure 2.2 – Schematic of a dual-MLC.
2.3 Algorithmic results for new MLC variants
These new variants of MLCs were conjectured to increase the complexity of the total
beam on time and total setup time minimization problems, as mentioned in the articles
cited previously. However, to the best of our knowledge, this has not been proven. That
is why, in the next sections we formally show the algorithmic hardness of these problems.
More precisely, we study the Dual-MLC Decomposition (DMD) problem that consid-
ers two orthogonal layers of MLCs and the Matrix Orthogonal Decomposition (MOD)
problem introduced in [Dou et al., 2006] that considers the decomposition problem of an
intensity matrix using a unique 90◦ rotation. The following results were published in Blin
et al. [2014].
2.3.1 Algorithmic results for Dual MLC
In order to prove the hardness of the total setup time minimization problem, we will
use the construction of Baatar et al. [2005] as a starting point. Therefore, let us first
briefly present a slightly modified version of their proof. As a reminder, they originally
proved the hardness of total setup time decomposition even for matrices with a single row
by a reduction from the NP-complete 3-Partition problem. This problem asks to partition
3Q positive numbers – say S = (b1, b2, . . . , b3Q) – (allowing duplicates) into Q triples –
say {T1, T2, . . . , TQ}, such that each triple has the same sum. Considering that all 3Q
numbers sum to N , then every triple should have a sum of B = N
Q
(we may assume that
B
4
< bi <
B
2
for every bi ∈ S).
From any instance S of the 3-Partition problem, one can construct in polynomial time
an integer vector A = x1 x2 . . . x3Q yQ yQ−1 . . . y1 z0 such that xi =
∑i
j=1 bj, yi = i ·B and
z0 = b1
1. Then, one can ask for a decomposition with at most 3Q MLC configurations. As
1. We added z0 to the original construction for ease of the demonstration
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a reminder, any solution of the problem is a set of C1P vectors (i.e., configurations) pro-
vided with corresponding intensities. Therefore, for each configuration, we will denote, in
the corresponding row vector, by left (respectively right) endpoint the first (respectively
last) position of a 1.
First, notice that since {xi|1 ≤ i ≤ 3Q} is a set of 3Q different values, any decom-
position of A will need at least 3Q configurations and thus 3Q corresponding intensities
(among which one is b1 due to x1) each having their left endpoint disjointly in one of
{xi|1 ≤ i ≤ 3Q} positions. Moreover, the configuration with the intensity b1 is defined
as a totally open configuration (i.e., a vector of 4Q + 1 1′s). Among the at most Q · B
intensity units that can go through x3Q, exactly B of them are needed to irradiate y1. To
respect the consecutiveness of the 1′s, whatever the left endpoints of the configurations
used, the corresponding configurations will contribute exactly B to each of {yi|2 ≤ i ≤ Q}.
Repeating this last argument over {yi|2 ≤ i ≤ Q}, one can prove that each yi is the right
endpoint of some configurations, whose overall contribution sums to B. Furthermore, by
construction, z0 needs b1 intensity units that has to be included into the B needed by y1.
Consequently, since one of the configurations contributed b1 to all positions of A, x2 now
only needs an extra b2 contribution, which should be delivered at once. Repeating this
argument over {xi|3 ≤ i ≤ 3Q}, one can prove that the set of configuration intensities is
indeed {bi|1 ≤ i ≤ 3Q}.
Since, for any 1 ≤ i ≤ 3Q, B
4
< bi <
B
2
, any yi will need to be the right endpoint of
exactly 3 configurations to get an overall irradiation summing to B (recall that there are
at most 3Q configurations). Provided with these properties, one can easily prove that (⇐)
given a solution to the 3-Partition problem such that, w.l.o.g., b1 ∈ T1, for all 2 ≤ i ≤ 3Q,
irradiating the interval [xi, yq] with intensity bi, if bi ∈ Tq, and irradiating the full vector
with b1, leads to a valid decomposition of exactly 3Q configurations. Moreover, (⇒) con-
sidering any solution of the decomposition problem, defining the triples {Ti|1 ≤ i ≤ Q}
such that bj ∈ Tq ⇔ there exists a configuration of intensity bi with respectively left and
right endpoints xi and yq leads to a solution to 3-Partition.
Back to our original problem, we will use a slightly similar reduction using A as a
starting point. We, thus now consider the decomposition of a matrix. For ease, in the
rest of the paper, [x]k will denote a sequence of k copies of element x. The reduction is
again from the 3-Partition problem. From any instance S, one can construct in polyno-
mial time a matrix M = (R1, R2, . . . R6Q+3) (illustrated in Figure 2.3) composed of 6Q+3
rows, where for all 1 ≤ i ≤ 3Q, Ri = R6Q+4−i = [x3Q+1−i]4Q+1, R3Q+1 = R3Q+3 = [0]4Q+1
and R3Q+2 is the vector A designed in the previous proof and ask again for a decomposi-
tion with at most 3Q Dual-MLC configurations. In other words, the vector A is vertically
surrounded by two opposed sorted heaps of vectors (increasing, when going away from A)
filled with the {xi|1 ≤ i ≤ 3Q} values defined in the previous proof and two null rows.
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M =

x3Q x3Q . . . x3Q x3Q x3Q . . . x3Q x3Q
...
...
...
...
...
...
...
...
...
x2 x2 . . . x2 x2 x2 . . . x2 x2
x1 x1 . . . x1 x1 x1 . . . x1 x1
0 0 . . . 0 0 0 . . . 0 0
x1 x2 . . . x3Q yQ yQ−1 . . . y1 z0
0 0 . . . 0 0 0 . . . 0 0
x1 x1 . . . x1 x1 x1 . . . x1 x1
x2 x2 . . . x2 x2 x2 . . . x2 x2
...
...
...
...
...
...
...
...
...
x3Q x3Q . . . x3Q x3Q x3Q . . . x3Q x3Q

Figure 2.3 – Illustration of Matrix M
The correctness of the proof relies on proving that, whereas one may use the vertical
leaves to make a different set of configurations for realizing the peculiar row A, this would
not lead to a valid solution. Indeed, the rows R3Q+1 and R3Q+3 ensures that if a vertical
leaf was used to tune the irradiation configuration used for A – say the one in column j –
then the corresponding intensity could not be used for any element of column j except in
A. Again, since by construction, exactly 3Q configurations are required, there will exist
at least one row in the end with a non-null value on the column j. This property ensures
that if the vertical leaves are used, this is not to disturb the configurations plan of row
R3Q+2.
Provided with these properties, one can easily prove that (⇐) given a solution to the
3-Partition problem such that, w.l.o.g., b1 ∈ T1, for all 2 ≤ j ≤ 3Q, irradiating the inter-
val R3Q+2[xj, yq] and fully the rows R3Q−j and R6Q+3−j with intensity bj if bj ∈ Tq and
irradiating the full rows R3Q, R3Q+2 and R3Q+4 with b1 leads to a valid decomposition of
exactly 3Q configurations. Moreover, (⇒) considering any solution of the decomposition
problem, defining the triples {Ti|1 ≤ i ≤ Q} such that bj ∈ Tq ⇔ there exists a configu-
ration of intensity bj with respectively left and right endpoints at xj and yq in row R3Q+2
leads to a solution to 3-partitioning. This concludes the proof of the following theorem.
Theorem 2.3.1. The Dual-MLC Decomposition problem is NP-hard when minimizing
the total setup time.
2.3.2 Algorithmic results for Rotating MLC
This section is dedicated to proving a stronger result for the MOD problem: mini-
mizing the total setup time is NP-hard even if the intensity matrix is binary. This result
shows that the problem is also NP-hard when one wants to minimize the beam-on time
(whereas it is polynomial when the MLC angle is not changed during decomposition).
However, we will also prove that the problem can be approximated in this later case.
For ease of presentation, we will first introduce a construction using a positive integer
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matrix and show afterwards how to make it binary. In order to prove the hardness of the
problem, we define a reduction from the NP-complete 3-Hitting Set problem: given a col-
lection C = {C1, . . . , Cm} of m subsets of size at most three of a finite set S = {x1, . . . xn}
of n elements and a positive integer k, the problem asks for a subset S ′ ⊆ S with |S ′| ≤ k
such that S ′ contains at least one element from each Ci’s.
From any instance (C, k) of the 3-Hitting Set problem, one can construct in polynomial
time a square matrix M composed of two rows and columns of independent sub-matrices.
A sub-matrix of 2n + 9 columns and 2n + 8 rows, referred to as MDHV , defined below,
is placed top-right of M . Another sub-matrix of 3n + 2 columns and m + 4 rows named
M3HS, and defined later on, is placed bottom-left. The rest of the matrix M is filled with
0’s in order to obtain a square matrix. One can ask for a decomposition of M with at
most n+ 3 MLC configurations.
The sub-matrix MDHV is designed in such a way that it will ensure that any solution to
the decomposition problem will use only one vertical configuration and (n+ 2) horizontal
ones. Indeed, by construction:
• there are (n+ 4) horizontal blocks of single 1′s in the first row.
• all the 2(n + 2) last columns are each composed of (n + 4) vertical blocks of single
1′s.
Therefore, any solution (i.e., not inducing more than (n+3) configurations) must have
at least one horizontal and one vertical configurations. Moreover, any solution has to use
exactly one vertical configuration. Suppose the following contradiction, that a given solu-
tion uses more – say k′ vertical configurations, then at most k′ 1′s from each column can
be irradiated by those k′ configurations. Unfortunately, since k′ ≤ (n + 2), at least two
1′s per column (except the five leftmost ones) will subsist. In order for the solution to
be correct, one would then have to irradiate the remaining 1′s with a unique horizontal
configuration. To do so, the remaining 1′s should be placed in order to have no more than
one 1 per row: presenting a contradiction since we have at least 2 × (2n + 4) 1′s and at
most 2n + 8 rows. We just proved that the sub-matrix MDHV will force any solution to
use exactly one vertical configuration and (n+ 2) horizontal ones, each with an intensity
of 1.
M =
[
0 MDHV
M3HS 0
]
with
MDHV =

0 1 0 1 0 1 0 1 0 . . . 1 0
0
0 0 1 0 1 . . . 0 1
0 1 0 1 0 . . . 1 0
...
...
...
...
... . . .
...
...
0 1 0 1 0 . . . 1 0
0 0 1 0 1 . . . 0 1
0 1 0 1 0 . . . 1 0

and
101
MSPT: Motion Simulator for Proton Therapy
M3HS =

CTRLVU{ (n+3) 0 1 1 0 1 1 0 . . .1 1 0
GATE{ 0 0 0 0 0 0 0 0 . . .0 0 0
CTRLVD{ (n+2) 0 0 0 1 0 0 1 . . .0 0 1
CTRLmax{(n+2-k) 0 0 1 1 1 1 1 . . .1 1 1
C1{ c1 0 0 1 x11 0 1 x21 . . .0 1 xn1
C2{ c2 0 0 1 x12 0 1 x22 . . .0 1 xn2
...
...
Cm{ cm 0 0 1 x1m0 1 x2m. . .0 1 xnm

C
{ { {
x1 x2 . . . xn

Let us now describe the sub-matrix M3HS which is totally independent of MDHV but
which will inherit the repartition of the vertical and horizontal configurations that we just
showed. M3HS is defined as pictured above and where x
j
i = 2 if xj ∈ Ci; xji = 1 otherwise
and ci = 0 if |Ci| = 3; ci = 1 otherwise. The sub-matrix M3HS is designed to encode the
3-Hitting Set instance. In other words, each subset Ci of C is encoded by a row whereas
each element xi of S is encoded by a column. Let us now prove some interesting properties
about this construction.
Let us have a look at the constraints of the unique vertical configuration. Since
CTRLVU [0] is set to (n+ 3) – that is both the maximal number of configurations and in-
tensity. The first column of the vertical configuration will have to irradiate CTRLVU [0] and
so does the corresponding row (i.e., (2n+ 9)th of M) of all the horizontal configurations.
It has many consequences:
• all the 1′s of CTRLVU will have to be irradiated during the vertical configuration.
This yields that no other 1′s in the corresponding columns can be irradiated during
the vertical configuration – namely columns in {3j − 1, 3j|1 ≤ j ≤ n}.
• CTRLVD[0], CTRLmax[0] and any Ci[0] will all only be irradiated by horizontal
configurations2.
Since CTRLVD[0] is set to (n + 2), all the horizontal configurations for this specific row
CTRLVD will need to be dedicated to CTRL
V
D[0]. This implies, that all remaining 1
′s
of CTRLVD – that is {CTRLVD[i]|i = 2 + 3j, 1 ≤ j ≤ n} – would have to be vertically
irradiated. With the exception of the set of bottom leaves for the columns {i = 2+3j|1 ≤
2. For ease, in the above description of M3HS matrix, all the cells which will not have a contribution
from the vertical configuration have been put in gray.
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j ≤ n}, we know exactly what is the endpoint position of each leave (top and bottom) of
the vertical configuration in M3HS:
• for all i ∈ {0, 3j, 3j − 1|1 ≤ j ≤ n} the ith top leave (respectively bottom one)
precisely blocks all the rows preceding (respectively succeeding) CTRLVU .
• column 1 is totally blocked.
• for all i ∈ {3j+1|1 ≤ j ≤ n} the ith top leave precisely blocks all the rows preceding
CTRLVD.
One can observe that any Ci needs at least (n + 3) configurations to be realized. This
implies that any Ci should be irradiated at least in one of its column by the vertical
configuration. By construction, this irradiation can only occur in (xji )
′s positions (i.e.,
{3j + 1|1 ≤ j ≤ n}) moreover set to 2 (otherwise it will not help decreasing the total
irradiation needed to realize Ci) – later referred to as target positions. The CTRL
max
row is designed to ensure that at least n− k cells among {CTRLmax[3j + 1]|1 ≤ j ≤ n}
will be blocked by bottom leaves. In other words, at least n− k bottom leaves will block
all the succeeding rows of CTRLmax. Thus, at most k bottom leaves will be able to
allow vertical irradiation contribution for the target positions. As we just prove, the only
difference between both solutions to the decomposition problem is the position of bottom
leaves endpoints for positions in {3j + 1|1 ≤ j ≤ n}. Thus, we will characterize any such
solution as a set of n positions in [2n + 13, 2n + m + 14] (corresponding to all possible
solutions – 2n+m+ 14 being a leave not used at all).
Given these properties, one can easily prove that (⇐) given a solution (S ′ ⊆ S) to
3-Hitting Set problem, for each 1 ≤ i ≤ n, if xi ∈ S ′, P [i] = 2n+m+ 14; P [i] = 2n+ 13
otherwise. We claim that P corresponds to valid positions for the bottom leaves in
{3j + 1|1 ≤ j ≤ n}. Since S ′ is a Hitting Set of size at most k, we can ensure that at
least one element of each subset in C belongs to S ′. This guarantees that all C ′is rows
and CTRLmax are realized. Moreover, (⇒) considering any solution to the decomposi-
tion problem, one can define the Hitting Set S ′ such that xj ∈ S ′ ⇔ the position of the
(3j + 1)th bottom leaf is strictly greater than 2n+ 13.
Let us now try to transform the construction in order to obtain a binary matrix with
the same property. First, one can encode the x′is using two columns rather than one as
follows. Insert a column just before each actual column representing an xi, fill it with
0′s except on the CTRLVU row which has to be set to 1 and the C
′
js rows where the
corresponding columns have to be set to 0 1 if xi ∈ Cj; 1 1 otherwise. This update
is clearly not changing the original proof. The delicate part stands in the replacement
of CTRLVU [0]. Indeed, it should still requires all the horizontal configurations and the
vertical one. To do so, one can design a sub-matrix of 2(n+ 4) rows defined as follows:
• each odd row is filled with 0′s.
• the ith even row is defined as [0]i−1 1 0[1 0]n+2[0]n+3−i.
In other words, the block representing (n+3) (i.e., [1 0]n+3) is shifted right of one position
every new even row. This ensures that no one under the position of this sub-matrix will
be able to have a vertical contribution. Moreover, in any of the corresponding rows, all
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the remaining 1′s will need to be irradiated vertically. We just showed that the properties
of the original matrix are preserved. Both CTRLVD[0] and CTRL
max[0] can be easily
replaced by resp. [0 1]n+2[0]3n+7 and [0 1]n+2−k[0]3n+7. Again, the properties of the
original matrix are preserved. This concludes the proof of the following theorem.
Theorem 2.3.2. The Matrix Orthogonal Decomposition problem is NP-hard when mini-
mizing either the total setup or the total beam-on time.
Now, let us prove that there exists an algorithm based on linear programming and
rounding techniques that produces an approximate solution for minimizing the total beam-
on time. First, recall that for horizontal configurations, rows can be dealt with separately.
It is also the case for vertical configurations and columns. Indeed, an intensity matrix is
realized by a sequence of MLC configurations each of which is maintained for a certain
amount of time (corresponding to the intensity). Since the problem is to minimize the
sum of intensities and not the number of configurations, one can always consider that
configurations can be changed every unit of time. This implies that any row (column)
can be processed independently of the others and that the overall beam-on time will be
deduced by the (most) expensive row (column). The problem can be phrased, as an
Integer Linear Programming, as defined in Figure 2.4.
minimize H + V
subject to ∀1 ≤ k ≤ m,
∑
i≤j
Hkij ≤ H (2.1)
∀1 ≤ k ≤ m,
∑
i≤j
V kij ≤ V (2.2)
∀k, k′ ∈ {1, . . .m}2,
∑
i≤k′≤j
Hkij +
∑
i′≤k≤j′
V k
′
i′j′ = M [k][k
′] (2.3)
∀i, j, k, Hkij ≥ 0, V kij ≥ 0
1 ≤ i ≤ j ≤ m, 1 ≤ i′ ≤ j′ ≤ m,H ≥ 0, V ≥ 0.
Figure 2.4 – Integer Linear Program minimizing the total beam-on time for MOD
For any row of the intensity matrix M , let Hkij be a variable indicating the amount
of time the following horizontal configuration is maintained: considering the kth pair of
leaves, the left one’s endpoint is at position i−1 and the right one’s endpoint is at position
j + 1. This configuration irradiates any position between i and j in row k. Similarly, for
any column of the intensity matrix M , let V kij be a variable indicating the amount of time
the following vertical configuration is maintained: considering the kth pair of leaves, the
left one’s endpoint is at position i − 1 and the right one’s endpoint is at position j + 1.
This configuration irradiates any position between i and j in column k. Finally, variables
H and V are respectively horizontal and vertical costs of a solution computed respec-
tively as maxk
∑
i≤j H
k
ij and maxk
∑
i≤j V
k
ij (which is encoded by constraints (1) and (2)).
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Constraint (3) ensures that the desired intensity matrix is realized. Indeed,
∑
i≤k′≤j H
k
ij
(respectively
∑
i′≤k≤j′ V
k′
i′j′) represents the overall contribution of all the horizontal (re-
spectively vertical) configurations contributing to the entry M [k][k′]. There are about
2m3 +2 variables, 2n inequalities and n2 equalities. Our linear programming problem can
be rewritten with only inequalities. Indeed, each equality constraint may be removed by
solving it for variable Hk0k′ and substituting this solution into the corresponding form of
constraint (1) (i.e., for the corresponding k).
Of course Integer Linear Programming is NP-hard. Therefore, we relax the integrality
constraint, that is, allowing all variables to take a non-integral but still positive value. We
end-up with a fractional linear program that can be solved in polynomial time. Notice
that the solution provided by this linear program cannot be greater than the optimal
integer one, since we only allow more solutions to become feasible. We apply a rounding
of the fractional solution to obtain an integral feasible solution not too far from optimal.
Assume that fL : {V,H,Hkij, V kij |1 ≤ i ≤ j ≤ m, 1 ≤ k ≤ m} → R is an optimal frac-
tional solution of the relaxed version of our problem. If one slightly modifies the values of
Hkij
′s then due to constraint (3) the values of V k
′
i′j′
′s will need to be modified accordingly
and with a comparable amount. The basic idea is to provide an integral rounding of the
horizontal configurations and compute in polynomial time the corresponding vertical con-
figurations while guaranteeing that the corresponding solution is a good approximation
of the optimal one.
Let us present the rounding technique for a single row – say the kth. Considering
all the corresponding variables {Hkij|1 ≤ i ≤ j ≤ m}, one can represent each non-null
variable Hkij by an interval [i, j] over the real line on [1,m] weighted by H
k
ij. To illustrate
the process we will use the kth row presented in Figure 2.5.
6.6 3.9 10.5 10.5 11.7 15.6 11.7 10.5 7.8 3.9 7.8
Mk
[6, 6]
3.9
[8, 9]
1.2
[5, 7]
[4, 7]
[1, 1]
2.7
[3, 8] [11, 11]
[1, 3]
[1, 9]
[3, 11]
Figure 2.5 – Initial state of the rounding technique: the kth row of the horizontal config-
urations. A segment [x, y] of weight w (in blue) is represented by a line which thickness
corresponds to the weight. For each column, the resulting weight is in red.
Let us transform this set of intervals I into a set I ′, where given any pair of intervals
either one is included into the other or they are disjoint. To do so, we process I with the
following algorithm:
1. While there exists two intervals [i, j] and [k, l] with respective weights w1 and w2
such that i < k < j < l (i.e., crossing) remove [i, j] and [k, l] from I and add
105
MSPT: Motion Simulator for Proton Therapy
[i, k− 1], [k, j] and [j + 1, l] with respective weights w1, w1 +w2 and w2. This aims
at transforming the set of interval into a set where intervals are either nested or
independent. For example, in Figure 2.5, the interval [1, 9] of weight 2.7 and [3, 11]
of weight 3.9: we remove them from the initial set. Then we add 3 intervals (see
Figure 2.6): [1, 2] of weight 2.7, [3, 9] of weight 3.9 + 2.7 = 6.6 and [10, 11] of weight
3.9.
6.6 3.9 10.5 10.5 11.7 15.6 11.7 10.5 7.8 3.9 7.8
Mk
[6, 6] [9, 9]
[5, 7]
[4, 7]
[1, 1]
[4, 7]
[8, 8] [11, 11][3, 3]
[1, 2]
[1, 2]
[3, 9]
6.6
[10, 11]
Figure 2.6 – First step: Transform the original set into a set where intervals are either
nested or independent.
2. Now that all intervals are nested or independent:
• given two copies of an interval [i, j] with respective weights w1 and w2, remove
them and add an interval [i, j] with weight w1 + w2. For example (see Figure
2.7), the intervals [1, 2] of weight w1 and [1, 2] of weight w2 are removed from
the original set and the interval [1, 2] of weight w1 + w2 is added.
[1, 2]
w1
[1, 2]
w2
[1, 2]
w1 + w2
Figure 2.7 – Second step - first possible transformation: copy of an interval. (Left : initial
interval set, right: resulting interval set)
• while there exists three intervals [x, y], [i, j] and [k, l] with respective weights
w1, w2 and w3 such that x ≤ i < j ≤ k < l ≤ y:
– if j < k then remove [x, y] from I and add [x, j] and [j + 1, y] both
weighted by w1.For example (see Figure 2.8), the interval [1, 5] of weight
w1 is removed and the intervals [1, 3] and [4, 5] of weight w1 are added.
[2, 3]
w2
[1, 5]
w1
[4, 5]
w3
[2, 3]
w2
[4, 5]
w3
[1, 3]
w1
[4, 5]
w1
Figure 2.8 – Second step - second possible transformation. (Left : initial interval set,
right: resulting interval set)
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– Otherwise (j = k) remove [i, j] and [k, l] from I. If w2 < w3 then add [i, l]
and [k, l] with respective weights w2 and w3 − w2. Otherwise (w2 ≥ w3)
add [i, l] and [i, j] with respective weights w3 and w2 −w3. For example
(see Figure 2.9), the intervals [3, 4] of weight w3 and [2, 3] of weight w2
are removed and the intervals [3, 4] of weight w3−w2 and [2, 4] of weight
w2 are added.
[2, 3]
w2
[1, 5]
w1
[3, 4]
w3
[3, 4]
w3 − w2
[2, 4]
w2
[1, 5]
w1
Figure 2.9 – Second step - third possible transformation. (Left : initial interval set, right:
resulting interval set)
We end up with a set of independent subsets of nested intervals (later referred to as
a stack) as illustrated in Figure 2.10. Note that there are at most m such stacks. We
will proceed to the rounding of each stack separately. We will do so while ensuring that
the sum of the original weights is smaller than the sum of the rounded ones with a gap
of at most 1. This will induce that for a given row of the horizontal configuration, we
manage to get an integral solution with an at most m extra cost. For ease, considering
the stack as increasingly sorted by interval size and let wi and w
′
i denote respectively the
original and rounded weights of the ith interval of the stack. The rounding algorithm
proceeds as follows: start from the wider interval and round up w1
3. Then consider
iteratively each remaining interval – say the jth, round it down if possible – that is if
bwjc+
∑j−1
i=1 w
′
i ≥
∑j
i=1wi – round it up otherwise.
6.6 3.9 10.5 10.5 11.7 15.6 11.7 10.5 7.8 3.9 7.8
Mk
[6, 6]
[5, 7]
[1, 1] [8, 8] [11, 11]
[1, 2]
3.9 [3, 7]
10.5 [8, 9]
7.8
[10, 11]
Figure 2.10 – Set of stacks delimited by red dotted lines.
Let us proceed to the rounding of the stacks in Figure 2.10:
• 1st stack:
1. Round up [1, 2]: 3.9⇒ 4 (since it’s the first stack interval).
2. Round up [1, 1]: 2.7⇒ 3 (since (2 + 4) < (2.7 + 3.9)).
• 2nd stack:
3. One cannot do differently since there exists at least one position not covered by another interval.
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1. Round up [3, 7]: 10.5⇒ 11
2. Round down [5, 7]: 1.2⇒ 1 (since (1 + 11) ≥ (1.2 + 10.5)).
3. Round up [6, 6]: 3.9⇒ 4
• 3rd stack:
1. Round up [8, 9]: 7.8⇒ 8
2. Round up [8, 8]: 2.7⇒ 3
• 4th stack:
1. Round up [10, 11]: 3.9⇒ 4
2. Round up [11, 11]: 3.9⇒ 4
Finally, we obtain the following rounded solution for the kth row: see Figure 2.11.
7 4 11 11 12 16 12 11 8 4 8
Mk
[6, 6]
4
[5, 7]
1
[1, 1]
3
[8, 8]
3
[11, 11]
4
[1, 2]
4 [3, 7]
11 [8, 9]
8
[10, 11]
4
Figure 2.11 – Resulting rounded solution.
Applying the rounding to each row of the horizontal configurations leads to an integral
solution for the horizontal configurations that we can subtract for the original intensity
matrix. Then, we compute in polynomial time the vertical configurations on the result-
ing matrix. We claim that the overall solution is at most 2m from the optimal solution.
Indeed, in the resulting matrix, each cell is at most greater by one than the fractional
matrix. This means that the sum of the elements in any column is at most greater by m
than the fractional matrix. Thus, we loose at most m with the rounding of the horizontal
configurations plus at most m for adjusting the vertical configurations, for a total of a 2m
additional cost.
This approximation algorithm could yield new interests in the use of rotating MLCs
in order to reduce the duration of the patient irradiation and the unnecessary dose to
preserve healthy tissues.
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Conclusion
The primary goal of this thesis was to improve the robustness to motion of proton
therapy treatments using the spot scanning technique. Due to the limited availability
of 4D treatment planning system to simulate these treatments we developed MSPT, an
open-source software able to perform a 4D simulation of the treatment delivery while
considering patient motions during the delivery (i.e., intra-fraction motions).
A series of tests was performed to evaluate MSPT’s dose calculation. A first set simu-
lating the delivery of single proton beams of energies varying between 30 MeV and 230
MeV with a step of 5 MeV in a volume of water showed an excellent agreement with the
corresponding dose distributions simulated with the beam model ProtonMachine from the
commercial software RayStation (RaySearch Laboratories). In a second set we simulated
the delivery of treatments planned for patient cases. The dose distributions obtained in
MSPT and in ProtonMachine were coherent, however a systemic artifact was observed in
MSPT’s calculation. This artifact results in higher dose on the distal border of the tumor
and a lower dose after the tumor. The cause of this artifact was investigated but couldn’t
be found. The main assumption is that it is linked to the radiological depth calculation.
Therefore, MSPT couldn’t be used to perform comparison with dose distributions obtained
from a treatment planning system in order to study intra-fraction motions. Such motions
must be studied between simulations performed in MSPT.
We proposed a new strategy to reduce the impact of motion on the dose distribution
in the patient body due to intra-fraction motions. This strategy aims at compensating
the motion by an adaptation of pencil beam weights used in the treatment based on pa-
tient motions and by several re-scanning of each energy layer. We also added a feature
to add beam new beam positions with a weight null. This ensures a larger number of
beam positions that can be used for the compensation. These new positions are called
margin. Moreover, the compensation strategy relies on the assumption that the patient
position is obtained during the delivery via a motion monitoring system. The accuracy of
the monitoring system can be modified for the simulation but is not taken into account
in the mitigation technique.
To show some interests and limitations of our motion compensation strategy we per-
formed a series of tests. A first set of simulations aimed at showing the difference between
the dose distribution for a static patient and a dynamic patient being treated with and
without the compensation technique for a moderate and a large motion amplitude. These
simulations showed that for both motion amplitudes the impact of motion was greatly
110
MSPT: Motion Simulator for Proton Therapy
reduced and provided a dose distribution close to the static situation and clinically accept-
able. The accuracy of the compensated dose distribution relies on the spatial parameters
controlling whether the compensation is possible or not for a specific beam position. The
larger these parameters are the larger the errors are. A second set of simulations was per-
formed to compare compensated deliveries with and without margin. These simulations
showed that dose distributions are comparable with and without a margin. However, we
showed that the use of a margin allows reducing greatly the number of re-scanning per
energy layer but increases the number of beam shifts. This greater number of transi-
tion results in a longer delivery. Therefore, a margin could be used when the number
of repainting must be controlled and must be minimized. A last set of simulations was
achieved to evaluate the impact of the accuracy of the motion monitoring system on the
compensation strategy. These last experiments revealed that the accuracy of the motion
monitoring system plays an important role in the quality of the resulting dose distribution
and that the standard deviation of the measurement error should be less than 3 mm.
MSPT and the compensation technique provide new possibilities and a new approach
both for the study of intra-fraction and the improvement of the treatment robustness to
these motions.
A secondary study focused on the study of new technologies of MLCs for the delivery
of photon therapy treatments from an algorithmic point of view. The underlying problem
is to find a set of MLC configurations achieving the treatment, which minimizes the total
setup time (i.e., minimize the number of configuration), and which minimizes the total
beam-on time (i.e., minimize the sum of intensities used for the configurations). The new
MLCs are namely the rotating MLC and the dual-layer MLC. These new variants were
conjectured to increase the complexity of the minimization problems. However, to the
best of our knowledge, this has not been demonstrated. We proved the hardness of the de-
composition for these MLCs. In addition, we proposed a polynomial time approximation
algorithm to obtain a decomposition, of the rotating MLC, minimizing the total beam-on
time.
111
Future work
Throughout the development of MSPT we simulated the patient motions with rigid
body transformations. Motions such as breathing are not applied to the entire body in a
same way. For example, upper regions of the lungs tend to move less than lower regions.
The use of deformable transformations could provide more accurate simulations and more
accurate dose distributions. Moreover, other MSPT improvements could be achieved such
as the capability of loading 4D CT dataset that could be used both for the patient and
motion modeling. This feature could bring more interest to MSPT and would facilitate
simulations of real patient cases.
In Part II Section 4.2.2, we showed the MSPT systemic artifact that tends to overdose
the border of the tumor when comparing the dose distributions obtained from the TPS,
which computed the treatment plan MSPT uses, and the one computed in MSPT. Despite
an investigation, the exact cause was not found and we assume it to be related to the ra-
diological depth calculation in the patient. Therefore, if one were to use MSPT to compare
the dose distributions computed by our software and by a TPS, a deeper investigation
would be necessary.
As previously mentioned, MSPT could be improved with motions relying on deformable
transformations. If such transformation was implemented, the compensation technique
could be evaluated which could lead to new improvements of the strategy. Moreover, ex-
tending the strategy to 3D motions and taking into account the radiological depth would
allow a more general application of our approach.
Finally, further algorithmic research on the non-conventional MLCs could be led to
try to find efficient decomposition methods for the problems that are not solvable with
the approximation algorithm proposed. In addition, if such algorithm were found, their
application could be the topic of other studies to measure the improvements brought by
these MLCs combined with these algorithms.
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